BPG is committed to discovery and dissemination of knowledge
Cited by in CrossRef
Number Cited Articles
1
Adrian M. Di Bisceglie, Anne M. Stoddard, Jules L. Dienstag, Mitchell L. Shiffman, Leonard B. Seeff, Herbert L. Bonkovsky, Chihiro Morishima, Elizabeth C. Wright, Kristin K. Snow, William M. Lee, Robert J. Fontana, Timothy R. Morgan, Marc G. Ghany. Excess mortality in patients with advanced chronic hepatitis C treated with long-term peginterferonHepatology 2011; 53(4): 1100 doi: 10.1002/hep.24169
2
Julie Blaising, Eve-Isabelle Pécheur. Lipids ‒ A key for hepatitis C virus entry and a potential target for antiviral strategiesBiochimie 2013; 95(1): 96 doi: 10.1016/j.biochi.2012.07.016
3
Partha K. Chandra, Lili Bao, Kyoungsub Song, Fatma M. Aboulnasr, Darren P. Baker, Nathan Shores, William C. Wimley, Shuanghu Liu, Curt H. Hagedorn, Serge Y. Fuchs, Tong Wu, Luis A. Balart, Srikanta Dash. HCV Infection Selectively Impairs Type I but Not Type III IFN SignalingThe American Journal of Pathology 2014; 184(1): 214 doi: 10.1016/j.ajpath.2013.10.005
4
James N. Laditka, Sarah B. Laditka, Janice C. Probst. Health care access in rural areas: Evidence that hospitalization for ambulatory care-sensitive conditions in the United States may increase with the level of ruralityHealth & Place 2009; 15(3): 761 doi: 10.1016/j.healthplace.2008.12.007
5
P. Skums, D. S. Campo, Z. Dimitrova, G. Vaughan, D. T. Lau, Y. Khudyakov. Modelling differential interferon resistance of HCV quasispecies2011 IEEE International Conference on Bioinformatics and Biomedicine Workshops (BIBMW) 2011; : 144 doi: 10.1109/BIBMW.2011.6112367
6
Hui-Chun Li, Shih-Yen Lo. Hepatitis C virus: Virology, diagnosis and treatmentWorld Journal of Hepatology 2015; 7(10): 1377-1389 doi: 10.4254/wjh.v7.i10.1377
7
Stephanie Jiménez Irausquin, Austin L. Hughes. Conflicting selection pressures target the NS3 protein in hepatitis C virus genotypes 1a and 1bVirus Research 2010; 147(2): 202 doi: 10.1016/j.virusres.2009.11.001
8
Mohamed A. Daw, Aghnaya A. Dau. Hepatitis C Virus in Arab World: A State of ConcernThe Scientific World Journal 2012; 2012: 1 doi: 10.1100/2012/719494
9
Jianquan Li, Ke Men, Yali Yang, Duan Li. Dynamical analysis on a chronic hepatitis C virus infection model with immune responseJournal of Theoretical Biology 2015; 365: 337 doi: 10.1016/j.jtbi.2014.10.039
10
Alexandra Wimmer, János Fehér, Gabriella Lengyel. Successful clearing of hepatitis C virus after liver lobectomy in a patient with hepatocellular carcinomaOrvosi Hetilap 2008; 149(45): 2143 doi: 10.1556/oh.2008.28489
11
Laura Waley, Laura McManus. Tackling Students’ Attitudes Towards Substance Use DisordersAcademic Psychiatry 2017; 41(4): 567 doi: 10.1007/s40596-017-0747-8
12
Nabeen C. Nayak. Cirrhosis and end-stage chronic liver disease: The changing scenes on etiopathogenesisCurrent Medicine Research and Practice 2014; 4(2): 62 doi: 10.1016/j.cmrp.2014.03.003
13
Winifred Nyinoh Iveren. Genotypic variation, demographic characteristics and risk factors of hepatitis C virus in ScotlandJournal of Public Health and Epidemiology 2018; 10(7): 241 doi: 10.5897/JPHE2018.1031
14
Noah Hoffman, Misha Roshal. Lennette's Laboratory Diagnosis of Viral InfectionsInfectious Disease and Therapy 2010; : 59 doi: 10.3109/9781420084962.005
15
D. Silver, G. Karnik, A. Osinusi, R. Silk, L. Stabinski, L. Doonquah, S. Henn, G. Teferi, H. Masur, S. Kottilil, D. Fishbein. Effect of HIV on Liver Fibrosis Among HCV-Infected African AmericansClinical Infectious Diseases 2013; 56(9): 1280 doi: 10.1093/cid/cit037
16
R. Bahsi, Z. Dogan, N. Taser, M. N. Aktas, L. Filik. Acute cor pulmonale: an unusual presentation of hepatocellular carcinomaActa Clinica Belgica 2015; 70(1): 76 doi: 10.1179/2295333714Y.0000000071
17
Anne Frentzen, Kathrin Hüging, Julia Bitzegeio, Martina Friesland, Sibylle Haid, Juliane Gentzsch, Markus Hoffmann, Dirk Lindemann, Gert Zimmer, Florian Zielecki, Friedemann Weber, Eike Steinmann, Thomas Pietschmann, Charles M. Rice. Completion of Hepatitis C Virus Replication Cycle in Heterokaryons Excludes Dominant Restrictions in Human Non-liver and Mouse Liver Cell LinesPLoS Pathogens 2011; 7(4): e1002029 doi: 10.1371/journal.ppat.1002029
18
Noha Gamal Bader El Din, Ghada M. Salum, Mohamed A. Anany, Marwa Khalil Ibrahim, Reham Mohamed Dawood, Naglaa Zayed, Yasmine S. El Abd, Reem El-Shenawy, Mostafa K. El Awady. Association of Myxovirus Resistance Gene Promoter Polymorphism with Response to Combined Interferon Treatment and Progression of Liver Disease in Chronic HCV Egyptian PatientsJournal of Interferon & Cytokine Research 2015; 35(8): 641 doi: 10.1089/jir.2014.0137
19
Aaditya Bhatt, K.R. Gurukumar, Amartya Basu, Maulik R. Patel, Neerja Kaushik-Basu, Tanaji T. Talele. Synthesis and SAR optimization of diketo acid pharmacophore for HCV NS5B polymerase inhibitionEuropean Journal of Medicinal Chemistry 2011; 46(10): 5138 doi: 10.1016/j.ejmech.2011.08.028
20
Lyuba Azbel, Jeffrey A. Wickersham, Yevgeny Grishaev, Sergey Dvoryak, Frederick L. Altice, Joan A. Caylà. Burden of Infectious Diseases, Substance Use Disorders, and Mental Illness among Ukrainian Prisoners Transitioning to the CommunityPLoS ONE 2013; 8(3): e59643 doi: 10.1371/journal.pone.0059643
21
Caleb Kesse Firempong, Hui Yun Zhang, Yan Wang, Jingjing Chen, Xia Cao, Wenwen Deng, Jie Zhou, Qiang Wang, Shan-Shan Tong, Jiangnan Yu, Ximing Xu. Segetoside I, a plant-derived bisdesmosidic saponin, induces apoptosis in human hepatoma cells in vitro and inhibits tumor growth in vivoPharmacological Research 2016; 110: 101 doi: 10.1016/j.phrs.2016.04.032
22
Hiam Chemaitelly, Sarwat Mahmud, Ahmad Masoud Rahmani, Laith J. Abu-Raddad. The epidemiology of hepatitis C virus in Afghanistan: systematic review and meta-analysisInternational Journal of Infectious Diseases 2015; 40: 54 doi: 10.1016/j.ijid.2015.09.011
23
Amedeo Lonardo, Luigi Elio Adinolfi, Salvatore Petta, Antonio Craxì, Paola Loria. Hepatitis C and diabetes: the inevitable coincidence?Expert Review of Anti-infective Therapy 2009; 7(3): 293 doi: 10.1586/eri.09.3
24
Janaina Cristiana de Oliveira Crispim, Tarsia Giabardo Alves Silva, Francisco José Dutra Souto, Fernanda Fernandes Souza, Carmen Lucia Bassi, Christiane Pienna Soares, Sérgio Zucoloto, Philippe Moreau, Ana de Lourdes Candolo Martinelli, Eduardo Antonio Donadi. Upregulation of soluble and membrane-bound human leukocyte antigen G expression is primarily observed in the milder histopathological stages of chronic hepatitis C virus infectionHuman Immunology 2012; 73(3): 258 doi: 10.1016/j.humimm.2011.12.004
25
E. Papasavvas, L. Azzoni, X. Yin, Q. Liu, J. Joseph, A. Mackiewicz, B. Ross, K. M. Lynn, J. M. Jacobson, K. Mounzer, J. R. Kostman, L. J. Montaner. HCV viraemia associates with NK cell activation and dysfunction in antiretroviral therapy-treated HIV/HCV-co-infected subjectsJournal of Viral Hepatitis 2017; 24(10): 865 doi: 10.1111/jvh.12714
26
M. F. Bassendine, D. A. Sheridan, S. H. Bridge, D. J. Felmlee, R. D. G. Neely. Lipids and HCVSeminars in Immunopathology 2013; 35(1): 87 doi: 10.1007/s00281-012-0356-2
27
Jiaren Sun, Gaurav Chaturvedi, Steven A. Weinman. Molecular Pathology of Liver DiseasesMolecular Pathology Library 2011; 5: 569 doi: 10.1007/978-1-4419-7107-4_38
28
Jama M. Darling, Stanley M. Lemon, Michael W. Fried. Schiff's Diseases of the Liver2011; : 582 doi: 10.1002/9781119950509.ch25
29
A.C.G. Jardim, Z. Igloi, J.F. Shimizu, V.A.F.F.M. Santos, L.G. Felippe, B.F. Mazzeu, Y. Amako, M. Furlan, M. Harris, P. Rahal. Natural compounds isolated from Brazilian plants are potent inhibitors of hepatitis C virus replication in vitroAntiviral Research 2015; 115: 39 doi: 10.1016/j.antiviral.2014.12.018
30
Chunfu Wang, Haichang Huang, Lourdes Valera, Jin-Hua Sun, Donald R. O'Boyle, Peter T. Nower, Lingling Jia, Dike Qiu, Xin Huang, Aneela Altaf, Min Gao, Robert A. Fridell. Hepatitis C Virus RNA Elimination and Development of Resistance in Replicon Cells Treated with BMS-790052Antimicrobial Agents and Chemotherapy 2012; 56(3): 1350 doi: 10.1128/AAC.05977-11
31
Ashraf Elbahrawy, Ahmed Elwassief, Abdallah Mahmoud Abdallah, Arafat Kasem, Sadek Mostafa, Khaled Makboul, Mohamed Salah Ali, Ahmed Alashker, Ahmed Maher Eliwa, Hossam Shahbah, Mohamed Abdellah Othman, Mohamed Hanafy Morsy, Mohamed Ali Abdelbaseer, Hafez Abdelhafeez. Hepatitis C virus exposure rate among health-care workers in rural Lower Egypt governoratesJournal of Translational Internal Medicine 2017; 5(3): 164 doi: 10.1515/jtim-2017-0024
32
Tim J Benstead, Colin H Chalk, Natalie E Parks, Tim J Benstead. Cochrane Database of Systematic Reviews2013;  doi: 10.1002/14651858.CD010404
33
Jessica Taaffe, David Wilson. Mobilising a global response to hepatitis: Lessons learned from the HIV movementGlobal Public Health 2018; 13(4): 473 doi: 10.1080/17441692.2016.1233989
34
Alejandro Escobar-Gutiérrez, Hugo Soudeyns, Ariane Larouche, Juan Carlos Carpio-Pedroza, Armando Martinez-Guarneros, Carlos A. Vazquez-Chacon, Salvador Fonseca-Coronado, Lilian H.T. Yamasaki, Karina Ruiz-Tovar, Mayra Cruz-Rivera. Vertical transmission of hepatitis C virus: A tale of multiple outcomesInfection, Genetics and Evolution 2013; 20: 465 doi: 10.1016/j.meegid.2013.10.005
35
Mitchell L. Shiffman, Nadege T. Gunn. Management and Treatment of Chronic HBV and HCV Co-Infection and the Impact of Anti-Viral TherapyCurrent Hepatology Reports 2017; 16(3): 169 doi: 10.1007/s11901-017-0352-z
36
Jennifer E. Layden, Richard O. Phillips, Shirley Owusu-Ofori, Fred Stephen Sarfo, Stephanie Kliethermes, Nallely Mora, Dorcas Owusu, Kenrad Nelson, Ohene Opare-Sem, Lara Dugas, Amy Luke, David Shoham, Joseph C. Forbi, Yury E. Khudyakov, Richard S. Cooper. High Frequency of Active HCV Infection Among Seropositive Cases in West Africa and Evidence for Multiple Transmission PathwaysClinical Infectious Diseases 2015; 60(7): 1033 doi: 10.1093/cid/ciu965
37
Evangelos Cholongitas, Chrysoula Pipili, George Papatheodoridis. Interferon-free regimens for the treatment of hepatitis C virus in liver transplant candidates or recipientsWorld Journal of Gastroenterology 2015; 21(32): 9526-9533 doi: 10.3748/wjg.v21.i32.9526
38
Hirofumi Akari, Yuki Iwasaki, Tomoyuki Yoshida, Sayuki Iijima. Non-human primate surrogate model of hepatitis C virus infectionMicrobiology and Immunology 2009; 53(1): 53 doi: 10.1111/j.1348-0421.2008.00087.x
39
N. Palmateer, S. Hutchinson, G. McAllister, A. Munro, S. Cameron, D. Goldberg, A. Taylor. Risk of transmission associated with sharing drug injecting paraphernalia: analysis of recent hepatitis C virus (HCV) infection using cross-sectional survey dataJournal of Viral Hepatitis 2014; 21(1): 25 doi: 10.1111/jvh.12117
40
Sergio Abrignani, Eva Reali, Michael Houghton, Raffaele De Francesco. Vaccines2013; : 1074 doi: 10.1016/B978-1-4557-0090-5.00051-3
41
Kazeem Oare Okosun, Oluwole Daniel Makinde. Optimal control analysis of hepatitis C virus with acute and chronic stages in the presence of treatment and infected immigrantsInternational Journal of Biomathematics 2014; 7(02): 1450019 doi: 10.1142/S1793524514500193
42
Irene Vafiadis, Panagiotis Trilianos, Jiannis Vlachogiannakos, Markisia Karagiorga, Antonia Hatziliami, Ersi Voskaridou, Spiros D. Ladas. Efficacy and safety of interferon-based therapy in the treatment of adult thalassemic patients with chronic hepatitis C: a 12 years auditAnnals of Hepatology 2013; 12(4): 364 doi: 10.1016/S1665-2681(19)31336-5
43
Shaimaa B. Abdelaziz, Yasmine S. Galal, Amal S. Sedrak, Dina S. Shaheen. Association of Hepatitis C Virus Infection and Type 2 Diabetes in Egypt: A Hospital-Based StudyJournal of Diabetes Mellitus 2016; 6(01): 77 doi: 10.4236/jdm.2016.61009
44
Poupak Fallahi, Silvia Martina Ferrari, Roberto Vita, Salvatore Benvenga, Alessandro Antonelli. The role of human parvovirus B19 and hepatitis C virus in the development of thyroid disordersReviews in Endocrine and Metabolic Disorders 2016; 17(4): 529 doi: 10.1007/s11154-016-9361-4
45
Yong-Yuan Zhang, Bai-Hua Zhang, Koji Ishii, T. Jake Liang. Novel Function of CD81 in Controlling Hepatitis C Virus ReplicationJournal of Virology 2010; 84(7): 3396 doi: 10.1128/JVI.02391-09
46
Lynn B. Dustin. HCV Infection and Cryoglobulinemia2012; : 21 doi: 10.1007/978-88-470-1705-4_3
47
Diego F. Cuadros, Adam J. Branscum, F. DeWolfe Miller, Laith J. Abu-Raddad. Spatial epidemiology of hepatitis C virus infection in Egypt: Analyses and implicationsHepatology 2014; 60(4): 1150 doi: 10.1002/hep.27248
48
Garrick K. Wilson, Zania Stamataki. In Vitro Systems for the Study of Hepatitis C Virus InfectionInternational Journal of Hepatology 2012; 2012: 1 doi: 10.1155/2012/292591
49
Alina M. Allen, W. Ray Kim, James P. Moriarty, Nilay D. Shah, Joseph J. Larson, Patrick S. Kamath. Time trends in the health care burden and mortality of acute on chronic liver failure in the United StatesHepatology 2016; 64(6): 2165 doi: 10.1002/hep.28812
50
Julie Bruneau, Élise Roy, Nelson Arruda, Geng Zang, Didier Jutras-Aswad. The rising prevalence of prescription opioid injection and its association with hepatitis C incidence among street-drug usersAddiction 2012; 107(7): 1318 doi: 10.1111/j.1360-0443.2012.03803.x
51
Jing-Hong Hu, Mei-Yen Chen, Chau-Ting Yeh, Wen-Nan Chiu, Ming-shih Chiang, Ming-Ling Chang. Effects of gender and age on prevalence of cholelithiasis in patients with chronic HCV infectionMedicine 2018; 97(22): e10846 doi: 10.1097/MD.0000000000010846
52
Marinus van Hulst, Cees Th. Smit Sibinga, Maarten J. Postma. Health economics of blood transfusion safety – focus on sub-Saharan AfricaBiologicals 2010; 38(1): 53 doi: 10.1016/j.biologicals.2009.10.006
53
Xianfeng Li, Yang Liu, Yong-Kang Zhang, Jacob J. Plattner, Stephen J. Baker, Wei Bu, Liang Liu, Yasheen Zhou, Charles Z. Ding, Suoming Zhang, Wieslaw M. Kazmierski, Robert Hamatake, Maosheng Duan, Lois L. Wright, Gary K. Smith, Richard L. Jarvest, Jing-Jing Ji, Joel P. Cooper, Matthew D. Tallant, Renae M. Crosby, Katrina Creech, Amy Wang. Synthesis and antiviral activity of novel HCV NS3 protease inhibitors with P4 capping groupsBioorganic & Medicinal Chemistry Letters 2012; 22(24): 7351 doi: 10.1016/j.bmcl.2012.10.075
54
Maiko Sakamoto, Steven Paul Woods, Michael Kolessar, Daniel Kriz, J. Renee Anderson, Hannah Olavarria, Anna W. Sasaki, Michael Chang, Kenneth D. Flora, Jennifer M. Loftis, Marilyn Huckans. Protective effects of higher cognitive reserve for neuropsychological and daily functioning among individuals infected with hepatitis CJournal of NeuroVirology 2013; 19(5): 442 doi: 10.1007/s13365-013-0196-4
55
Cara S. Kosack, Sigrid Nick, Leslie Shanks. Diagnostic accuracy evaluation of the ImmunoFlow HCV rapid immunochromatographic test for the detection of hepatitis C antibodiesJournal of Virological Methods 2014; 204: 6 doi: 10.1016/j.jviromet.2014.03.012
56
Christine Meffre, Yann Le Strat, Elisabeth Delarocque-Astagneau, Fréderic Dubois, Denise Antona, Jean-Marie Lemasson, Josiane Warszawski, Josiane Steinmetz, Dominique Coste, Jean-François Meyer, Sandrine Leiser, Jean-Pierre Giordanella, René Gueguen, Jean-Claude Desenclos. Prevalence of hepatitis B and hepatitis C virus infections in France in 2004: Social factors are important predictors after adjusting for known risk factorsJournal of Medical Virology 2010; 82(4): 546 doi: 10.1002/jmv.21734
57
Sergio Cortelazzo, Andrés Ferreri, Dieter Hoelzer, Maurilio Ponzoni. Lymphoblastic lymphomaCritical Reviews in Oncology/Hematology 2017; 113: 304 doi: 10.1016/j.critrevonc.2017.03.020
58
Tatiana Martins, Janaína Luz Narciso-Schiavon, Leonardo de Lucca Schiavon. Epidemiologia da infecção pelo vírus da hepatite CRevista da Associação Médica Brasileira 2011; 57(1): 107 doi: 10.1590/S0104-42302011000100024
59
Mitchell L Shiffman, Yves Benhamou. Cure of HCV related liver diseaseLiver International 2015; 35: 71 doi: 10.1111/liv.12734
60
Camila Rodrigues Bressane Cruz, Miriam Matsura Shirassu, Wellington P. Martins. Comparação do perfil epidemiológico das hepatites B e C em um serviço público de São PauloArquivos de Gastroenterologia 2009; 46(3): 225 doi: 10.1590/S0004-28032009000300016
61
Tatsuya Aikawa, Maki Kojima, Kuniko Miyamoto, Chisato Ueno, Masaharu Takahashi, Hiroaki Okamoto. A case of acute hepatitis C, most likely by interspousal sexual transmission after 40 years of marriageKanzo 2008; 49(8): 352 doi: 10.2957/kanzo.49.352
62
Shih-Yi Lin, Cheng-Li Lin, Shu-Woei Ju, I-Kuan Wang, Cheng-Chieh Lin, Chih-Hsueh Lin, Wu-Huei Hsu, Ji-An Liang, Tatsuo Kanda. Increasing risk of cataract in HCV patients receiving anti-HCV therapy: A nationwide cohort studyPLOS ONE 2017; 12(3): e0173125 doi: 10.1371/journal.pone.0173125
63
Muhammad Ali, Irshad Ur Rehman, Muhammad Idrees. Emergence of genetically variant Hepatitis C virus population in response to increased antiviral drug pressure, PakistanVirus Genes 2014; 48(3): 543 doi: 10.1007/s11262-014-1047-y
64
Mohamed Abo El-Asrar, Nancy Samir Elbarbary, Eman Abdel Rahman Ismail, Ahmed Mohamed Elshenity. Serum YKL-40 in young patients with β-thalassemia major: Relation to hepatitis C virus infection, liver stiffness by transient elastography and cardiovascular complicationsBlood Cells, Molecules, and Diseases 2016; 56(1): 1 doi: 10.1016/j.bcmd.2015.09.006
65
Don C Des Jarlais, Jonathan P Feelemyer, Shilpa N Modi, Abu Abdul-Quader, Holly Hagan. High coverage needle/syringe programs for people who inject drugs in low and middle income countries: a systematic reviewBMC Public Health 2013; 13(1) doi: 10.1186/1471-2458-13-53
66
Fawad Karim, Abu Nasar, Ibrar Alam, Iftikhar Alam, Said Hassan, Rahmat Gul, Sana Ullah, Muhammad Rizwan. Incidence of Active HCV infection amongst Blood Donors of Mardan District, PakistanAsian Pacific Journal of Cancer Prevention 2016; 17(1): 235 doi: 10.7314/APJCP.2016.17.1.235
67
Ching-Chih Hu, Chih-Lang Lin, Liang-Che Chang, Cheng-Hung Chien, Li-Wei Chen, Ching-Jung Liu, Rong-Nan Chien. Interleukin-28B gene non-TT allele strongly predicts treatment failure for genotype 1 infected chronic hepatitis C patients with advanced fibrosis: a case control studyBMC Infectious Diseases 2015; 15(1) doi: 10.1186/s12879-015-0888-x
68
David Goldberg, Ivo C. Ditah, Kia Saeian, Mona Lalehzari, Andrew Aronsohn, Emmanuel C. Gorospe, Michael Charlton. Changes in the Prevalence of Hepatitis C Virus Infection, Nonalcoholic Steatohepatitis, and Alcoholic Liver Disease Among Patients With Cirrhosis or Liver Failure on the Waitlist for Liver TransplantationGastroenterology 2017; 152(5): 1090 doi: 10.1053/j.gastro.2017.01.003
69
F. D. Miller, L. J. Abu-Raddad. Evidence of intense ongoing endemic transmission of hepatitis C virus in EgyptProceedings of the National Academy of Sciences 2010; 107(33): 14757 doi: 10.1073/pnas.1008877107
70
Amira Mohsen, Adeline Bernier, Lenaig LeFouler, Elisabeth Delarocque-Astagneau, Mai El-Daly, Sherif El-Kafrawy, Salwa El-Mango, Mohamed Abdel-Hamid, Mohsen Gadallah, Gamal Esmat, Mostafa K. Mohamed, Arnaud Fontanet. Hepatitis C virus acquisition among Egyptians: analysis of a 10-year surveillance of acute hepatitis CTropical Medicine & International Health 2015; 20(1): 89 doi: 10.1111/tmi.12410
71
M. Castells, G. Bello, S. Ifrán, S. Pereyra, S. Boschi, R. Uriarte, J. Cristina, R. Colina. Epidemic history of major genotypes of hepatitis C virus in UruguayInfection, Genetics and Evolution 2015; 32: 231 doi: 10.1016/j.meegid.2015.03.021
72
Eslam Saber Esmail, Fat-heyah Elsayed Asal, Mohammed Yussif, Asem Ahmed Elfert. Low dose ribavirin has been effective in the treatment of incapacitating muco-cutaneous extrahepatic manifestations in patients with hepatitis C with contraindication or no access for approved antiviral treatmentArab Journal of Gastroenterology 2015; 16(3-4): 125 doi: 10.1016/j.ajg.2015.09.012
73
Abdallah M. AlQaraawi, Faisal M. Sanai, Hussa Al-Husseini, Ali Albenmousa, Abdulmalik AlSheikh, Lubna Rizwan Ahmed, Ahmad Hersi, Molfi M. Al-Otaibi, Mohammed Syed, Safiyya M. Ali, Waleed Al-hamoudi, Khalid A. Alswat, Ayman A. Abdo. Prevalence and Impact of Hepatic Steatosis on the Response to Antiviral Therapy in Saudi Patients with Genotypes 1 and 4 Chronic Hepatitis CDigestive Diseases and Sciences 2011; 56(4): 1222 doi: 10.1007/s10620-010-1417-9
74
Zeze Th. Atwa, Wafaa Y. Abdel Wahed. Transfusion transmitted infections in frequently transfused thalassemic children living in Fayoum Governorate, Egypt: Current prevalence and risk factorsJournal of Infection and Public Health 2017; 10(6): 870 doi: 10.1016/j.jiph.2017.02.012
75
Carrie Reed, Caleb Bliss, Sherri O. Stuver, Timothy Heeren, Sheila Tumilty, C. Robert Horsburgh, Jeffrey H. Samet, Deborah J. Cotton. Predictors of Active Injection Drug Use in a Cohort of Patients Infected With Hepatitis C VirusAmerican Journal of Public Health 2013; 103(1): 105 doi: 10.2105/AJPH.2012.300819
76
Sofia Lourenço, Sébastien Boni, Denis Furling, François-Loïc Cosset, Annie Cahour. A cell-based bicistronic lentiviral reporter system for identification of inhibitors of the hepatitis C virus internal ribosome entry siteJournal of Virological Methods 2009; 158(1-2): 152 doi: 10.1016/j.jviromet.2009.02.007
77
Adela Paez Jimenez, Mostafa K. Mohamed, Noha Sharaf Eldin, Hasnaa Abou Seif, Said El Aidi, Yehia Sultan, Nasr Elsaid, Claire Rekacewicz, Mostafa El-Hoseiny, May El-Daly, Mohamed Abdel-Hamid, Arnaud Fontanet, Matthew Baylis. Injection Drug Use Is a Risk Factor for HCV Infection in Urban EgyptPLoS ONE 2009; 4(9): e7193 doi: 10.1371/journal.pone.0007193
78
Naoki Ogura, Yukiyo Toyonaga, Izuru Ando, Kunihiro Hirahara, Tsutomu Shibata, Gabriela Turcanu, Sudhakar Pai, Kan Yee, Barbara Gerhardt, Maribel Rodriguez-Torres, Toru Noguchi. Genotypic and Phenotypic Analyses of Hepatitis C Virus from Patients Treated with JTK-853 in a Three-Day MonotherapyAntimicrobial Agents and Chemotherapy 2013; 57(1): 436 doi: 10.1128/AAC.01432-12
79
Eric Tatara, Nicholson T. Collier, Jonathan Ozik, Alexander Gutfraind, Scott J. Cotler, Harel Dahari, Marian Major, Basmattee Boodram. Multi-Objective Model Exploration of Hepatitis C Elimination in an Agent-Based Model of People who Inject Drugs2019 Winter Simulation Conference (WSC) 2019; : 1008 doi: 10.1109/WSC40007.2019.9004747
80
Clarice Souza Pinto, Regina Maria Bringel Martins, Sonia Maria Oliveira de Andrade, Alcione Cavalheiro Faro Stief, Roberto Dias de Oliveira, Ana Rita Coimbra Motta de Castro. Infecção pelo vírus da hepatite C em gestantes em Mato Grosso do Sul, 2005-2007Revista de Saúde Pública 2011; 45(5): 974 doi: 10.1590/S0034-89102011005000053
81
Min Zhong, Eric Peng, Ningwu Huang, Qi Huang, Anja Huq, Meiyen Lau, Richard Colonno, Leping Li. Potent bisimidazole-based HCV NS5A inhibitors bearing annulated tricyclic motifsBioorganic & Medicinal Chemistry Letters 2014; 24(24): 5738 doi: 10.1016/j.bmcl.2014.10.056
82
Paul Targett-Adams, Steeve Boulant, Mark W. Douglas, John McLauchlan. Lipid Metabolism and HCV InfectionViruses 2010; 2(5): 1195 doi: 10.3390/v2051195
83
Zobair Younossi, Georgios Papatheodoridis, Patrice Cacoub, Francesco Negro, Heiner Wedemeyer, Linda Henry, Angelos Hatzakis. The comprehensive outcomes of hepatitis C virus infection: A multi-faceted chronic diseaseJournal of Viral Hepatitis 2018; 25: 6 doi: 10.1111/jvh.13005
84
Izuru Ando, Tsuyoshi Adachi, Naoki Ogura, Yukiyo Toyonaga, Kazuyuki Sugimoto, Hiroyuki Abe, Masafumi Kamada, Toru Noguchi. Preclinical Characterization of JTK-853, a Novel Nonnucleoside Inhibitor of the Hepatitis C Virus RNA-Dependent RNA PolymeraseAntimicrobial Agents and Chemotherapy 2012; 56(8): 4250 doi: 10.1128/AAC.00312-12
85
Victor Virlogeux, Pascale Berthillon, Isabelle Bordes, Sylvie Larrat, Stéphanie Crouy, Caroline Scholtès, Pierre Pradat, Marianne Maynard, Fabien Zoulim, Vincent Leroy, Isabelle Chemin, Christian Trépo, Marie-Anne Petit. Anti-E1E2 antibodies status prior therapy favors direct-acting antiviral treatment efficacyClinics and Research in Hepatology and Gastroenterology 2018; 42(4): 313 doi: 10.1016/j.clinre.2018.02.002
86
Maria Stepanova, Fasiha Kanwal, Hashem B. El-Serag, Zobair M. Younossi. Insurance status and treatment candidacy of hepatitis C patients: Analysis of population-based data from the United StatesHepatology 2011; 53(3): 737 doi: 10.1002/hep.24131
87
M. M. G. Godoy, E. P. A. Lopes, R. O. Silva, F. Hallwass, L. C. A. Koury, I. M. Moura, S. M. C. Gonçalves, A. M. Simas. Hepatitis C virus infection diagnosis using metabonomicsJournal of Viral Hepatitis 2010; 17(12): 854 doi: 10.1111/j.1365-2893.2009.01252.x
88
Udayan Chatterji, Michael Bobardt, Andrew Tai, Malcolm Wood, Philippe A. Gallay. Cyclophilin and NS5A Inhibitors, but Not Other Anti-Hepatitis C Virus (HCV) Agents, Preclude HCV-Mediated Formation of Double-Membrane-Vesicle Viral FactoriesAntimicrobial Agents and Chemotherapy 2015; 59(5): 2496 doi: 10.1128/AAC.04958-14
89
Seyed Moayed Alavian. Determination of Whether Vitiligo is a Contraindication to Interferon Therapy in Chronic Hepatitis CJournal of Skin and Stem Cell 2014; 1(1) doi: 10.17795/jssc16639
90
Chia-Chun Hung, El-Wui Loh, Tsung-Ming Hu, Hsien-Jane Chiu, Hung-Chieh Hsieh, Chin-Hong Chan, Tsuo-Hung Lan. Prevalence of hepatitis B and hepatitis C in patients with chronic schizophrenia living in institutionsJournal of the Chinese Medical Association 2012; 75(6): 275 doi: 10.1016/j.jcma.2012.03.002
91
Rima Chaudhuri, Hyun Lee, Lena Truong, Jaime Torres, Kavankumar Patel, Michael E. Johnson. Identification of Non-Macrocyclic Small Molecule Inhibitors against the NS3/4A Serine Protease of Hepatitis C Virus through in Silico ScreeningJournal of Chemical Information and Modeling 2012; 52(8): 2245 doi: 10.1021/ci300177p
92
Christina Greenaway, Ann Thu Ma, Lorie A. Kloda, Marina Klein, Sonya Cnossen, Guido Schwarzer, Ian Shrier, Jason Grebely. The Seroprevalence of Hepatitis C Antibodies in Immigrants and Refugees from Intermediate and High Endemic Countries: A Systematic Review and Meta-AnalysisPLOS ONE 2015; 10(11): e0141715 doi: 10.1371/journal.pone.0141715
93
Inna Rytsareva, David S. Campo, Yueli Zheng, Seth Sims, Sharma V. Thankachan, Cansu Tetik, Jain Chirag, Sriram P. Chockalingam, Amanda Sue, Srinivas Aluru, Yury Khudyakov. Efficient detection of viral transmissions with Next-Generation Sequencing dataBMC Genomics 2017; 18(S4) doi: 10.1186/s12864-017-3732-4
94
Stephanie E. Perrett, Noel Craine, Marion Lyons. Developing blood borne virus services across prisons in Wales, UKInternational Journal of Prisoner Health 2013; 9(1): 31 doi: 10.1108/17449201311310788
95
Madeline C. Frost, Theresa E. Matson, Judith I. Tsui, Emily C. Williams. Influence of comorbid drug use disorder on receipt of evidence-based treatment for alcohol use disorder among VA patients with alcohol use disorder and Hepatitis C and/or HIVDrug and Alcohol Dependence 2019; 194: 288 doi: 10.1016/j.drugalcdep.2018.10.008
96
Jihene Bettaieb, Anissa Chouikha, Marwa Khedhiri, Ghassen Kharroubi, Malek Badreddine, Nabil Bel Hadj Hmida, Adel Gharbi, Walid Hammemi, Amel Sadraoui, Ahlem Ben Yahia, Zina Meddeb, Afif Ben Salah, Henda Triki. Hepatitis C virus epidemiology in Central-West Tunisia: a population-based cross-sectional studyArchives of Virology 2019; 164(9): 2243 doi: 10.1007/s00705-019-04308-8
97
Liang-Jen Wang, Shuo-Wei Chen, Chih-Ken Chen, Cho-Li Yen, Jia-Jang Chang, Tsung-Shih Lee, Ching-Jung Liu, Li-Wei Chen, Rong-Nan Chien. Treatment-emergent depression and anxiety between peginterferon alpha-2a versus alpha-2b plus ribavirin for chronic hepatitis CBMC Psychiatry 2016; 16(1) doi: 10.1186/s12888-016-1135-8
98
R. K. Sterling, A. Kuo, V. K. Rustgi, M. S. Sulkowski, T. G. Stewart, J. M. Fenkel, H. El-Genaidi, M. A. Mah'moud, G. M. Abraham, P. W. Stewart, L. Akushevich, D. R. Nelson, M. W. Fried, A. M. Di Bisceglie. Virological outcomes and treatment algorithms utilisation in observational study of patients with chronic hepatitis C treated with boceprevir or telaprevirAlimentary Pharmacology & Therapeutics 2015; 41(7): 671 doi: 10.1111/apt.13095
99
Chang Ho Lee, Seung Ryul Han, Seong-Wook Lee. Therapeutic applications of group I intron-based trans -splicing ribozymesWiley Interdisciplinary Reviews: RNA 2018; 9(3): e1466 doi: 10.1002/wrna.1466
100
Fiona Fonseca, Bijal Kulkarni, Meenal Hastak, Vinay Kumaran, Vibha Varma, Sorabh Kapoor. An Overview of Liver Transplant Pathology: Data from a Tertiary Referral Centre in Western IndiaAnnals of Hepatology 2018; 17(3): 426 doi: 10.5604/01.3001.0011.7387
101
Safak Kaya, Selcuk Aksoz, Birol Baysal, Nurettin Ay, Ramazan Danis. Evaluation of telaprevir-containing triple therapy in the treatment of chronic hepatitis C in hemodialysed patientsInfectious Diseases 2015; 47(9): 658 doi: 10.3109/23744235.2015.1034769
102
Mary E. Mackesy-Amiti, Lorna Finnegan, Lawrence J. Ouellet, Elizabeth T. Golub, Holly Hagan, Sharon M. Hudson, Mary H. Latka, Richard S. Garfein. Peer-Education Intervention to Reduce Injection Risk Behaviors Benefits High-Risk Young Injection Drug Users: A Latent Transition Analysis of the CIDUS 3/DUIT StudyAIDS and Behavior 2013; 17(6): 2075 doi: 10.1007/s10461-012-0373-0
103
Philippe Gallay. Handbook of Antimicrobial Resistance2014; : 1 doi: 10.1007/978-1-4939-0667-3_3-1
104
Daniel Fuster, Arantza Sanvisens, Ferran Bolao, Inmaculada Rivas, Jordi Tor, Robert Muga. Alcohol use disorder and its impact on chronic hepatitis C virus and human immunodeficiency virus infectionsWorld Journal of Hepatology 2016; 8(31): 1295-1308 doi: 10.4254/wjh.v8.i31.1295
105
Dimitrios Vassilopoulos, Leonard H Calabrese. Risks of immunosuppressive therapies including biologic agents in patients with rheumatic diseases and co-existing chronic viral infectionsCurrent Opinion in Rheumatology 2007; 19(6): 619 doi: 10.1097/BOR.0b013e3282f05b63
106
Anuj Sharma, Sharanjit Kaur, Neeraj Sharma. PERCUTANEOUS ROUTE AS A RISK FACTOR FOR SEROPOSITIVITY OF HEPATITIS C VIRUS INFECTIONJournal of Evolution of Medical and Dental Sciences 2015; 4(05): 843 doi: 10.14260/jemds/2015/121
107
Syed‐Mohammed Jafri, Stuart C. Gordon. Epidemiology of Hepatitis CClinical Liver Disease 2018; 12(5): 140 doi: 10.1002/cld.783
108
Ivan Gentile, Maria Aurora Carleo, Federico Borgia, Giuseppe Castaldo, Guglielmo Borgia. The efficacy and safety of telaprevir – a new protease inhibitor against hepatitis C virusExpert Opinion on Investigational Drugs 2010; 19(1): 151 doi: 10.1517/13543780903501505
109
Maha Mahmoud Abou El-Alamin, Maha Abd Elrahman Sultan, Maha Hegazy, Alastair William Wark, Marwa Mohamed Azab. Pure component contribution (PCCA) and synergy interval partial least squares (siPLS) algorithms for efficient resolution and quantification of overlapped signals; an application to novel antiviral tablets of daclatasvir, sofosbuvir and ribavirinEuropean Journal of Chemistry 2019; 10(4): 350 doi: 10.5155/eurjchem.10.4.350-357.1899
110
Céline Miroux, Thibaut Vausselin, Nadira Delhem. Regulatory T cells in HBV and HCV liver diseases: implication of regulatory T lymphocytes in the control of immune responseExpert Opinion on Biological Therapy 2010; 10(11): 1563 doi: 10.1517/14712598.2010.529125
111
N. El-Hage, S. M. Dever, S. Fitting, T. Ahmed, K. F. Hauser. HIV-1 Coinfection and Morphine Coexposure Severely Dysregulate Hepatitis C Virus-Induced Hepatic Proinflammatory Cytokine Release and Free Radical Production: Increased Pathogenesis Coincides with Uncoordinated Host DefensesJournal of Virology 2011; 85(22): 11601 doi: 10.1128/JVI.05239-11
112
Masahiro Ishikane, Koji Watanabe, Kunihisa Tsukada, Yuichi Nozaki, Mikio Yanase, Toru Igari, Naohiko Masaki, Yoshimi Kikuchi, Shinichi Oka, Hiroyuki Gatanaga, Golo Ahlenstiel. Acute Hepatitis C in HIV-1 Infected Japanese Cohort: Single Center Retrospective Cohort StudyPLoS ONE 2014; 9(6): e100517 doi: 10.1371/journal.pone.0100517
113
Nik Howes, Sam Lattimore, William Lucien Irving, Brian James Thomson. Clinical Care Pathways for Patients With Hepatitis C: Reducing Critical Barriers to Effective TreatmentOpen Forum Infectious Diseases 2016; 3(1): ofv218 doi: 10.1093/ofid/ofv218
114
T. C. R. AZEVEDO, N. A. FILGUEIRA, E. P. LOPES. Risk factors for hepatitis C virus infection in former Brazilian soccer playersEpidemiology and Infection 2012; 140(1): 70 doi: 10.1017/S0950268811000458
115
Feifei Lei, Xu Lei, Rugui Li, Huabing Tan. Microcystin-LR in peripheral circulation worsens the prognosis partly through oxidative stress in patients with hepatocellular carcinomaClinical and Experimental Medicine 2019; 19(2): 235 doi: 10.1007/s10238-019-00550-1
116
Liliane Hobeika, Monica Srivastava, Mai Vo, Marie D. Philipneri, David S. Brink, Nadia Wasi, Krista L. Lentine. Lupus-like glomerulonephritis: an autoimmune complication of hepatitis C infectionCEN Case Reports 2012; 1(1): 29 doi: 10.1007/s13730-012-0008-3
117
Joanna Bladowska, Anna Zimny, Anna Kołtowska, Paweł Szewczyk, Brygida Knysz, Jacek Gąsiorowski, Michał Furdal, Marek J. Sąsiadek. Evaluation of metabolic changes within the normal appearing gray and white matters in neurologically asymptomatic HIV-1-positive and HCV-positive patients: Magnetic resonance spectroscopy and immunologic correlationEuropean Journal of Radiology 2013; 82(4): 686 doi: 10.1016/j.ejrad.2012.11.029
118
Yousra A Mohamoud, Ghina R Mumtaz, Suzanne Riome, DeWolfe Miller, Laith J Abu-Raddad. The epidemiology of hepatitis C virus in Egypt: a systematic review and data synthesisBMC Infectious Diseases 2013; 13(1) doi: 10.1186/1471-2334-13-288
119
Ana Maria Sandri, Usama Elewa, John J. Poterucha, Fernando C. Fervenza. Treatment of Hepatitis C-Mediated Glomerular DiseaseNephron Clinical Practice 2011; 119(2): c121 doi: 10.1159/000325220
120
Fred Leland McClure, Justin K. Niles, Harvey W. Kaufman, Jeffrey Gudin. Drug Misuse and Hepatitis C Virus Infection Profiles for Three Generations of Patients Being Monitored for Prescription Drug AdherenceJournal of Addiction Medicine 2019; 13(2): 123 doi: 10.1097/ADM.0000000000000460
121
Silvia Portugal, Nyamekye Obeng-Adjei, Susan Moir, Peter D. Crompton, Susan K. Pierce. Atypical memory B cells in human chronic infectious diseases: An interim reportCellular Immunology 2017; 321: 18 doi: 10.1016/j.cellimm.2017.07.003
122
Garrick K. Wilson, Michelle J. Farquhar, Luke Meredith, Anil Dhawan, Ragai Mitry, Peter Balfe, Jane A. McKeating. Permissivity of primary hepatocytes and hepatoma cell lines to support hepatitis C virus infection Journal of General Virology 2015; 96(6): 1369 doi: 10.1099/vir.0.000085
123
Robert Flisiak, Waldemar Halota, Andrzej Horban, Jacek Juszczyk, Malgorzata Pawlowska, Krzysztof Simon. Prevalence and risk factors of HCV infection in PolandEuropean Journal of Gastroenterology & Hepatology 2011; 23(12): 1213 doi: 10.1097/MEG.0b013e32834d173c
124
Sirio Fiorino, Letizia Bacchi-Reggiani, Dario de Biase, Adele Fornelli, Michele Masetti, Andrea Tura, Fabio Grizzi, Matteo Zanello, Laura Mastrangelo, Raffaele Lombardi, Giorgia Acquaviva, Luca di Tommaso, Arrigo Bondi, Michela Visani, Sergio Sabbatani, Laura Pontoriero, Carlo Fabbri, Andrea Cuppini, Annalisa Pession, Elio Jovine. Possible association between hepatitis C virus and malignancies different from hepatocellular carcinoma: A systematic reviewWorld Journal of Gastroenterology 2015; 21(45): 12896-12953 doi: 10.3748/wjg.v21.i45.12896
125
Vivien Sheehan, Alva Weir, Bradford Waters. Severe Neutropenia in Patients with Chronic Hepatitis C: A Benign ConditionActa Haematologica 2013; 129(2): 96 doi: 10.1159/000342964
126
John McLauchlan. Hepatitis C virus: viral proteins on the moveBiochemical Society Transactions 2009; 37(5): 986 doi: 10.1042/BST0370986
127
Ryan J. Malonis, Jonathan R. Lai, Olivia Vergnolle. Peptide-Based Vaccines: Current Progress and Future ChallengesChemical Reviews 2020; 120(6): 3210 doi: 10.1021/acs.chemrev.9b00472
128
Mohammed A. El Feki, Heba H. El Demellawy, Tamer Hifnawy. Prevalence and risk factors of hepatitis C virus and its association with diabetes mellitus in rural versus urban districts in the Beni-Suef Governorate, EgyptEgyptian Liver Journal 2013; 3(2): 28 doi: 10.1097/01.ELX.0000427104.13118.0e
129
Gisele Barreto Lopes Menezes, Fernanda Albuquerque Pereira, César Augusto Barros Duarte, Theomira Mauadie Azevedo Carmo, Hermes Pedreira da Silva Filho, Maria Alice Zarife, Marco Aurélio Krieger, Eliana Almeida Gomes Reis, Mitermayer G Reis. Hepatitis C virus quantification in serum and saliva of HCV-infected patientsMemórias do Instituto Oswaldo Cruz 2012; 107(5): 680 doi: 10.1590/S0074-02762012000500016
130
M.S. Kupka, M. Franz, K. Friese. Hepatitis, HIV und KinderwunschDer Gynäkologe 2007; 40(10): 780 doi: 10.1007/s00129-007-2047-y
131
Seyed Moayed Alavian, Kamran Bagheri Lankarani, Ala I. Sharara. Treatment of Chronic HCV in Special Populations: Thalassemia, Hemophilia, and Hemodialysis PatientsCurrent Hepatitis Reports 2012; 11(4): 256 doi: 10.1007/s11901-012-0147-1
132
A. Salmon-Rousseau, E. Piednoir, V. Cattoir, A. de La Blanchardière. Hajj-associated infectionsMédecine et Maladies Infectieuses 2016; 46(7): 346 doi: 10.1016/j.medmal.2016.04.002
133
Xi-Jing Qian, Yong-Zhe Zhu, Ping Zhao, Zhong-Tian Qi. Entry inhibitors: New advances in HCV treatmentEmerging Microbes & Infections 2016; 5(1): 1 doi: 10.1038/emi.2016.3
134
Mehtap Tınazlı, Meryem Güvenir, Aslı Aykaç, Kaya Süer. Hepatitis C virus infection among patients admitted to a rheumatology ward in northern CyprusThe Egyptian Rheumatologist 2017; 39(4): 245 doi: 10.1016/j.ejr.2017.04.014
135
Karima Chaabna, Silva P. Kouyoumjian, Laith J. Abu-Raddad, Jason Blackard. Hepatitis C Virus Epidemiology in Djibouti, Somalia, Sudan, and Yemen: Systematic Review and Meta-AnalysisPLOS ONE 2016; 11(2): e0149966 doi: 10.1371/journal.pone.0149966
136
Aritra Biswas, Debanjali Gupta, Kallol Saha, Kahini Sarkar, Rushna Firdaus, Provash Chandra Sadhukhan. Emerging new HCV strains among intravenous drug users and their route of transmission in the north eastern state of Mizoram, IndiaMolecular Phylogenetics and Evolution 2017; 116: 239 doi: 10.1016/j.ympev.2017.09.006
137
Yasser M. Gohary, Amin M.A. El-Baky. Straight-erected hair in hepatitis C male patients treated with pegylated interferon and ribavirinJournal of the Egyptian Womenʼs Dermatologic Society 2018; 15(2): 111 doi: 10.1097/01.EWX.0000532147.57931.38
138
Zhengxian Gu, Jason D. Graci, Frederick C. Lahser, Jamie J. Breslin, Stephen P. Jung, James H. Crona, Patricia McMonagle, Ellen Xia, Shaotang Liu, Gary Karp, Jin Zhu, Song Huang, Amin Nomeir, Marla Weetall, Neil G. Almstead, Stuart W. Peltz, Xiao Tong, Robert Ralston, Joseph M. Colacino. Identification of PTC725, an Orally Bioavailable Small Molecule That Selectively Targets the Hepatitis C Virus NS4B ProteinAntimicrobial Agents and Chemotherapy 2013; 57(7): 3250 doi: 10.1128/AAC.00527-13
139
Ranil Gunewardene, Lisa Lampe, Ralf Ilchef. Prevalence of Hepatitis C in Two Inpatient Psychiatry PopulationsAustralasian Psychiatry 2010; 18(4): 330 doi: 10.3109/10398561003763273
140
Donald Gardenier, Angie Woody, Catherine Amory, Jeffrey J. Weiss. Interprofessional team-based approach to patients with chronic hepatitis C and personality disorder: Three case studiesArchives of Psychiatric Nursing 2019; 33(4): 352 doi: 10.1016/j.apnu.2019.02.001
141
Claro Yu, Denali Boon, Shannon L. McDonald, Timothy G. Myers, Keiko Tomioka, Hanh Nguyen, Ronald E. Engle, Sugantha Govindarajan, Suzanne U. Emerson, Robert H. Purcell. Pathogenesis of Hepatitis E Virus and Hepatitis C Virus in Chimpanzees: Similarities and DifferencesJournal of Virology 2010; 84(21): 11264 doi: 10.1128/JVI.01205-10
142
Zobair M Younossi, Aybike Birerdinc, Mike Estep, Maria Stepanova, Arian Afendy, Ancha Baranova. The impact of IL28B genotype on the gene expression profile of patients with chronic hepatitis C treated with pegylated interferon alpha and ribavirinJournal of Translational Medicine 2012; 10(1) doi: 10.1186/1479-5876-10-25
143
Mohamed M. Al-Daydamony, El-Sayed M. Farag. CRUSADE bleeding score as a predictor of bleeding events in patients with acute coronary syndrome in Zagazig University HospitalIndian Heart Journal 2016; 68(5): 632 doi: 10.1016/j.ihj.2016.03.007
144
Hannes Hagström. Alcohol Consumption in Concomitant Liver Disease: How Much is Too Much?Current Hepatology Reports 2017; 16(2): 152 doi: 10.1007/s11901-017-0343-0
145
Mary E. Mackesy-Amiti, Basmattee Boodram, Michael W. Spiller, Gabriela Paz-Bailey, Nikhil Prachand, Dita Broz. Injection-Related Risk Behavior and Engagement in Outreach, Intervention and Prevention Services Across 20 US CitiesJAIDS Journal of Acquired Immune Deficiency Syndromes 2017; 75: S316 doi: 10.1097/QAI.0000000000001406
146
Chien-Jen Chen, Wan-Lun Hsu, Hwai-I Yang, Mei-Hsuan Lee, Hui-Chi Chen, Yin-Chu Chien, San-Lin You. Viruses and Human CancerRecent Results in Cancer Research 2014; 193: 11 doi: 10.1007/978-3-642-38965-8_2
147
Paul K Nelson, Bradley M Mathers, Benjamin Cowie, Holly Hagan, Don Des Jarlais, Danielle Horyniak, Louisa Degenhardt. Global epidemiology of hepatitis B and hepatitis C in people who inject drugs: results of systematic reviewsThe Lancet 2011; 378(9791): 571 doi: 10.1016/S0140-6736(11)61097-0
148
Erika Castro, Elena Roger. Hepatitis C virus/human T lymphotropic virus 1/2 co-infection: Regional burden and virological outcomes in people who inject drugsWorld Journal of Virology 2016; 5(2): 68-72 doi: 10.5501/wjv.v5.i2.68
149
Zhenwei Shen, Xiaoxue Zhu, Hong Zhang, Hong Chen, Junqi Niu, Guiling Chen, Xiaojiao Li, Yanhua Ding. Pharmacokinetic Profile of a Generic Formulation of Sofosbuvir and Its Metabolite GS‐331007 in Healthy Chinese SubjectsClinical Pharmacology in Drug Development 2019; 8(8): 1073 doi: 10.1002/cpdd.674
150
Samar Samir Youssef, Eman Abd El- Razek Abbas, Asmaa Mostafa Abd el Aal, Moataza Hassan Omran, Ahmed Barakat, Sameh Mohamed Seif. IL28B rs 12979860 Predicts Response to Treatment in Egyptian Hepatitis C Virus Genotype 4 Patients and Alpha Fetoprotein Increases Its Predictive StrengthJournal of Interferon & Cytokine Research 2014; 34(7): 505 doi: 10.1089/jir.2013.0115
151
Aldemir B Oliveira-Filho, Leila Sawada, Laine C Pinto, Daiane Locks, Santana L Bahia, JairoA A Castro, Renata B Hermes, Igor Brasil-Costa, CarlosE M Amaral, José Alexandre R Lemos. Epidemiological aspects of HCV infection in non-injecting drug users in the Brazilian state of Pará, eastern AmazonVirology Journal 2014; 11(1) doi: 10.1186/1743-422X-11-38
152
Karn Wijarnpreecha, Charat Thongprayoon, Patompong Ungprasert. Impact of caffeine in hepatitis C virus infectionEuropean Journal of Gastroenterology & Hepatology 2017; 29(1): 17 doi: 10.1097/MEG.0000000000000757
153
Wieslaw M. Kazmierski, Andrew Maynard, Maosheng Duan, Sam Baskaran, Janos Botyanszki, Renae Crosby, Scott Dickerson, Matthew Tallant, Rick Grimes, Robert Hamatake, Martin Leivers, Christopher D. Roberts, Jill Walker. Novel Spiroketal Pyrrolidine GSK2336805 Potently Inhibits Key Hepatitis C Virus Genotype 1b Mutants: From Lead to Clinical CompoundJournal of Medicinal Chemistry 2014; 57(5): 2058 doi: 10.1021/jm4013104
154
Ye Yu, Jing-feng Jing, Xian-kun Tong, Pei-lan He, Yuan-chao Li, You-hong Hu, Wei Tang, Jian-ping Zuo. Discovering novel anti-HCV compounds with inhibitory activities toward HCV NS3/4A proteaseActa Pharmacologica Sinica 2014; 35(8): 1074 doi: 10.1038/aps.2014.55
155
Zobair M. Younossi, Dolores Limongi, Maria Stepanova, Mariaelena Pierobon, Arian Afendy, Rohini Mehta, Ancha Baranova, Lance. Liotta, Emanuel. Petricoin. Protein Pathway Activation Associated with Sustained Virologic Response in Patients with Chronic Hepatitis C Treated with Pegylated Interferon (PEG-IFN) and Ribavirin (RBV)Journal of Proteome Research 2011; 10(2): 774 doi: 10.1021/pr100923u
156
İlkay Küçükgüzel, Gökhan Satılmış, K.R. Gurukumar, Amartya Basu, Esra Tatar, Daniel B. Nichols, Tanaji T. Talele, Neerja Kaushik-Basu. 2-Heteroarylimino-5-arylidene-4-thiazolidinones as a new class of non-nucleoside inhibitors of HCV NS5B polymeraseEuropean Journal of Medicinal Chemistry 2013; 69: 931 doi: 10.1016/j.ejmech.2013.08.043
157
Zaigham Abbas, Ghiasun Nabi Tayyab, Mustafa Qureshi, Mohammad Sadik Memon, Amna Subhan, Tanzila Shakir, Wasim Jafri, Saeed Hamid. Consensus Interferon Plus Ribavirin for Hepatitis C Genotype 3 Patients Previously Treated With Pegylated Interferon Plus RibavirinHepatitis Monthly 2013; 13(12) doi: 10.5812/hepatmon.14146
158
Djadé I. Soumana, Nese Kurt Yilmaz, Kristina L. Prachanronarong, Cihan Aydin, Akbar Ali, Celia A. Schiffer. Structural and Thermodynamic Effects of Macrocyclization in HCV NS3/4A Inhibitor MK-5172ACS Chemical Biology 2016; 11(4): 900 doi: 10.1021/acschembio.5b00647
159
Marie-Josée Massariol, Songping Zhao, Martin Marquis, Diane Thibeault, Peter W. White. Protease and helicase activities of hepatitis C virus genotype 4, 5, and 6 NS3–NS4A proteinsBiochemical and Biophysical Research Communications 2010; 391(1): 692 doi: 10.1016/j.bbrc.2009.11.122
160
Ednelza da Silva Graça Amoras, Samara Tatielle Monteiro Gomes, Felipe Bonfim Freitas, Bárbara Brasil Santana, Geraldo Ishak, Marialva Tereza Ferreira de Araújo, Sâmia Demachki, Simone Regina Souza da Silva Conde, Marluísa de Oliveira Guimarães Ishak, Ricardo Ishak, Antonio Carlos Rosário Vallinoto, Matthaios Speletas. Intrahepatic mRNA Expression of FAS, FASL, and FOXP3 Genes Is Associated with the Pathophysiology of Chronic HCV InfectionPLOS ONE 2016; 11(5): e0156604 doi: 10.1371/journal.pone.0156604
161
Mun Hyuk Seong, Ho Kil, Young Seok Kim, Si Hyun Bae, Youn Jae Lee, Han Chu Lee, Byung Hak Kang, Sook-Hyang Jeong. Clinical and epidemiological features of hepatitis C virus infection in South Korea: A prospective, multicenter cohort studyJournal of Medical Virology 2013; 85(10): 1724 doi: 10.1002/jmv.23661
162
Allah Nawaz, Syed Faisal Zaidi, Khan Usmanghani, Irshad Ahmad. Concise review on the insight of hepatitis CJournal of Taibah University Medical Sciences 2015; 10(2): 132 doi: 10.1016/j.jtumed.2014.08.004
163
Basmattee Boodram, Mary-Ellen Mackesy-Amiti, Carl Latkin. The role of social networks and geography on risky injection behaviors of young persons who inject drugsDrug and Alcohol Dependence 2015; 154: 229 doi: 10.1016/j.drugalcdep.2015.06.042
164
Shakir Saleem, Md Adil Shaharyar, Mohammad Jawed Khusroo, Parwej Ahmad, Rais Ur Rahman, Kamran Ahmad, Md Jahangir Alam, Naif O Al-Harbi, Muzaffar Iqbal, Faisal Imam. Anticancer potential of rhamnocitrin 4′-β-d-galactopyranoside against N-diethylnitrosamine-induced hepatocellular carcinoma in ratsMolecular and Cellular Biochemistry 2013; 384(1-2): 147 doi: 10.1007/s11010-013-1792-6
165
Marian Major, Alexander Gutfraind, Louis Shekhtman, Qingwen Cui, Alla Kachko, Scott J. Cotler, Behzad Hajarizadeh, Rachel Sacks-Davis, Kimberly Page, Basmattee Boodram, Harel Dahari. Modeling of patient virus titers suggests that availability of a vaccine could reduce hepatitis C virus transmission among injecting drug usersScience Translational Medicine 2018; 10(449): eaao4496 doi: 10.1126/scitranslmed.aao4496
166
Soriane de Souza-Cruz, Marilú Barbieri Victória, Andréa Monteiro Tarragô, Allyson Guimarães da Costa, João Paulo Diniz Pimentel, Ericka Florêncio Pires, Lorene de Paula Araújo, Jordana Grazziela Coelho-dos-Reis, Matheus de Souza Gomes, Laurence Rodrigues Amaral, Andréa Teixeira-Carvalho, Olindo Assis Martins-Filho, Flamir da Silva Victória, Adriana Malheiro. Liver and blood cytokine microenvironment in HCV patients is associated to liver fibrosis score: a proinflammatory cytokine ensemble orchestrated by TNF and tuned by IL-10BMC Microbiology 2016; 16(1) doi: 10.1186/s12866-015-0610-6
167
Kendall R. Van Keuren-Jensen, Ivana Malenica, Amanda L. Courtright, Layla T. Ghaffari, Alex P. Starr, Raghu P. Metpally, Taylor A. Beecroft, Elizabeth W.J. Carlson, Jeffrey A. Kiefer, Paul J. Pockros, Jorge Rakela. microRNA changes in liver tissue associated with fibrosis progression in patients with hepatitis CLiver International 2016; 36(3): 334 doi: 10.1111/liv.12919
168
George Papatheodoridis, Angelos Hatzakis. Public health issues of hepatitis C virus infectionBest Practice & Research Clinical Gastroenterology 2012; 26(4): 371 doi: 10.1016/j.bpg.2012.09.012
169
Maryam L. Famouri, Stacey A. Shaw, Assel Terlikbayeva, Louisa Gilbert, Tim Hunt, Yelena Rozental, Nabila El-Bassel. Partner notification among HCV-positive couples who inject drugsJournal of Substance Use 2016; 21(1): 78 doi: 10.3109/14659891.2014.960015
170
S. Karbanova, L. Cerveny, L. Jiraskova, R. Karahoda, M. Ceckova, Z. Ptackova, F. Staud. Transport of ribavirin across the rat and human placental barrier: Roles of nucleoside and ATP-binding cassette drug efflux transportersBiochemical Pharmacology 2019; 163: 60 doi: 10.1016/j.bcp.2019.01.024
171
Fabrizio Fabrizi, Vivek Dixit, Paul Martin, Piergiorgio Messa. The Evidence-Based Epidemiology of HCV-Associated Kidney DiseaseThe International Journal of Artificial Organs 2012; 35(9): 621 doi: 10.1177/039139881203500901
172
Feyza Gunduz, Chaithanya Mallikarjun, Luis A. Balart, Srikanta Dash. Interferon alpha induced intrahepatic pSTAT1 inversely correlate with serum HCV RNA levels in chronic HCV infectionExperimental and Molecular Pathology 2014; 96(1): 36 doi: 10.1016/j.yexmp.2013.10.016
173
Malgorzata Sidorkiewicz, Barbara Józwiak, Barbara Durys, Ewa Majda-Stanislawska, Anna Piekarska, Natalia Kosciuk, Jadwiga Ciechowicz, Ewa Majewska, Jacek Bartkowiak. Mevalonate pathway modulation is associated with hepatitis C virus RNA presence in peripheral blood mononuclear cellsVirus Research 2009; 145(1): 141 doi: 10.1016/j.virusres.2009.06.001
174
M. El-Bendary, M. Neamatallah, G. Esmat, E. Kamel, H. Elalfy, T. Besheer, D. Eldeib, A.-H. Eladl, M. El-Setouhy, A.-H. El-Gilany, A. El-Waseef. Associations of human leucocyte antigen class II-DQB1 alleles with hepatitis C virus infection in Egyptian population: a multicentre family-based studyJournal of Viral Hepatitis 2016; 23(12): 961 doi: 10.1111/jvh.12573
175
Ye Chen, Alain Bopda-Waffo, Amartya Basu, Ramalingam Krishnan, Erica Silberstein, Deborah R Taylor, Tanaji T Talele, Payal Arora, Neerja Kaushik-Basu. Characterization of Aurintricarboxylic Acid as a Potent Hepatitis C Virus Replicase InhibitorAntiviral Chemistry and Chemotherapy 2009; 20(1): 19 doi: 10.3851/IMP1286
176
Claudia Roeder, Sabine Jordan, Julian Schulze zur Wiesch, Heike Pfeiffer-Vornkahl, Dietrich Hueppe, Stefan Mauss, Elmar Zehnter, Sabine Stoll, Ulrich Alshuth, Ansgar W Lohse, Stefan Lueth. Age-related differences in response to peginterferon alfa-2a/ribavirin in patients with chronic hepatitis C infectionWorld Journal of Gastroenterology 2014; 20(31): 10984-10993 doi: 10.3748/wjg.v20.i31.10984
177
O. Ndiaye, J. Gozlan, H. Diop-Ndiaye, A.S. Sall, S. Chapelain, A. Leprêtre, M. Maynart, M. Gueye, G Lo, M. Thiam, I. Ba, K. Lacombe, P.M. Girard, S. Mboup, C.T. Kane. Usefulness of Dried Blood Spots (DBS) to perform hepatitis C virus genotyping in drug users in SenegalJournal of Medical Virology 2017; 89(3): 484 doi: 10.1002/jmv.24460
178
Shamim Saleha, Anwar Kamal, Farman Ullah, Nasar Khan, Asif Mahmood, Sanaullah Khan. Prevalence of Hepatitis C Virus Genotypes in District Bannu, Khyber Pakhtunkhwa, PakistanHepatitis Research and Treatment 2014; 2014: 1 doi: 10.1155/2014/165826
179
Shingo Iwasa, Naoko Satoh, Hayato Irokawa, Junichi Kikuchi, Jun Okawa, Masataka Nomoto, Gi-Wook Hwang, Akira Naganuma, Shusuke Kuge. Hepatitis C virus core can induce lipid droplet formation in a yeast model systemFundamental Toxicological Sciences 2016; 3(1): 13 doi: 10.2131/fts.3.13
180
Salwa Sabet, Marina A. George, Haidan M. El-Shorbagy, Heba Bassiony, Khaled Y. Farroh, Tareq Youssef, Taher A. Salaheldin, Abhijit De. Gelatin nanoparticles enhance delivery of hepatitis C virus recombinant NS2 genePLOS ONE 2017; 12(7): e0181723 doi: 10.1371/journal.pone.0181723
181
Daniel Schmidt-Martin, Orla Crosbie, Elizabeth Kenny-Walsh, Liam J. Fanning. Intensive temporal mapping of hepatitis C hypervariable region 1 quasispecies provides novel insights into hepatitis C virus evolution in chronic infection Journal of General Virology 2015; 96(8): 2145 doi: 10.1099/vir.0.000149
182
Manola Comar, Francesco De Seta, Nunzia Zanotta, Serena Del Bue, Pasquale Ferrante. Sexually Transmitted Infections2020; : 107 doi: 10.1007/978-3-030-02200-6_6
183
Magdalena Perić, Zinka Bošnjak, Bojan Šarkanj, Jerko Barbić, Arlen Antolović-Požgain, Nataša Ružman, Ivana Roksandić-Križan, Dubravka Vuković. Polymorphisms of Toll-like receptors 2 and 4 in chronically infected hepatitis C patients from north-east CroatiaArchives of Virology 2015; 160(1): 297 doi: 10.1007/s00705-014-2283-0
184
Masahiro Kobayashi, Fumitaka Suzuki, Shunichiro Fujiyama, Yusuke Kawamura, Hitomi Sezaki, Tetsuya Hosaka, Norio Akuta, Yoshiyuki Suzuki, Satoshi Saitoh, Yasuji Arase, Kenji Ikeda, Hiromitsu Kumada. Sustained virologic response by direct antiviral agents reduces the incidence of hepatocellular carcinoma in patients with HCV infectionJournal of Medical Virology 2017; 89(3): 476 doi: 10.1002/jmv.24663
185
Maemu Petronella Gededzha, M. Jeffrey Mphahlele, Jason T. Blackard, Selokela Gloria Selabe. Prevalence of NS5B Resistance Mutations in Hepatitis C Virus (HCV) Treatment Naive South AfricansHepatitis Monthly 2017; 17(6) doi: 10.5812/hepatmon.14248
186
Arturo Panduro, Sonia Roman, Anis Khan, Yasuhito Tanaka, Fuat Kurbanov, Erika Martinez-Lopez, Octavio Campollo, Zamira Hernandez-Nazara, Masashi Mizokami. Molecular epidemiology of hepatitis C virus genotypes in West MexicoVirus Research 2010; 151(1): 19 doi: 10.1016/j.virusres.2010.03.009
187
Hannes Hagström. Alcohol, smoking and the liver disease patientBest Practice & Research Clinical Gastroenterology 2017; 31(5): 537 doi: 10.1016/j.bpg.2017.09.003
188
Nancy Agmon-Levin, Maya Ram, Ori Barzilai, Bat sheva Porat-Katz, Ronit Parikman, Carlo Selmi, M. Eric Gershwin, Juan-Manuel Anaya, Pierre Youinou, Nicola Bizzaro, Angela Tincani, Athanasios G. Tzioufas, Ricard Cervera, Ljudmila Stojanovich, Javier Martin, Miguel Angel Gonzalez-Gay, Gabriele Valentini, Miri Blank, Marielle SanMarco, Blaž Rozman, Stefano Bombardieri, Salvatore De Vita, Yehuda Shoenfeld. Prevalence of hepatitis C serum antibody in autoimmune diseasesJournal of Autoimmunity 2009; 32(3-4): 261 doi: 10.1016/j.jaut.2009.02.017
189
Debasis Das. Viral Proteases and Their Inhibitors2017; : 189 doi: 10.1016/B978-0-12-809712-0.00008-3
190
J Trinks, M L Hulaniuk, M Caputo, L Burgos Pratx, V Ré, L Fortuny, A Pontoriero, A Frías, O Torres, F Nuñez, A Gadano, D Corach, D Flichman. Distribution of genetic polymorphisms associated with hepatitis C virus (HCV) antiviral response in a multiethnic and admixed populationThe Pharmacogenomics Journal 2014; 14(6): 549 doi: 10.1038/tpj.2014.20
191
Portulaca oleracea L. as a Prospective Candidate Inhibitor of Hepatitis C Virus NS3 Serine ProteaseViral Immunology 2015; 28(5): 282 doi: 10.1089/vim.2014.0079
192
Shingo Iwasa, Naoko Sato, Chao-Wen Wang, Yun-Hsin Cheng, Hayato Irokawa, Gi-Wook Hwang, Akira Naganuma, Shusuke Kuge, Clarissa Menezes Maya-Monteiro. The Phospholipid:Diacylglycerol Acyltransferase Lro1 Is Responsible for Hepatitis C Virus Core-Induced Lipid Droplet Formation in a Yeast Model SystemPLOS ONE 2016; 11(7): e0159324 doi: 10.1371/journal.pone.0159324
193
Florian R. Fritzsche, Manfred Dietel, Wilko Weichert, Ann-Christin Buckendahl. Cut-resistant protective gloves in pathology—effective and cost-effectiveVirchows Archiv 2008; 452(3): 313 doi: 10.1007/s00428-008-0576-y
194
Atkinson G. Longmire, Seth Sims, Inna Rytsareva, David S. Campo, Pavel Skums, Zoya Dimitrova, Sumathi Ramachandran, Magdalena Medrzycki, Hong Thai, Lilia Ganova-Raeva, Yulin Lin, Lili T. Punkova, Amanda Sue, Massimo Mirabito, Silver Wang, Robin Tracy, Victor Bolet, Thom Sukalac, Chris Lynberg, Yury Khudyakov. GHOST: global hepatitis outbreak and surveillance technologyBMC Genomics 2017; 18(S10) doi: 10.1186/s12864-017-4268-3
195
Fernanda Bernadelli Garcia, Gilberto de Araújo Pereira, Paulo Roberto Juliano Martins, Helio Moraes-Souza. Epidemiological profile of hepatitis C in blood donors at the Uberaba Regional Blood CenterRevista da Sociedade Brasileira de Medicina Tropical 2009; 42(1): 1 doi: 10.1590/S0037-86822009000100001
196
Henry Namme Luma, Servais Albert Fiacre Bagnaka Eloumou, Agnes Malongue, Elvis Temfack, Dominique Noah Noah, Olivier Donfack-Sontsa, Ivo Che Ditah. Characteristics of anti-hepatitis C virus antibody-positive patients in a hospital setting in Douala, CameroonInternational Journal of Infectious Diseases 2016; 45: 53 doi: 10.1016/j.ijid.2016.02.013
197
Seyed Moayed Alavian, Seyed Hossein Aalaei-Andabili. Lack of Knowledge About Hepatitis C Infection Rates Among Patients With Inherited Coagulation Disorders in Countries Under the Eastern Mediterranean Region Office of WHO (EMRO): A Meta-AnalysisHepatitis Monthly 2012; 12(4): 244 doi: 10.5812/hepatmon.6050
198
Roghayeh Teimourpour, Zahra Meshkat, Aida Gholoubi, Hosein Nomani, Sina Rostami. Viral Load Analysis of Hepatitis C Virus in Huh7.5 Cell Culture SystemJundishapur Journal of Microbiology 2015; 8(5) doi: 10.5812/jjm.8(5)2015.19279
199
Weidong Hu, Ping’an Wang, Chuanjun Song, Zhenliang Pan, Qiang Wang, Xiaohe Guo, Xuejun Yu, Zhenhua Shen, Shuyang Wang, Junbiao Chang. Synthesis and anti-HCV activity of a new 2′-deoxy-2′-fluoro-2′-C-methyl nucleoside analogueBioorganic & Medicinal Chemistry Letters 2010; 20(24): 7297 doi: 10.1016/j.bmcl.2010.10.076
200
Nathan A. Cannon, Maureen J. Donlin, Xiaofeng Fan, Rajeev Aurora, John E. Tavis, Sheila Mary Bowyer. Hepatitis C Virus Diversity and Evolution in the Full Open-Reading Frame during Antiviral TherapyPLoS ONE 2008; 3(5): e2123 doi: 10.1371/journal.pone.0002123
201
Lucia Flores-Contreras, Ana S Sandoval-Rodríguez, Mayra G Mena-Enriquez, Silvia Lucano-Landeros, Inmaculada Arellano-Olivera, Arnulfo Álvarez-Álvarez, M Guadalupe Sanchez-Parada, Juan Armendáriz-Borunda. Treatment with pirfenidone for two years decreases fibrosis, cytokine levels and enhances CB2 gene expression in patients with chronic hepatitis CBMC Gastroenterology 2014; 14(1) doi: 10.1186/1471-230X-14-131
202
Vaithilingaraja Arumugaswami, Roland Remenyi, Vidhya Kanagavel, Eric Yiang Sue, Tuyet Ngoc Ho, Chang Liu, Vanessa Fontanes, Asim Dasgupta, Ren Sun, Donald E. Ganem. High-Resolution Functional Profiling of Hepatitis C Virus GenomePLoS Pathogens 2008; 4(10): e1000182 doi: 10.1371/journal.ppat.1000182
203
Françoise Stoll-Keller, Heidi Barth, Samira Fafi-Kremer, Mirjam B Zeisel, Thomas F Baumert. Development of hepatitis C virus vaccines: challenges and progressExpert Review of Vaccines 2009; 8(3): 333 doi: 10.1586/14760584.8.3.333
204
Laura Patrícia Viana Maia, Olindo Assis Martins-Filho, Andréa Teixeira-Carvalho, Elaine Speziali, Rolandro Vermhren, Edson Fonseca Lira, Tatiane Amabile Lima, Wornei Silva Braga, Kátia Luz Torres, Adriana Malheiro. Hepatitis C virus screening and clinical monitoring of biomarkers in patients undergoing hemodialysisJournal of Medical Virology 2009; 81(7): 1220 doi: 10.1002/jmv.21521
205
Ling Lu, Chunhua Li, Yan Xu, Donald G. Murphy. Full-length genomes of 16 hepatitis C virus genotype 1 isolates representing subtypes 1c, 1d, 1e, 1g, 1h, 1i, 1j and 1k, and two new subtypes 1m and 1n, and four unclassified variants reveal ancestral relationships among subtypes Journal of General Virology 2014; 95(7): 1479 doi: 10.1099/vir.0.064980-0
206
Resat Ozaras, Veysel Tahan. Acute hepatitis C: prevention and treatmentExpert Review of Anti-infective Therapy 2009; 7(3): 351 doi: 10.1586/eri.09.8
207
Mauro Viganò, Carlo Federico Perno, Antonio Craxì, Alessio Aghemo, Alfredo Alberti, Pietro Andreone, Massimo Andreoni, Stefano Bonora, Maurizia Rossana Brunetto, Raffaele Bruno, Savino Bruno, Vincenza Calvaruso, Nicola Caporaso, Francesca Ceccherini-Silberstein, Valeria Cento, Alessia Ciancio, Piero Colombatto, Elisabetta Degasperi, Vito Di Marco, Giovanni Di Perri, Gianpiero D’offizi, Stefano Fagiuoli, Carlo Ferrari, Giovanni Battista Gaeta, Adriano Pellicelli, Salvatore Petta, Sara Piovesan, Massimo Puoti, Giovanni Raimondo, Francesco Paolo Russo, Gloria Taliani, Ugo Trama, Erica Villa, Anna Linda Zignego. Treatment of Hepatitis C virus infection in Italy: A consensus report from an expert panelDigestive and Liver Disease 2017; 49(7): 731 doi: 10.1016/j.dld.2017.03.027
208
Jae Young Jang, Raymond T. Chung. Chronic Hepatitis CGut and Liver 2011; 5(2): 117 doi: 10.5009/gnl.2011.5.2.117
209
Alice Russell, Nilay Hepgul, Naghmeh Nikkheslat, Alessandra Borsini, Zuzanna Zajkowska, Natalie Moll, Daniel Forton, Kosh Agarwal, Trudie Chalder, Valeria Mondelli, Matthew Hotopf, Anthony Cleare, Gabrielle Murphy, Graham Foster, Terry Wong, Gregor A. Schütze, Markus J. Schwarz, Neil Harrison, Patricia A. Zunszain, Carmine M. Pariante. Persistent fatigue induced by interferon-alpha: a novel, inflammation-based, proxy model of chronic fatigue syndromePsychoneuroendocrinology 2019; 100: 276 doi: 10.1016/j.psyneuen.2018.11.032
210
Adam Trickey, Hannah Fraser, Aaron G Lim, Amy Peacock, Samantha Colledge, Josephine G Walker, Janni Leung, Jason Grebely, Sarah Larney, Natasha K Martin, Matthew Hickman, Louisa Degenhardt, Margaret T May, Peter Vickerman. The contribution of injection drug use to hepatitis C virus transmission globally, regionally, and at country level: a modelling studyThe Lancet Gastroenterology & Hepatology 2019; 4(6): 435 doi: 10.1016/S2468-1253(19)30085-8
211
Samar Samir Youssef, Ahmed Mohamed Fahmy, Moataza Hassan Omran, Amr Saad Mohamed, Mohamed Ali El Desouki, Mostafa K. El-Awady. In VitroInhibition of Hepatitis C Virus by Antisense Oligonucleotides in PBMC Compared to Hepatoma CellsBioMed Research International 2014; 2014: 1 doi: 10.1155/2014/196712
212
Carmen L R Lopes, Sheila A Teles, Márcia P Espírito-Santo, Elisabete Lampe, Fabiana P Rodrigues, Ana Rita C Motta-Castro, Thaís A Marinho, Nádia R Reis, Ágabo M C Silva, Regina M B Martins. Prevalência, fatores de risco e genótipos da hepatite C entre usuários de drogasRevista de Saúde Pública 2009; 43(suppl 1): 43 doi: 10.1590/S0034-89102009000800008
213
Sahar EL Hadad, Hesa Al-Hamdan, Sabah Linjawi, Yury E Khudyakov. Partial sequencing analysis of the NS5B region confirmed the predominance of hepatitis C virus genotype 1 infection in Jeddah, Saudi ArabiaPLOS ONE 2017; 12(5): e0178225 doi: 10.1371/journal.pone.0178225
214
Vincenza Calvaruso, Marta Mazza, Piero L Almasio. Pegylated-interferon-α2ain clinical practice: how to manage patients suffering from side effectsExpert Opinion on Drug Safety 2011; 10(3): 429 doi: 10.1517/14740338.2011.559161
215
John Halliday, Paul Klenerman, Eleanor Barnes. Vaccination for hepatitis C virus: closing in on an evasive targetExpert Review of Vaccines 2011; 10(5): 659 doi: 10.1586/erv.11.55
216
Pankaj Puri, Anil C. Anand, Vivek A. Saraswat, Subrat K. Acharya, Radha K. Dhiman, Rakesh Aggarwal, Shivram P. Singh, Deepak Amarapurkar, Anil Arora, Mohinish Chhabra, Kamal Chetri, Gourdas Choudhuri, Vinod K. Dixit, Ajay Duseja, Ajay K. Jain, Dharmesh Kapoorz, Premashis Kar, Abraham Koshy, Ashish Kumar, Kaushal Madan, Sri P. Misra, Mohan V.G. Prasad, Aabha Nagral, Amarendra S. Puri, R. Jeyamani, Sanjiv Saigal, Shiv K. Sarin, Samir Shah, P.K. Sharma, Ajit Sood, Sandeep Thareja, Manav Wadhawan. Consensus Statement of HCV Task Force of the Indian National Association for Study of the Liver (INASL). Part I: Status Report of HCV Infection in IndiaJournal of Clinical and Experimental Hepatology 2014; 4(2): 106 doi: 10.1016/j.jceh.2014.05.006
217
Otávio M. Espíndola, Alexandre G. Vizzoni, Elisabeth Lampe, Maria José Andrada-Serpa, Abelardo Q.C. Araújo, Ana Claudia C. Leite. Hepatitis C virus and human T-cell lymphotropic virus type 1 co-infection: impact on liver disease, virological markers, and neurological outcomesInternational Journal of Infectious Diseases 2017; 57: 116 doi: 10.1016/j.ijid.2017.01.037
218
Jayendrakumar Patel, Preeti Sharma. Design of a novel rapid immunoassay for simultaneous detection of hepatitis C virus core antigen and antibodiesArchives of Virology 2020; 165(3): 627 doi: 10.1007/s00705-019-04518-0
219
Nicholas A. Meanwell, John F. Kadow, Paul M. Scola. Annual Reports in Medicinal Chemistry Volume 44Annual Reports in Medicinal Chemistry 2009; 44: 397 doi: 10.1016/S0065-7743(09)04420-0
220
Lindsay A. Petty, Jennifer L. Steinbeck, Kenneth Pursell, Donald M. Jensen. Human Immunodeficiency Virus and Coinfection with Hepatitis B and CInfectious Disease Clinics of North America 2014; 28(3): 477 doi: 10.1016/j.idc.2014.05.005
221
Pavel Skums, Zoya Dimitrova, David S Campo, Gilberto Vaughan, Livia Rossi, Joseph C Forbi, Jonny Yokosawa, Alex Zelikovsky, Yury Khudyakov. Efficient error correction for next-generation sequencing of viral ampliconsBMC Bioinformatics 2012; 13(S10) doi: 10.1186/1471-2105-13-S10-S6
222
Guangming Chen, Hongyu Ren, Nanjing Zhang, William Lennox, Anthony Turpoff, Steven Paget, Chunshi Li, Neil Almstead, F. George Njoroge, Zhengxian Gu, Jason Graci, Stephen P. Jung, Joseph Colacino, Fred Lahser, Xin Zhao, Marla Weetall, Amin Nomeir, Gary M. Karp. 6-(Azaindol-2-yl)pyridine-3-sulfonamides as potent and selective inhibitors targeting hepatitis C virus NS4BBioorganic & Medicinal Chemistry Letters 2015; 25(4): 781 doi: 10.1016/j.bmcl.2014.12.093
223
Robert Flisiak, Saya V. Feinman, Maciej Jablkowski, Andrzej Horban, Wieslaw Kryczka, Małgorzata Pawlowska, Jenny E. Heathcote, Giuseppe Mazzella, Carmen Vandelli, Valérie Nicolas-Métral, Pierre Grosgurin, Jorge S. Liz, Pietro Scalfaro, Hervé Porchet, Raf Crabbé. The cyclophilin inhibitor Debio 025 combined with PEG IFNα2a significantly reduces viral load in treatment-naïve hepatitis C patientsHepatology 2009; 49(5): 1460 doi: 10.1002/hep.22835
224
Lauren Tal Grinspan, Elizabeth C. Verna. Liver Anesthesiology and Critical Care Medicine2018; : 21 doi: 10.1007/978-3-319-64298-7_2
225
Anita Netyő, Gabriella Lengyel, János Fehér. Intrafamilial hepatitis C virus infectionOrvosi Hetilap 2008; 149(11): 517 doi: 10.1556/oh.2008.28333
226
Smitha Kota, Virginia Takahashi, Feng Ni, John K. Snyder, A. Donny Strosberg, Gunnar F. Kaufmann. Direct Binding of a Hepatitis C Virus Inhibitor to the Viral Capsid ProteinPLoS ONE 2012; 7(2): e32207 doi: 10.1371/journal.pone.0032207
227
Min Zhong, Eric Peng, Ningwu Huang, Qi Huang, Anja Huq, Meiyen Lau, Richard Colonno, Leping Li. Discovery of novel potent HCV NS5B polymerase non-nucleoside inhibitors bearing a fused benzofuran scaffoldBioorganic & Medicinal Chemistry Letters 2018; 28(5): 963 doi: 10.1016/j.bmcl.2018.01.029
228
Gretja Schnell, Yueh-Ming Loo, Joseph Marcotrigiano, Michael Gale, Karen L. Mossman. Uridine Composition of the Poly-U/UC Tract of HCV RNA Defines Non-Self Recognition by RIG-IPLoS Pathogens 2012; 8(8): e1002839 doi: 10.1371/journal.ppat.1002839
229
Ching-Chih Hu, Cheng-Hao Weng, Chih-Lang Lin, Hui-Ching Tien, Yen-Lin Kuo, Cheng-Hung Chien, Cho-Li Yen, Chun-Yen Lin, Rong-Nan Chien. Predictors of Changes in Hemoglobin Levels in Patients with Chronic Hepatitis C Treated with Ribavirin Plus Pegylated Interferon-αRenal Failure 2012; 34(4): 429 doi: 10.3109/0886022X.2011.650562
230
Dimitrios Paraskevis, Dora C. Stylianou, Johana Hezka, Zachariah Stern, Martha Oikonomopoulou, Ioannis Mamais, Leondios G. Kostrikis. HCV Phylogeography of the General Population and High-Risk Groups in Cyprus Identifies the Island as a Global Sink for and Source of InfectionScientific Reports 2019; 9(1) doi: 10.1038/s41598-019-46552-7
231
Birke Bartosch, Jean Dubuisson. Recent Advances in Hepatitis C Virus Cell EntryViruses 2010; 2(3): 692 doi: 10.3390/v2030692
232
Emma R. Miller, Jan M. Moore, Peng Bi. Harm Reduction Behind BarsSAGE Open 2013; 3(3): 215824401349420 doi: 10.1177/2158244013494209
233
Jin-Ching Lee, Wei-Chun Chen, Shou-Fang Wu, Chin-kai Tseng, Ching-Yi Chiou, Fang-Rong Chang, Shih-hsien Hsu, Yang-Chang Wu. Anti-hepatitis C virus activity of Acacia confusa extract via suppressing cyclooxygenase-2Antiviral Research 2011; 89(1): 35 doi: 10.1016/j.antiviral.2010.11.003
234
Alexander Gutfraind, Basmattee Boodram, Nikhil Prachand, Atesmachew Hailegiorgis, Harel Dahari, Marian E. Major, Lars Kaderali. Agent-Based Model Forecasts Aging of the Population of People Who Inject Drugs in Metropolitan Chicago and Changing Prevalence of Hepatitis C InfectionsPLOS ONE 2015; 10(9): e0137993 doi: 10.1371/journal.pone.0137993
235
Mustafa Altindis, Tuba Dal, Isin Akyar, Onur Karatuna, Selma Gokahmetoglu, Seda Tezcan Ulger, Canan Kulah, Berrin Uzun, Aslı Gamze Şener, Mehmet Ozdemir, Sibel Aydogan, Mert Ahmet Kuskucu, Kenan Midilli, Baris Otlu, Mustafa Kemal Celen, Kurtulus Buruk, Huseyin Guducuoglu. Six-year distribution pattern of hepatitis C virus in Turkey: a multicentre studyBiotechnology & Biotechnological Equipment 2016; 30(2): 335 doi: 10.1080/13102818.2015.1093430
236
Poupak Fallahi, Silvia Martina Ferrari, Ugo Politti, Dilia Giuggioli, Clodoveo Ferri, Alessandro Antonelli. Autoimmune and Neoplastic Thyroid Diseases Associated with Hepatitis C Chronic InfectionInternational Journal of Endocrinology 2014; 2014: 1 doi: 10.1155/2014/935131
237
Sanaa M. Kamal, Ahmed M. Fouad. Hepatitis C in Developing Countries2018; : 177 doi: 10.1016/B978-0-12-803233-6.00014-X
238
Simona Bota, Ioan Sporea, Roxana Şirli, Alina Popescu, Adriana Maria Neghină, Mirela Dănilă, Mihnea Străin. Severe adverse events during antiviral therapy in hepatitis C virus cirrhotic patients: A systematic reviewWorld Journal of Hepatology 2013; 5(3): 120-126 doi: 10.4254/wjh.v5.i3.120
239
Nabeen C. Nayak, Deepali Jain, Nandini Vasdev, Hanni Gulwani, Sanjiv Saigal, Arvinder Soin. Etiologic types of end-stage chronic liver disease in adultsEuropean Journal of Gastroenterology & Hepatology 2012; 24(10): 1199 doi: 10.1097/MEG.0b013e32835643f1
240
Babita Agrawal, Rakesh Kumar. Symbiotic chemo- and immuno-therapy for hepatitis B and C virusesWorld Journal of Gastroenterology 2016; 22(25): 5623-5626 doi: 10.3748/wjg.v22.i25.5623
241
MM Sohail, MG Yasin, S Ahmad. A phenomenological account of social sources, coping effects and relational role of social support in nursing among chronic patients with hepatitisJournal of Research in Nursing 2018; 23(1): 23 doi: 10.1177/1744987117736362
242
Behzad Hajarizadeh, Jason Grebely, Gregory J. Dore. Epidemiology and natural history of HCV infectionNature Reviews Gastroenterology & Hepatology 2013; 10(9): 553 doi: 10.1038/nrgastro.2013.107
243
Gaby S. Steba, Sylvie M. Koekkoek, Michael W. T. Tanck, Joost W. Vanhommerig, Jan T. M. van der Meer, David Kwa, Kees Brinkman, Maria Prins, Ben Berkhout, Georgios Pollakis, Richard Molenkamp, Janke Schinkel, William A. Paxton. SNP rs688 within the low-density lipoprotein receptor (LDL-R) gene associates with HCV susceptibilityLiver International 2019; 39(3): 463 doi: 10.1111/liv.13978
244
Dorothea Bankwitz, Eike Steinmann, Julia Bitzegeio, Sandra Ciesek, Martina Friesland, Eva Herrmann, Mirjam B. Zeisel, Thomas F. Baumert, Zhen-yong Keck, Steven K. H. Foung, Eve-Isabelle Pécheur, Thomas Pietschmann. Hepatitis C Virus Hypervariable Region 1 Modulates Receptor Interactions, Conceals the CD81 Binding Site, and Protects Conserved Neutralizing EpitopesJournal of Virology 2010; 84(11): 5751 doi: 10.1128/JVI.02200-09
245
S. B. MATOS, A. L. S. R. JESUS, K. C. M. C. PEDROZA, H. R. S. SODRE, T. L. H. FERREIRA, F. W. M. LIMA. Prevalence of serological markers and risk factors for bloodborne pathogens in Salvador, Bahia state, BrazilEpidemiology and Infection 2013; 141(1): 181 doi: 10.1017/S0950268812000386
246
Giody Bartolomei, Recep Emrah Cevik, Alessandro Marcello. Modulation of hepatitis C virus replication by iron and hepcidin in Huh7 hepatocytes Journal of General Virology 2011; 92(9): 2072 doi: 10.1099/vir.0.032706-0
247
Federico Alejandro Di Lello, Adrián Alejandro Farias, Andrés Carlos Alberto Culasso, Paula Soledad Pérez, María Belén Pisano, Marta Silvia Contigiani, Rodolfo Héctor Campos, Viviana Elizabeth Ré. Changing epidemiology of hepatitis C virus genotypes in the central region of ArgentinaArchives of Virology 2015; 160(4): 909 doi: 10.1007/s00705-015-2390-6
248
David S. Campo, Guo-Liang Xia, Zoya Dimitrova, Yulin Lin, Joseph C. Forbi, Lilia Ganova-Raeva, Lili Punkova, Sumathi Ramachandran, Hong Thai, Pavel Skums, Seth Sims, Inna Rytsareva, Gilberto Vaughan, Ha-Jung Roh, Michael A. Purdy, Amanda Sue, Yury Khudyakov. Accurate Genetic Detection of Hepatitis C Virus Transmissions in Outbreak SettingsJournal of Infectious Diseases 2016; 213(6): 957 doi: 10.1093/infdis/jiv542
249
Coral Lever, Kathryn L. Nash. Hepatitis CMedicine 2011; 39(9): 550 doi: 10.1016/j.mpmed.2011.06.007
250
Carlos Santos, Alexanda Reis, Cintia Vilhena dos Santos, Cristine Damas, Mariliza Henrique Silva, Mônica Valverde Viana, Maria Lucia Ferraz, Dimas Carnauba, Fabiane El-Far, Fernando Serra, Ricardo Sobhie Diaz. The use of real-time PCR to detect hepatitis C virus RNA in dried blood spots from Brazilian patients infected chronicallyJournal of Virological Methods 2012; 179(1): 17 doi: 10.1016/j.jviromet.2011.06.012
251
Norah J. Shire, Kenneth E. Sherman. Epidemiology of Hepatitis C VirusGastroenterology Clinics of North America 2015; 44(4): 699 doi: 10.1016/j.gtc.2015.07.002
252
Ugo Fedeli, Enrico Grande, Francesco Grippo, Luisa Frova. Mortality associated with hepatitis C and hepatitis B virus infection: A nationwide study on multiple causes of death dataWorld Journal of Gastroenterology 2017; 23(10): 1866-1871 doi: 10.3748/wjg.v23.i10.1866
253
Nusrat Subhan, Geoffrey E. Burrows, Philip G. Kerr, Hassan K. Obied. Studies in Natural Products Chemistry 2018; 57: 247 doi: 10.1016/B978-0-444-64057-4.00009-0
254
Alejandro Soza, Pilar Labbé, Marco Arrese, Arnoldo Riquelme, Francisco Barrera, Carlos Benítez, Alvaro Huete, M. Elvira Balcells, Jaime Labarca. Mycobacterium abscessus pulmonary infection during hepatitis C treatment with telaprevir, peginterferon and ribavirinAnnals of Hepatology 2015; 14(1): 132 doi: 10.1016/S1665-2681(19)30811-7
255
Michael James Babineaux, Miriam J. Alter. Netter’s Infectious Diseases2012; : 400 doi: 10.1016/B978-1-4377-0126-5.00067-7
256
M.S. Kupka. Reproduktionsmedizin2013; : 425 doi: 10.1007/978-3-642-30181-0_38
257
Aldemir B Oliveira-Filho, Adriana SC Pimenta, Márcia FM Rojas, Márcia CM Chagas, José Ângelo B Crescente, Deborah M Crespo, José Alexandre R Lemos. Prevalence and genotyping of hepatitis C virus in blood donors in the state of Pará, Northern BrazilMemórias do Instituto Oswaldo Cruz 2010; 105(1): 103 doi: 10.1590/S0074-02762010000100016
258
Maria Z. Sulbarán, Federico A. Di Lello, Yoneira Sulbarán, Clarisa Cosson, Carmen L. Loureiro, Héctor R. Rangel, Jean F. Cantaloube, Rodolfo H. Campos, Gonzalo Moratorio, Juan Cristina, Flor H. Pujol, Sheila Mary Bowyer. Genetic History of Hepatitis C Virus in Venezuela: High Diversity and Long Time of Evolution of HCV Genotype 2PLoS ONE 2010; 5(12): e14315 doi: 10.1371/journal.pone.0014315
259
Gaby S. Steba, Sylvie M. Koekkoek, Maria Prins, Kees Brinkman, David Kwa, Jan T.M. van der Meer, Marc van der Valk, Richard Molenkamp, Georgios Pollakis, Janke Schinkel, William A. Paxton. Bile-salt stimulated lipase polymorphisms do not associate with HCV susceptibilityVirus Research 2019; 274: 197715 doi: 10.1016/j.virusres.2019.197715
260
Aparna Goel, Aijaz Ahmed, Imam Waked. Clinical Epidemiology of Chronic Liver Diseases2019; : 149 doi: 10.1007/978-3-319-94355-8_12
261
Partha Roy, Anubha Patel, Kavita Lole, R.M. Gupta, Arun Kumar, S. Hazra. Prevalence and genotyping pattern of hepatitis C virus among patients on maintenance hemodialysis at five centers in Pune, IndiaMedical Journal Armed Forces India 2019; 75(1): 74 doi: 10.1016/j.mjafi.2018.08.001
262
Loubna Jouan, Pierre Melançon, Ian-Gaël Rodrigue-Gervais, Valérie-Ann Raymond, Subajini Selliah, Geneviève Boucher, Marc Bilodeau, Nathalie Grandvaux, Daniel Lamarre. Distinct antiviral signaling pathways in primary human hepatocytes and their differential disruption by HCV NS3 proteaseJournal of Hepatology 2010; 52(2): 167 doi: 10.1016/j.jhep.2009.11.011
263
Thomas Astell-Burt, Robin Flowerdew, Paul Boyle, John Dillon. Is travel-time to a specialist centre a risk factor for non-referral, non-attendance and loss to follow-up among patients with hepatitis C (HCV) infection?Social Science & Medicine 2012; 75(1): 240 doi: 10.1016/j.socscimed.2012.02.046
264
Guangming Chen, Hongyu Ren, Anthony Turpoff, Alexander Arefolov, Richard Wilde, James Takasugi, Atiyya Khan, Neil Almstead, Zhengxian Gu, Takashi Komatsu, Connie Freund, Jamie Breslin, Joseph Colacino, Jean Hedrick, Marla Weetall, Gary M. Karp. Discovery of N-(4′-(indol-2-yl)phenyl)sulfonamides as novel inhibitors of HCV replicationBioorganic & Medicinal Chemistry Letters 2013; 23(13): 3942 doi: 10.1016/j.bmcl.2013.04.050
265
Chapter 9: Infection-related glomerulonephritisKidney International Supplements 2012; 2(2): 200 doi: 10.1038/kisup.2012.22
266
Ijaz S Jamall, Shafaq Yusuf, Maimoona Azhar, Selene Jamall. Is pegylated interferon superior to interferon, with ribavarin, in chronic hepatitis C genotypes 2/3?World Journal of Gastroenterology 2008; 14(43): 6627-6631 doi: 10.3748/wjg.14.6627
267
Yalin Liao, Esmail El-Fakkarany, Bo Lönnerdal, Elrashdy M. Redwan. Inhibitory effects of native and recombinant full-length camel lactoferrin and its N and C lobes on hepatitis C virus infection of Huh7.5 cells Journal of Medical Microbiology 2012; 61(3): 375 doi: 10.1099/jmm.0.033894-0
268
Koen Van Herck, A. Vorsters, P. Van Damme. Prevention of viral hepatitis (B and C) reassessedBest Practice & Research Clinical Gastroenterology 2008; 22(6): 1009 doi: 10.1016/j.bpg.2008.11.008
269
Alison Jazwinski, Andrew Muir. IL28B: Implications for Clinical PracticeCurrent Hepatitis Reports 2012; 11(1): 15 doi: 10.1007/s11901-011-0118-y
270
G. P. WATT, K. P. VATCHEVA, L. BERETTA, J. J. PAN, M. B. FALLON, J. B. McCORMICK, S. P. FISHER-HOCH. Hepatitis C virus in Mexican Americans: a population-based study reveals relatively high prevalence and negative association with diabetesEpidemiology and Infection 2016; 144(2): 297 doi: 10.1017/S0950268815001247
271
Debasis Das, Jian Hong, Shu-Hui Chen, Guangyi Wang, Leonid Beigelman, Scott D. Seiwert, Brad O. Buckman. Recent advances in drug discovery of benzothiadiazine and related analogs as HCV NS5B polymerase inhibitorsBioorganic & Medicinal Chemistry 2011; 19(16): 4690 doi: 10.1016/j.bmc.2011.06.079
272
Cara S. Kosack, Sigrid Nick. Evaluation of two rapid screening assays for detecting hepatitis C antibodies in resource-constrained settingsTropical Medicine & International Health 2016; 21(5): 603 doi: 10.1111/tmi.12688
273
Juliane Doerrbecker, Martina Friesland, Sandra Ciesek, Thomas J. Erichsen, Pedro Mateu-Gelabert, Jörg Steinmann, Jochen Steinmann, Thomas Pietschmann, Eike Steinmann. Inactivation and Survival of Hepatitis C Virus on Inanimate SurfacesThe Journal of Infectious Diseases 2011; 204(12): 1830 doi: 10.1093/infdis/jir535
274
Chunhua Li, Richard Njouom, Jacques Pépin, Tatsunori Nakano, Phil Bennett, Oliver G. Pybus, Ling Lu. Characterization of full-length hepatitis C virus sequences for subtypes 1e, 1h and 1l, and a novel variant revealed Cameroon as an area in origin for genotype 1 Journal of General Virology 2013; 94(8): 1780 doi: 10.1099/vir.0.048835-0
275
Sadaf Badar, Sadaf Badar, Bushra Khubaib, Bushra Khubaib, Muhammad Idrees, Muhammad Idrees, Abrar Hussain, Abrar Hussain, Zunaira Awan, Zunaira Awan, Sadia Butt, Sadia Butt, Samia Afzal, Samia Afzal, Madeeha Akram, Madeeha Akram, Zareen Fatima, Zareen Fatima, Mahwish Aftab, Mahwish Aftab, Sana Saleem, Sana Saleem, Sara Munir, Sara Munir, Bisma Rauff, Bisma Rauff, Mahrukh Naudhani, Mahrukh Naudhani, Ali Liaquat, Liaquat Ali, Muhammaad Ali, Muhammaad Ali, Irshad-ul Rehman, Irshadul Rehman. Association of Hepatitis C Virus With Insulin Resistance: Evidences From Animal Studies and Clinical StudieHepatitis Monthly 2012; 12(1): 11 doi: 10.5812/hepatmon.4295
276
Jose A. Garcia-Rivera, Michael Bobardt, Udayan Chatterji, Sam Hopkins, Matthew A. Gregory, Barrie Wilkinson, Kai Lin, Philippe A. Gallay. Multiple Mutations in Hepatitis C Virus NS5A Domain II Are Required To Confer a Significant Level of Resistance to AlisporivirAntimicrobial Agents and Chemotherapy 2012; 56(10): 5113 doi: 10.1128/AAC.00919-12
277
Barbara Bertisch, Fabio Giudici, Francesco Negro, Darius Moradpour, Beat Müllhaupt, Alberto Moriggia, Janne Estill, Olivia Keiser, Yury E Khudyakov. Characteristics of Foreign-Born Persons in the Swiss Hepatitis C Cohort Study: Implications for Screening RecommendationsPLOS ONE 2016; 11(5): e0155464 doi: 10.1371/journal.pone.0155464
278
Simona Ruta, Costin Cernescu. Injecting drug use: A vector for the introduction of new hepatitis C virus genotypesWorld Journal of Gastroenterology 2015; 21(38): 10811-10823 doi: 10.3748/wjg.v21.i38.10811
279
Min Zhong, Eric Peng, Ningwu Huang, Qi Huang, Anja Huq, Meiyen Lau, Richard Colonno, Leping Li. Discovery of ravidasvir (PPI-668) as a potent pan-genotypic HCV NS5A inhibitorBioorganic & Medicinal Chemistry Letters 2016; 26(18): 4508 doi: 10.1016/j.bmcl.2016.07.066
280
Mithaq Sabeeh Khudur Al-Nassary, Batool Mutar Mahdi. Study of Hepatitis C Virus Detection AssaysAnnals of Medicine and Surgery 2018; 36: 47 doi: 10.1016/j.amsu.2018.10.002
281
Omar D. Lopez, Van N. Nguyen, Denis R. St. Laurent, Makonen Belema, Michael H. Serrano-Wu, Jason T. Goodrich, Fukang Yang, Yuping Qiu, Amy S. Ripka, Peter T. Nower, Lourdes Valera, Mengping Liu, Donald R. O’Boyle, Jin-Hua Sun, Robert A. Fridell, Julie A. Lemm, Min Gao, Andrew C. Good, Nicholas A. Meanwell, Lawrence B. Snyder. HCV NS5A replication complex inhibitors. Part 3: discovery of potent analogs with distinct core topologiesBioorganic & Medicinal Chemistry Letters 2013; 23(3): 779 doi: 10.1016/j.bmcl.2012.11.086
282
Nasar Khan, Muhammad Akmal, Muhammad Hayat, Attahullah xx, Iqbal Ahmed, Kashif Rahim, Sadar Ali, Sulaiman Bahadar, Shamim Saleha. Geographic Distribution of Hepatitis C Virus Genotypes in PakistanHepatitis Monthly 2014; 14(10) doi: 10.5812/hepatmon.20299
283
Qingxia Han, Chunlian Xu, Chunchen Wu, Wenbo Zhu, Rongge Yang, Xinwen Chen. Compensatory mutations in NS3 and NS5A proteins enhance the virus production capability of hepatitis C reporter virusVirus Research 2009; 145(1): 63 doi: 10.1016/j.virusres.2009.06.005
284
Victoria L. Demetriou, David A.M.C. van de Vijver, Johana Hezka, Leondios G. Kostrikis. Hepatitis C infection among intravenous drug users attending therapy programs in CyprusJournal of Medical Virology 2010; 82(2): 263 doi: 10.1002/jmv.21690
285
Maha A. Sultan, Maha M. Abou El-Alamin, Alastair W. Wark, Marwa M. Azab. Stability-indicating micellar enhanced spectro-fluorometric determination of Daclatasvir in its tablet and spiked human plasmaSpectrochimica Acta Part A: Molecular and Biomolecular Spectroscopy 2019; 211: 52 doi: 10.1016/j.saa.2018.11.023
286
Shu-Chi Wang, Jeng-Fu Yang, Chao-Ling Wang, Chung-Feng Huang, Yu-Yin Lin, Yi-You Chen, Chung-Ting Lo, Po-Yen Lee, Kuan-Ta Wu, Chia-I. Lin, Meng-Hsuan Hsieh, Hung-Yi Chuang, Chi-Kung Ho, Ming-Lung Yu, Chia-Yen Dai. Distinct subpopulations of hepatitis C virus infectious cells with different levels of intracellular hepatitis C virus core proteinThe Kaohsiung Journal of Medical Sciences 2016; 32(10): 487 doi: 10.1016/j.kjms.2016.08.002
287
Lindsay G Carter, John A D'Orazio, Kevin J Pearson. Resveratrol and cancer: focus on in vivo evidenceEndocrine-Related Cancer 2014; 21(3): R209 doi: 10.1530/ERC-13-0171
288
Tatiana Martins, Janaína Luz Narciso-Schiavon, Leonardo de Lucca Schiavon. Epidemiology of hepatitis C virus infectionRevista da Associação Médica Brasileira 2011; 57(1): 105 doi: 10.1016/S0104-4230(11)70024-0
289
Thomas Astell-Burt, Robin Flowerdew, Paul J. Boyle, John F. Dillon. Does geographic access to primary healthcare influence the detection of hepatitis C?Social Science & Medicine 2011; 72(9): 1472 doi: 10.1016/j.socscimed.2011.02.015
290
Fei Kong, Yu Pan, Xiumei Chi, Xiaomei Wang, Linjiao Chen, Juan Lv, Haibo Sun, Ruihong Wu, Jinglan Jin, Ge Yu, Zhenhua Ma, Yang Wang, Xinxing Huang, Hua Li, Yang Bai, Jing Jia, Gerald Y. Minuk, Jin Zhong, Bing Sun, Jing Jiang, Junqi Niu. Factors Associated with Spontaneous Clearance of Hepatitis C Virus in Chinese PopulationBioMed Research International 2014; 2014: 1 doi: 10.1155/2014/527030
291
Doaa I. Hashad, Perihan E. Salem, Dina M. Abdallah. Toll like receptor 3 expression as a novel predictor of response to treatment in chronic hepatitis C virus patientsScandinavian Journal of Clinical and Laboratory Investigation 2011; 71(8): 641 doi: 10.3109/00365513.2011.624196
292
Mohammed Mostafa Al-Tawil, Ahmed Saeed Shoeeb, Amal Abbas, Ahmed El-Tawil, Manal Hamdy El-Sayed. Lipid Profile and Hepatic Steatosis in Hepatitis C Infected Egyptian Survivors of Childhood CancerPediatric Hematology and Oncology 2015; 32(1): 70 doi: 10.3109/08880018.2013.825355
293
Paul Y. Kwo. Regimens for Cirrhotic PatientsClinics in Liver Disease 2015; 19(4): 657 doi: 10.1016/j.cld.2015.06.006
294
Alessandra Mangia, Maria Ripoli. Insulin resistance, steatosis and hepatitis C virusHepatology International 2013; 7(S2): 782 doi: 10.1007/s12072-013-9460-1
295
Claudia Suellen Ferro de Oliveira, Adenielson Vilar e Silva, Kemper Nunes dos Santos, Amanda Alves Fecury, Marcella Kelly Costa de Almeida, Adriana Prado Fernandes, Carlos Araújo da Costa, Andrei Silva Freitas, Tereza Cristina de Oliveira Corvelo, Luisa Caricio Martins. Hepatitis B and C virus infection among Brazilian Amazon ripariansRevista da Sociedade Brasileira de Medicina Tropical 2011; 44(5): 546 doi: 10.1590/S0037-86822011000500003
296
M. RONDY, L. WIESSING, S. J. HUTCHINSON, C. MATHEÏ, F. MATHIS, V. MRAVCIK, L. NORDEN, M. ROSIŃSKA, O. SCUTELNICIUC, B. SULIGOI, F. VALLEJO, M. VAN VEEN, M. KRETZSCHMAR. Hepatitis C prevalence in injecting drug users in Europe, 1990–2007: impact of study recruitment settingEpidemiology and Infection 2013; 141(3): 563 doi: 10.1017/S0950268812000921
297
Sobia Kanwal, Tariq Mahmood. Hepatitis C Viral Heterogeneity Based on Core Gene and an Attempt to Design Small Interfering RNA Against Strains Resistant to Interferon in Rawalpindi, PakistanHepatitis Monthly 2012; 12(6): 398 doi: 10.5812/hepatmon.6184
298
Jason T. Blackard, Ling Kong, Amanda K. Huber, Yaron Tomer. Hepatitis C Virus Infection of a Thyroid Cell Line: Implications for Pathogenesis of Hepatitis C Virus and ThyroiditisThyroid 2013; 23(7): 863 doi: 10.1089/thy.2012.0507
299
Yu-Lung Chiu, Herng-Ching Lin, Nai-Wen Kuo, Senyong Kao, Hsin-Chien Lee. Increased risk of concurrent hepatitis C among Male patients with schizophreniaPsychiatry Research 2017; 258: 217 doi: 10.1016/j.psychres.2017.08.036
300
Miriam J. Alter. Tropical Infectious Diseases: Principles, Pathogens and Practice2011; : 427 doi: 10.1016/B978-0-7020-3935-5.00065-3
301
Xiaoyong Zhang, Anke Kraft, Ruth Broering, Joerg F Schlaak, Ulf Dittmer, Mengji Lu. Preclinical development of TLR ligands as drugs for the treatment of chronic viral infectionsExpert Opinion on Drug Discovery 2012; 7(7): 597 doi: 10.1517/17460441.2012.689281
302
David Timm KVITKO, Gisele Alsina Nader BASTOS, Maria Eugênia Bresolin PINTO. PREVALENCE OF RISK FACTORS FOR HEPATITIS C AND ASSOCIATED FACTORS: a population-based study in southern BrazilArquivos de Gastroenterologia 2013; 50(2): 117 doi: 10.1590/S0004-28032013000200020
303
Umberto Vespasiani-Gentilucci, Giovanni Galati, Paolo Gallo, Antonio De Vincentis, Elisabetta Riva, Antonio Picardi. Hepatitis C treatment in the elderly: New possibilities and controversies towards interferon-free regimensWorld Journal of Gastroenterology 2015; 21(24): 7412-7426 doi: 10.3748/wjg.v21.i24.7412
304
Saira Sarfraz, Saeed Hamid, Syed Ali, Wasim Jafri, Anwar A Siddiqui. Modulations of cell cycle checkpoints during HCV associated diseaseBMC Infectious Diseases 2009; 9(1) doi: 10.1186/1471-2334-9-125
305
Isei Tanida, Yoshitaka Shirasago, Ryosuke Suzuki, Ryo Abe, Takaji Wakita, Kentaro Hanada, Masayoshi Fukasawa. Inhibitory Effects of Caffeic Acid, a Coffee-Related Organic Acid, on the Propagation of Hepatitis C VirusJapanese Journal of Infectious Diseases 2015; 68(4): 268 doi: 10.7883/yoken.JJID.2014.309
306
Patricia Baré. Hepatitis C virus and peripheral blood mononuclear cell reservoirs Patricia BaréWorld Journal of Hepatology 2009; 1(1): 67-71 doi: 10.4254/wjh.v1.i1.67
307
Wenkang Ma, Amr S Soliman, Wagida A Anwar, Ahmed Hablas, Tamer B El Din, Mohamed Ramadan, Ibrahim A Seifeldin, Mark L Wilson. Forecasted impacts of a sofosbuvir-based national hepatitis C treatment programme on Egypt’s hepatocellular cancer epidemic: simulation of alternativesBMJ Global Health 2018; 3(2): e000572 doi: 10.1136/bmjgh-2017-000572
308
Fabio Curcio, Giuseppina Villano, Salvatore Masucci, Marinella Plenzik, Ciro Veneruso, Giuseppe De Rosa. Epidemiological Survey of Hepatitis C Virus Infection in a Cohort of Patients From a Ser.T in Naples, ItalyJournal of Addiction Medicine 2011; 5(1): 43 doi: 10.1097/ADM.0b013e3181d131e0
309
Fatma Abdallah, Gehad Mohamed, Mohsen Ibrahim, Mokhtar El Tarabily. Effectiveness of Sofosbuvir, Ribavirin and PEG-IFNα-2a in the Treatment of Naïve Egyptian Patients With Chronic Hepatitis C Virus Genotype 4The American Journal of the Medical Sciences 2018; 355(5): 456 doi: 10.1016/j.amjms.2017.12.016
310
Cíntia Bittar, Ana Carolina G Jardim, Lilian HT Yamasaki, Artur TL de Queiróz, Claudia MA Carareto, João Renato R Pinho, Isabel Maria VG de Carvalho-Mello, Paula Rahal. Genetic diversity of NS5A protein from hepatitis C virus genotype 3a and its relationship to therapy responseBMC Infectious Diseases 2010; 10(1) doi: 10.1186/1471-2334-10-36
311
Gabor Lendvai, Katalin Jármay, Gizella Karácsony, Tünde Halász, Ilona Kovalszky, Kornélia Baghy, Tibor Wittmann, Zsuzsa Schaff, András Kiss. Elevated miR-33a and miR-224 in steatotic chronic hepatitis C liver biopsiesWorld Journal of Gastroenterology 2014; 20(41): 15343-15350 doi: 10.3748/wjg.v20.i41.15343
312
Jung-Chen Ho, Meng-Lun Hsieh, Po-Heng Chuang, Vivian Chia-Rong Hsieh. Cost-Effectiveness of Sorafenib Monotherapy and Selected Combination Therapy with Sorafenib in Patients with Advanced Hepatocellular CarcinomaValue in Health Regional Issues 2018; 15: 120 doi: 10.1016/j.vhri.2017.12.012
313
S. De Meyer, A. Ghys, G. R. Foster, M. Beumont, B. Van Baelen, T.-I. Lin, I. Dierynck, H. Ceulemans, G. Picchio. Analysis of genotype 2 and 3 hepatitis C virus variants in patients treated with telaprevir demonstrates a consistent resistance profile across genotypesJournal of Viral Hepatitis 2013; 20(6): 395 doi: 10.1111/jvh.12046
314
Milagros Dávalos Moscol. Indications for treatment in chronic HCV infectionAnnals of Hepatology 2010; 9: S49 doi: 10.1016/S1665-2681(19)31724-7
315
Judith I. Tsui, Stephen C. Ko, Evgeny Krupitsky, Dmitry Lioznov, Christine E. Chaisson, Natalia Gnatienko, Jeffrey H. Samet. Insights on the Russian HCV care cascade: minimal HCV treatment for HIV/HCV co-infected PWID in St. PetersburgHepatology, Medicine and Policy 2016; 1(1) doi: 10.1186/s41124-016-0020-x
316
Birke Bartosch, Robert Thimme, Hubert E. Blum, Fabien Zoulim. Hepatitis C virus-induced hepatocarcinogenesisJournal of Hepatology 2009; 51(4): 810 doi: 10.1016/j.jhep.2009.05.008
317
Gregory R Hart, Andrew L Ferguson. Empirical fitness models for hepatitis C virus immunogen designPhysical Biology 2015; 12(6): 066006 doi: 10.1088/1478-3975/12/6/066006
318
Sofia Lourenço, Fleur Costa, Béatrice Débarges, Thibault Andrieu, Annie Cahour. Hepatitis C virus internal ribosome entry site-mediated translation is stimulated by cis-acting RNA elements and trans-acting viral factorsFEBS Journal 2008; 275(16): 4179 doi: 10.1111/j.1742-4658.2008.06566.x
319
Chunhua Li, Manqiong Yuan, Ling Lu, Teng Lu, Wenjie Xia, Van H. Pham, An X.D. Vo, Mindie H. Nguyen, Kenji Abe. The genetic diversity and evolutionary history of hepatitis C virus in VietnamVirology 2014; : 197 doi: 10.1016/j.virol.2014.07.026
320
Jessica A. Briscoe, Sandra M. Quezada. Telemanagement of Inflammatory Bowel Disease2016; : 19 doi: 10.1007/978-3-319-22285-1_2
321
L. Bocket, S. Chevaliez, N. Talbodec, A. Sobaszek, J.M. Pawlotsky, Y. Yazdanpanah. Occupational transmission of hepatitis C virus resulting from use of the same supermarket meat slicerClinical Microbiology and Infection 2011; 17(2): 238 doi: 10.1111/j.1469-0691.2010.03245.x
322
Aldemir Branco de Oliveira-Filho, Adriana do Socorro Coelho Pimenta, Márcia de Fátima Maciel Rojas, Márcia Cristina Munhoz Chagas, Deborah Maia Crespo, José Ângelo Barletta Crescente, José Alexandre Rodrigues de Lemos. Likely transmission of hepatitis C virus through sharing of cutting and perforating instruments in blood donors in the State of Pará, Northern BrazilCadernos de Saúde Pública 2010; 26(4): 837 doi: 10.1590/S0102-311X2010000400025
323
Christoph T. Berger, Arthur Y. Kim. IL28B Polymorphisms as a Pretreatment Predictor of Response to HCV TreatmentInfectious Disease Clinics of North America 2012; 26(4): 863 doi: 10.1016/j.idc.2012.08.010
324
Aqsa Ikram, Sadia Anjum, Muhammad Tahir. InSilico Identification and Conservation Analysis of B-cell and T-Cell Epitopes of Hepatitis C Virus 3a Genotype Enveloped Glycoprotein 2From Pakistan: A Step Towards Heterologous Vaccine DesignHepatitis Monthly 2014; 14(4) doi: 10.5812/hepatmon.9832
325
Grégoire Vuagniaux, Arnaud Hamel, Rafael Crabbé, Hervé C. Porchet, Jean-Maurice Dumont. Antiviral Drug StrategiesMethods and Principles in Medicinal Chemistry 2011; : 147 doi: 10.1002/9783527635955.ch7
326
M. Michele Manos, Valentina A. Shvachko, Rosemary C. Murphy, Jean Marie Arduino, Norah J. Shire. Distribution of hepatitis C virus genotypes in a diverse US integrated health care populationJournal of Medical Virology 2012; 84(11): 1744 doi: 10.1002/jmv.23399
327
Noreen Akhtar, Muhammad Bilal, Muhammad Rizwan, Muhammad Asif Khan, Aurangzeb Khan. Genotypes of Hepatitis C Virus in Relapsed and Non-respondent Patients and their Response to Anti-Viral Therapy in District Mardan, Khyber Pakhtunkhawa, PakistanAsian Pacific Journal of Cancer Prevention 2015; 16(3): 1037 doi: 10.7314/APJCP.2015.16.3.1037
328
Arthur Zimmermann. Tumors and Tumor-Like Lesions of the Hepatobiliary Tract2016; : 1 doi: 10.1007/978-3-319-26587-2_164-1
329
Yan-Feng Pan, Yan Zheng, Tao Qin, Lei Feng, Qian Zhang, Xiao-Gong Ping, Yan-Ting Pan, Xiao-Ping Wang, Li Bai, Hua-Hua Li. Disease progression in Chinese patients with hepatitis C virus RNA-positive infection via blood transfusionExperimental and Therapeutic Medicine 2016; 12(5): 3476 doi: 10.3892/etm.2016.3792
330
Mark Aziz. Which of the direct acting anti-viral agents is the better drug in terms of efficacy, cost and safety, Boceprevir or Telaprevir?Medical Science and Discovery 2019; : 88 doi: 10.17546/msd.501220
331
Faraz Salehi Moghadam, Seyed Reza Mohebbi, Seyed Masoud Hosseini, Hanieh Mirtalebi, Sara Romani, Pedram Azimzadeh, Azar Sanati, Mohammad Reza Zali. Hepatitis C Virus Subtype 6a Infection in an Iranian Patient: A Case ReportJundishapur Journal of Microbiology 2013;  doi: 10.5812/jjm.6560
332
C. H. Lee, Y. J. Lee, J. H. Kim, J. H. Lim, J.-H. Kim, W. Han, S.-H. Lee, G.-J. Noh, S.-W. Lee. Inhibition of Hepatitis C Virus (HCV) Replication by Specific RNA Aptamers against HCV NS5B RNA ReplicaseJournal of Virology 2013; 87(12): 7064 doi: 10.1128/JVI.00405-13
333
Jeremiah Bowers, Emma Hughes, Nicholas Skill, Mary Maluccio, Daniel Raftery. Detection of hepatocellular carcinoma in hepatitis C patients: Biomarker discovery by LC–MSJournal of Chromatography B 2014; 966: 154 doi: 10.1016/j.jchromb.2014.02.043
334
Ricardo Andrade Carmo, Lorenza Nogueira Campos, Ana Paula Souto Melo, Mark Drew Crosland Guimarães. Hepatitis C among patients with mental illness in Brazil: an analysis of associated factorsGeneral Hospital Psychiatry 2013; 35(2): 129 doi: 10.1016/j.genhosppsych.2012.11.005
335
Sadaf Badar, Sadaf Badar, Bushra Khubaib, Bushra Khubaib, Muhammad Idrees, Muhammad Idrees, Abrar Hussain, Abrar Hussain, Zunaira Awan, Zunaira Awan, Sadia Butt, Sadia Butt, Samia Afzal, Samia Afzal, Madeeha Akram, Madeeha Akram, Zareen Fatima, Zareen Fatima, Mahwish Aftab, Mahwish Aftab, Sana Saleem, Sana Saleem, Sara Munir, Sara Munir, Bisma Rauff, Bisma Rauff, Mahrukh Naudhani, Mahrukh Naudhani, Ali Liaquat, Liaquat Ali, Muhammaad Ali, Muhammaad Ali, Irshad-ul Rehman, Irshadul Rehman. Association of Hepatitis C Virus With Insulin Resistance: Evidences From Animal Studies and Clinical StudieHepatitis Monthly 2012; 12(1): 11 doi: 10.5812/hepatmon.4295
336
Mohammad A. Ansari, Mohammad Irshad, Sanjay Kumar Agarwal, Kunzang Chosdol. Expression of the full-length HCV core subgenome from HCV gentoype-1a and genotype-3a and evaluation of the antigenicity of translational productsEuropean Journal of Gastroenterology & Hepatology 2013; 25(7): 806 doi: 10.1097/MEG.0b013e32835eb9b9
337
Nabiha Faisal, Khalid Mumtaz, Max Marquez, Eberhard L. Renner, Leslie B. Lilly. High sustained virological response to pegylated interferon and ribavirin for recurrent genotype 3 hepatitis C infection post-liver transplantationHepatology International 2015; 9(1): 76 doi: 10.1007/s12072-014-9589-6
338
Mustafa Atas, Arzu Seyhan Karatepe Hashas, Süleyman Demircan, Fatma Mutlu Sarıguzel, Burhan Baskan, Isa Yuvacı, Emine Pangal, Ilhami Celik, Gokmen Zararsiz. The Investigation of HCV RNA in Tear Fluid and Aqueous Humor in Patients with Anti-HCV Antibody Positive Who Underwent Cataract SurgeryOcular Immunology and Inflammation 2014; : 1 doi: 10.3109/09273948.2014.985386
339
Hiroyoshi Doi, Shiroh Tanoue, David E. Kaplan. Peripheral CD27−CD21− B-cells represent an exhausted lymphocyte population in hepatitis C cirrhosisClinical Immunology 2014; 150(2): 184 doi: 10.1016/j.clim.2013.12.001
340
Lance D. Presser, Steven McRae, Gulam Waris, Ching-Ping Tseng. Activation of TGF-β1 Promoter by Hepatitis C Virus-Induced AP-1 and Sp1: Role of TGF-β1 in Hepatic Stellate Cell Activation and InvasionPLoS ONE 2013; 8(2): e56367 doi: 10.1371/journal.pone.0056367
341
Lenka Benova, Yousra A. Mohamoud, Clara Calvert, Laith J. Abu-Raddad. Vertical Transmission of Hepatitis C Virus: Systematic Review and Meta-analysisClinical Infectious Diseases 2014; 59(6): 765 doi: 10.1093/cid/ciu447
342
Sobia Kanwal, Tariq Mahmood. Occurrence of genetic modifications in core, 5′UTR and NS5b of HCV associated with viral response to treatmentVirology Journal 2014; 11(1) doi: 10.1186/1743-422X-11-171
343
Reza Taherkhani, Fatemeh Farshadpour. Epidemiology of hepatitis C virus in IranWorld Journal of Gastroenterology 2015; 21(38): 10790-10810 doi: 10.3748/wjg.v21.i38.10790
344
Mei-Hing Ng, Jen-Yu Chou, Ta-Jen Chang, Pei-Chin Lee, Wen-Chuan Shao, Tsang-Yaw Lin, Vincent Chin-Hung Chen, Michael Gossop. High prevalence but low awareness of hepatitis C virus infection among heroin users who received methadone maintenance therapy in TaiwanAddictive Behaviors 2013; 38(4): 2089 doi: 10.1016/j.addbeh.2013.01.010
345
Sakshi Singh, Giovanni Colonna, Giovanni Di Bernardo, Francesca Bergantino, Marcella Cammarota, Giuseppe Castello, Susan Costantini. The gene expression profiling of hepatocellular carcinoma by a network analysis approach shows a dominance of intrinsically disordered proteins (IDPs) between hub nodesMolecular BioSystems 2015; 11(11): 2933 doi: 10.1039/C5MB00434A
346
Kenrad E. Nelson, Hua Shan. Confirmatory testing of hepatitis C virus–positive enzyme immunoassay results in limited-resource countries: should it be attempted?Transfusion 2008; 48(6): 1239 doi: 10.1111/j.1537-2995.2008.01696.x
347
A. M. G. Brunasso, M. Puntoni, A. Gulia, C. Massone. Safety of anti-tumour necrosis factor agents in patients with chronic hepatitis C infection: a systematic reviewRheumatology 2011; 50(9): 1700 doi: 10.1093/rheumatology/ker190
348
Hong-Min Ni, Jessica A. Williams, Hua Yang, Ying-Hong Shi, Jia Fan, Wen-Xing Ding. Targeting autophagy for the treatment of liver diseasesPharmacological Research 2012; 66(6): 463 doi: 10.1016/j.phrs.2012.07.003
349
Annagiulia Gramenzi, Fabio Conti, Calogero Cammà, Antonio Grieco, Antonino Picciotto, Caterina Furlan, Domenico Romagno, Paolo Costa, Maria Rendina, Fausto Ancarani, Maria Chiaramonte, Gabriella Verucchi, Antonio Craxì, Mauro Bernardi, Pietro Andreone. Hepatitis C in the elderly: A multicentre cross-sectional study by the Italian Association for the Study of the LiverDigestive and Liver Disease 2012; 44(8): 674 doi: 10.1016/j.dld.2012.03.009
350
Molly Jung, Mark H. Kuniholm, Gloria Y.F. Ho, Scott Cotler, Howard D. Strickler, Bharat Thyagarajan, Marston Youngblood, Robert C. Kaplan, Julia del Amo. The distribution of hepatitis B virus exposure and infection in a population-based sample of U.S. Hispanic adultsHepatology 2016; 63(2): 445 doi: 10.1002/hep.28328
351
Magdy Amin El Serafy, Abdel Meguid Kassem, Heba Omar, Mohammad Shaaban Mahfouz, Maissa El Said EL Raziky. APRI test and hyaluronic acid as non-invasive diagnostic tools for post HCV liver fibrosis: Systematic review and meta-analysisArab Journal of Gastroenterology 2017; 18(2): 51 doi: 10.1016/j.ajg.2017.05.005
352
Theresa Gather, Stephanie Walter, Daniel Todt, Stephanie Pfaender, Richard J. P. Brown, Alexander Postel, Paul Becher, Andreas Moritz, Florian Hansmann, Wolfgang Baumgaertner, Karsten Feige, Eike Steinmann, Jessika-M. V. Cavalleri. Vertical transmission of hepatitis C virus-like non-primate hepacivirus in horses Journal of General Virology 2016; 97(10): 2540 doi: 10.1099/jgv.0.000561
353
Fabiola Atzeni, Ignazio Francesco Masala, Manuela di Franco, Piercarlo Sarzi-Puttini. Infections in rheumatoid arthritisCurrent Opinion in Rheumatology 2017; 29(4): 323 doi: 10.1097/BOR.0000000000000389
354
Perdita Backes, Doris Quinkert, Simon Reiss, Marco Binder, Margarita Zayas, Ursula Rescher, Volker Gerke, Ralf Bartenschlager, Volker Lohmann. Role of Annexin A2 in the Production of Infectious Hepatitis C Virus ParticlesJournal of Virology 2010; 84(11): 5775 doi: 10.1128/JVI.02343-09
355
Ana Shulla, Glenn Randall. Hepatitis C virus—host interactions, replication, and viral assemblyCurrent Opinion in Virology 2012; 2(6): 725 doi: 10.1016/j.coviro.2012.09.013
356
Antonio Craxì, Carlo Federico Perno, Mauro Viganò, Francesca Ceccherini-Silberstein, Salvatore Petta, Alessio Aghemo, Alfredo Alberti, Pietro Andreone, Massimo Andreoni, Stefano Bonora, Maurizia Rossana Brunetto, Savino Bruno, Nicola Caporaso, Antonio Chirianni, Alessia Ciancio, Elisabetta Degasperi, Giovanni Di Perri, Stefano Fagiuoli, Carlo Ferrari, Giovanni Battista Gaeta, Adriano Pellicelli, Massimo Puoti, Giovanni Raimondo, Gloria Taliani, Erica Villa, Anna Linda Zignego. From current status to optimization of HCV treatment: Recommendations from an expert panelDigestive and Liver Disease 2016; 48(9): 995 doi: 10.1016/j.dld.2016.06.004
357
Huan-You Lin, Tzu-Cheng Chang, Shang-Tzen Chang. A review of antioxidant and pharmacological properties of phenolic compounds in Acacia confusaJournal of Traditional and Complementary Medicine 2018; 8(4): 443 doi: 10.1016/j.jtcme.2018.05.002
358
Z. M. Younossi, L. Zheng, M. Stepanova, C. Venkatesan, H. M. Mir. Moderate, excessive or heavy alcohol consumption: each is significantly associated with increased mortality in patients with chronic hepatitis CAlimentary Pharmacology & Therapeutics 2013; 37(7): 703 doi: 10.1111/apt.12265
359
José Barreto Cruz Nogueira, Laís Cristina Santana Sena, Jullyana de Souza Siqueira Quintans, Jackson Roberto Guedes da Silva Almeida, Alex Vianey Callado França, Lucindo José Quintans Júnior. Side Effects of the Therapy With Peginterferon and Ribavirin in Chronic Hepatitis CJournal of Pharmacy Practice 2012; 25(1): 85 doi: 10.1177/0897190011415687
360
Babita Agrawal, Shakti Singh, Nancy Gupta, Wen Li, Satish Vedi, Rakesh Kumar. Unsolved Puzzles Surrounding HCV Immunity: Heterologous Immunity Adds Another DimensionInternational Journal of Molecular Sciences 2017; 18(8): 1626 doi: 10.3390/ijms18081626
361
Nese Kurt Yilmaz, Ronald Swanstrom, Celia A. Schiffer. Improving Viral Protease Inhibitors to Counter Drug ResistanceTrends in Microbiology 2016; 24(7): 547 doi: 10.1016/j.tim.2016.03.010
362
Francisco Barrera M, Alejandro Soza. Shortened therapy for genotype 1 hepatitis C virus. The final answer?Annals of Hepatology 2010; 9(1): 112 doi: 10.1016/S1665-2681(19)31692-8
363
James Lara, Robert M. Wohlhueter, Zoya Dimitrova, Yury E. Khudyakov. Artificial neural network for prediction of antigenic activity for a major conformational epitope in the hepatitis C virus NS3 proteinBioinformatics 2008; 24(17): 1858 doi: 10.1093/bioinformatics/btn339
364
Rania A. Tohme, Scott D. Holmberg. Is sexual contact a major mode of hepatitis C virus transmission?Hepatology 2010; 52(4): 1497 doi: 10.1002/hep.23808
365
S. Ramachandran, D. S. Campo, Z. E. Dimitrova, G.-l. Xia, M. A. Purdy, Y. E. Khudyakov. Temporal Variations in the Hepatitis C Virus Intrahost Population during Chronic InfectionJournal of Virology 2011; 85(13): 6369 doi: 10.1128/JVI.02204-10
366
Chang Ho Lee, Soo-Han Lee, Ji Hyun Kim, Yook-Hwan Noh, Gyu-Jeong Noh, Seong-Wook Lee. Pharmacokinetics of a Cholesterol-conjugated Aptamer Against the Hepatitis C Virus (HCV) NS5B ProteinMolecular Therapy - Nucleic Acids 2015; 4: e254 doi: 10.1038/mtna.2015.30
367
Fu-Hsiung Su, Chien-Sheng Wu, Fung-Chang Sung, Shih-Ni Chang, Chien-Tien Su, Ying-Hua Shieh, Chih-Ching Yeh, Yury E. Khudyakov. Chronic Hepatitis C Virus Infection Is Associated with the Development of Rheumatoid Arthritis: A Nationwide Population-Based Study in TaiwanPLoS ONE 2014; 9(11): e113579 doi: 10.1371/journal.pone.0113579
368
Philippe A. Gallay. Cyclophilin inhibitors: a novel class of promising host-targeting anti-HCV agentsImmunologic Research 2012; 52(3): 200 doi: 10.1007/s12026-011-8263-5
369
C.-C. Hu, C.-L. Lin, Y.-L. Kuo, C.-H. Chien, S.-W. Chen, C.-L. Yen, C.-Y. Lin, R.-N. Chien. Efficacy and safety of ribavirin plus pegylated interferon alfa in geriatric patients with chronic hepatitis CAlimentary Pharmacology & Therapeutics 2013; 37(1): 81 doi: 10.1111/apt.12112
370
Kerui Cai, Tieling Li, Ling Guo, Haifeng Guo, Wei Zhu, Lei Yan, Fujuan Li. Long non-coding RNA LINC00467 regulates hepatocellular carcinoma progression by modulating miR-9-5p/PPARA expressionOpen Biology 2019; 9(9): 190074 doi: 10.1098/rsob.190074
371
Jennifer Ng, Jennifer Wu. Hepatitis B- and Hepatitis C-Related Hepatocellular Carcinomas in the United States: Similarities and DifferencesHepatitis Monthly 2012; 12(10 HCC) doi: 10.5812/hepatmon.7635
372
Jason T. Blackard, Ling Kong, Angela Lombardi, Dirk Homann, Sara Salehi Hammerstad, Yaron Tomer. A preliminary analysis of hepatitis C virus in pancreatic islet cellsVirology Journal 2017; 14(1) doi: 10.1186/s12985-017-0905-3
373
D. S. Campo, Z. Dimitrova, R. J. Mitchell, J. Lara, Y. Khudyakov. Coordinated evolution of the hepatitis C virusProceedings of the National Academy of Sciences 2008; 105(28): 9685 doi: 10.1073/pnas.0801774105
374
You-Wen Tan, Yan Tao, Long-Gen Liu, Yun Ye, Xin-Bei Zhou, Li Chen, Cong He. Epidemiological features of chronic hepatitis C infection caused by remunerated blood donors: A nearly 27-year period surveyWorld Journal of Gastroenterology 2018; 24(11): 1250-1258 doi: 10.3748/wjg.v24.i11.1250
375
Mayura M. Desai, Bin Gong, Tehsheng Chan, Robert A. Davey, Lynn Soong, Andrey A. Kolokoltsov, Jiaren Sun. Differential, Type I Interferon-Mediated Autophagic Trafficking of Hepatitis C Virus Proteins in Mouse LiverGastroenterology 2011; 141(2): 674 doi: 10.1053/j.gastro.2011.04.060
376
Edgar P. Simard, Ahmedin Jemal. The American Cancer Society's Principles of Oncology2017; : 72 doi: 10.1002/9781119468868.ch7
377
Suganya Selvarajah, Sheila Keating, John Heitman, Kai Lu, Graham Simmons, Philip J. Norris, Eva Operskalski, James W. Mosley, Michael P. Busch. Detection of host immune responses in acute phase sera of spontaneous resolution versus persistent hepatitis C virus infection Journal of General Virology 2012; 93(8): 1673 doi: 10.1099/vir.0.041277-0
378
Basmattee Boodram, Anna L. Hotton, Louis Shekhtman, Alexander Gutfraind, Harel Dahari. High-Risk Geographic Mobility Patterns among Young Urban and Suburban Persons who Inject Drugs and their Injection Network MembersJournal of Urban Health 2018; 95(1): 71 doi: 10.1007/s11524-017-0185-7
379
Tatiana Kuznetsova, Tatjana Tallo, Vadim Brjalin, Irina Reshetnjak, Riina Salupere, Ljudmilla Priimagi, Olga Katargina, Maria Smirnova, Juris Jansons, Valentina Tefanova. Amino Acid Polymorphisms Within the Entire HCV NS5A Region in Estonian Chronic HCV 1b Patients With Different Treatment ResponseHepatitis Monthly 2013; 13(12) doi: 10.5812/hepatmon.14481
380
Suganya Selvarajah, Leslie H Tobler, Graham Simmons, Michael P Busch. Host genetic basis for hepatitis C virus clearance: a role for blood collection centersCurrent Opinion in Hematology 2010; 17(6): 550 doi: 10.1097/MOH.0b013e32833e7544
381
Dawn N. Ward, Daniel C. Talley, Mrinalini Tavag, Samrawit Menji, Paul Schaughency, Andrea Baier, Paul J. Smith. UK-1 and structural analogs are potent inhibitors of hepatitis C virus replicationBioorganic & Medicinal Chemistry Letters 2014; 24(2): 609 doi: 10.1016/j.bmcl.2013.12.012
382
Jin-Kyoung Oh, Elisabete Weiderpass. Infection and Cancer: Global Distribution and Burden of DiseasesAnnals of Global Health 2014; 80(5): 384 doi: 10.1016/j.aogh.2014.09.013
383
Alastair Heffernan, Graham S Cooke, Shevanthi Nayagam, Mark Thursz, Timothy B Hallett. Scaling up prevention and treatment towards the elimination of hepatitis C: a global mathematical modelThe Lancet 2019; 393(10178): 1319 doi: 10.1016/S0140-6736(18)32277-3
384
J. I. O'Reilly, P. Ocama, C. K. Opio, A. Alfred, E. Paintsil, E. Seremba, A. N. Sofair. Risk Factors and Seroprevalence of Hepatitis C among Patients Hospitalized at Mulago Hospital, UgandaJournal of Tropical Medicine 2011; 2011: 1 doi: 10.1155/2011/598341
385
Talita de A. Fernandes, Dinesh Manvar, Jorge L.O. Domingos, Amartya Basu, Daniel Brian Nichols, Neerja Kaushik-Basu, Paulo R.R. Costa. 5-Carba-pterocarpens: A new scaffold with anti-HCV activityEuropean Journal of Medicinal Chemistry 2016; 112: 33 doi: 10.1016/j.ejmech.2016.02.010
386
Edoardo G. Giannini, Monica Basso, Vincenzo Savarino, Antonino Picciotto. Predictive Factors for Response to Peginterferon-Alpha and Ribavirin Treatment of Chronic HCV Infection in Patients Aged 65 Years and MoreDigestive Diseases and Sciences 2010; 55(11): 3193 doi: 10.1007/s10620-010-1408-x
387
Maria Victoria Preciado, Pamela Valva, Alejandro Escobar-Gutierrez, Paula Rahal, Karina Ruiz-Tovar, Lilian Yamasaki, Carlos Vazquez-Chacon, Armando Martinez-Guarneros, Juan Carlos Carpio-Pedroza, Salvador Fonseca-Coronado, Mayra Cruz-Rivera. Hepatitis C virus molecular evolution: Transmission, disease progression and antiviral therapyWorld Journal of Gastroenterology 2014; 20(43): 15992-16013 doi: 10.3748/wjg.v20.i43.15992
388
Jennifer R. Havens, Michelle R. Lofwall, Simon D. W. Frost, Carrie B. Oser, Carl G. Leukefeld, Richard A. Crosby. Individual and Network Factors Associated With Prevalent Hepatitis C Infection Among Rural Appalachian Injection Drug UsersAmerican Journal of Public Health 2013; 103(1): e44 doi: 10.2105/AJPH.2012.300874
389
Carla Treloar. The Wiley Blackwell Handbook of Mindfulness2014; : 818 doi: 10.1002/9781118294895.ch41
390
Matthew G.K. Benesch, Yi M. Ko, Todd P.W. McMullen, David N. Brindley. Autotaxin in the crosshairs: Taking aim at cancer and other inflammatory conditionsFEBS Letters 2014; 588(16): 2712 doi: 10.1016/j.febslet.2014.02.009
391
Suzanne Polis. Hepatitis C virus, pregnancy and postnatal careGastrointestinal Nursing 2015; 13(5): 26 doi: 10.12968/gasn.2015.13.5.26
392
Ndiémé Ndongo, Pascale Berthillon, Pierre Pradat, Claude Vieux, Isabelle Bordes, Françoise Berby, Marianne Maynard, Fabien Zoulim, Christian Trépo, Marie-Anne Petit. Association of anti-E1E2 antibodies with spontaneous recovery or sustained viral response to therapy in patients infected with hepatitis C virusHepatology 2010; 52(5): 1531 doi: 10.1002/hep.23862
393
Ching-Chih Hu, Cheng-Hao Weng, Man-Chin Hua, Pei-Hung Chang, Chih-Lang Lin, Yen-Ting Chen, Cheng-Hung Chien, Shu-Ting Lin, Rong-Nan Chien. New Scoring Method to Predict Risk of Hepatocellular Carcinoma in Patients with Chronic Hepatitis C After Pegylated Interferon and Ribavirin TherapyJournal of Interferon & Cytokine Research 2020; 40(2): 82 doi: 10.1089/jir.2019.0103
394
Farzin Roohvand, Niloufar Kossari. Advances in hepatitis C virus vaccines, part one: advances in basic knowledge for hepatitis C virus vaccine designExpert Opinion on Therapeutic Patents 2011; 21(12): 1811 doi: 10.1517/13543776.2011.630662
395
David S. Campo, Ha-Jung Roh, Brian L. Pearlman, Daniel S. Fierer, Sumathi Ramachandran, Gilberto Vaughan, Andrew Hinds, Zoya Dimitrova, Pavel Skums, Yury Khudyakov. Increased Mitochondrial Genetic Diversity in Persons Infected With Hepatitis C VirusCellular and Molecular Gastroenterology and Hepatology 2016; 2(5): 676 doi: 10.1016/j.jcmgh.2016.05.012
396
Moataz M. Sayed, Ahmed I. El-Shafie, Ahmed Fathy Hilal, Hoda A. Abdelsattar. Can hepatitis C virus core antigen be used as a reliable marker of viral load for hepatitis C virus infection in genotype 4?Egyptian Liver Journal 2017; 7(1 and 2): 1 doi: 10.1097/01.ELX.0000523559.96944.09
397
Shahroz Khan, Ijaz Ali, Malik Badshah, Mohammad Qaiser Khan, Zahida Haider, Sajid Ali, Imtiaz Ali Khan, Anwar Ullah. Molecular Epidemiology of Hepatitis C Virus Genotypes Among Chronically Infected Patients in PakistanJundishapur Journal of Microbiology 2019; (In Press) doi: 10.5812/jjm.86428
398
Mohammad Rahnavardi, Seyed Mohammadmehdi Hosseini Moghaddam, Seyed Moayed Alavian. Hepatitis C in Hemodialysis Patients: Current Global Magnitude, Natural History, Diagnostic Difficulties, and Preventive MeasuresAmerican Journal of Nephrology 2008; 28(4): 628 doi: 10.1159/000117573
399
Ghada H. Al-Ansary, Mohamed A.H. Ismail, Dalal A. Abou El Ella, Sameh Eid, Khaled A.M. Abouzid. Molecular design and synthesis of HCV inhibitors based on thiazolone scaffoldEuropean Journal of Medicinal Chemistry 2013; 68: 19 doi: 10.1016/j.ejmech.2013.07.006
400
Dibya Prakash. Nuclear Medicine2014; : 117 doi: 10.1007/978-81-322-1826-5_5
401
Vassiliki Papaevangelou, Marianna Varsami, Vassilios Papadakis, Aglaia Zellos, Agapi Parcharidou, Sophia Papargyri, Ourania Karentzou, Nina Manolaki, Eleftheria Roma, Sophia Polychronopoulou. HEPATITIS C TREATMENT CONCOMITANT TO CHEMOTHERAPY AS “SALVAGE” THERAPY IN CHILDREN WITH HEMATOLOGIC MALIGNANCIESThe Pediatric Infectious Disease Journal 2010; 29(3): 277 doi: 10.1097/INF.0b013e3181c2115a
402
Hong-Xin Piao, Ai-Ting Yang, Ya-Meng Sun, Yuan-Yuan Kong, Xiao-Ning Wu, Ying-Zhe Zhang, Bo Ding, Bao-En Wang, Ji-Dong Jia, Hong You, Matthew Law. Increasing Newly Diagnosed Rate and Changing Risk Factors of HCV in Yanbian Prefecture, a High Endemic Area in ChinaPLoS ONE 2014; 9(1): e86190 doi: 10.1371/journal.pone.0086190
403
Wei Leong Tan, Goh Yihui, Muhammad Radzi Abu Hassan. Demographic characteristics and intravenous drug use among hepatitis C patients in the Kota Setar district, Kedah, MalaysiaEpidemiology and Health 2015; 37: e2015032 doi: 10.4178/epih/e2015032
404
Nalini K. Sharma, Averell H. Sherker. Chronic Viral Hepatitis2009; : 33 doi: 10.1007/978-1-59745-565-7_2
405
Kimberly A. Dowd, Dale M. Netski, Xiao–Hong Wang, Andrea L. Cox, Stuart C. Ray. Selection Pressure From Neutralizing Antibodies Drives Sequence Evolution During Acute Infection With Hepatitis C VirusGastroenterology 2009; 136(7): 2377 doi: 10.1053/j.gastro.2009.02.080
406
Dennis Hernandez, Paul Falk, Fei Yu, Guangzhi Zhai, Yong Quan, Teresa Faria, Kai Cao, Paul Scola, Fiona McPhee. Establishment of a robust hepatitis C virus replicon cell line over-expressing P-glycoprotein that facilitates analysis of P-gp drug transporter effects on inhibitor antiviral activityBiochemical Pharmacology 2013; 85(1): 21 doi: 10.1016/j.bcp.2012.10.002
407
Ashly E. Jordan, Don C. Des Jarlais, Kamyar Arasteh, Courtney McKnight, Denis Nash, David C. Perlman. Incidence and prevalence of hepatitis c virus infection among persons who inject drugs in New York City: 2006–2013Drug and Alcohol Dependence 2015; 152: 194 doi: 10.1016/j.drugalcdep.2015.03.039
408
M. Cruz-Rivera, J. C. Carpio-Pedroza, A. Escobar-Gutierrez, D. Lozano, A. Vergara-Castaneda, P. Rivera-Osorio, A. Martinez-Guarneros, C. A. V. Chacon, S. Fonseca-Coronado, G. Vaughan. Rapid Hepatitis C Virus Divergence among Chronically Infected IndividualsJournal of Clinical Microbiology 2013; 51(2): 629 doi: 10.1128/JCM.03042-12
409
Guangzhi He, Chenhong Zheng, Huiping Huo, Huiming Zhang, Zhiquan Zhu, Junlai Li, Hongpeng Zhang. TACE combined with dendritic cells and cytokine-induced killer cells in the treatment of hepatocellular carcinoma: A meta-analysisInternational Immunopharmacology 2016; 40: 436 doi: 10.1016/j.intimp.2016.09.015
410
Lenka Benova, Susanne F. Awad, F. DeWolfe Miller, Laith J. Abu‐Raddad. Estimation of hepatitis C virus infections resulting from vertical transmission in EgyptHepatology 2015; 61(3): 834 doi: 10.1002/hep.27596
411
Anna R. Hemnes, Ivan M. Robbins. Sildenafil monotherapy in portopulmonary hypertension can facilitate liver transplantationLiver Transplantation 2009; 15(1): 15 doi: 10.1002/lt.21479
412
Qianqian Qin, M. Kumi Smith, Lu Wang, Yingying Su, Liyan Wang, Wei Guo, Lan Wang, Yan Cui, Ning Wang. Hepatitis C virus infection in China: an emerging public health issueJournal of Viral Hepatitis 2015; 22(3): 238 doi: 10.1111/jvh.12295
413
Daniel P Webster, Paul Klenerman, Jane Collier, Katie JM Jeffery. Development of novel treatments for hepatitis CThe Lancet Infectious Diseases 2009; 9(2): 108 doi: 10.1016/S1473-3099(09)70020-9
414
S. Ciesek, H. Wedemeyer. Immunosuppression, liver injury and post-transplant HCV recurrenceJournal of Viral Hepatitis 2012; 19(1): 1 doi: 10.1111/j.1365-2893.2011.01548.x
415
Boyoung Park, Kyu-Won Jung, Chang-Mo Oh, Kui Son Choi, Mina Suh, Jae Kwan Jun. Prevalence of and Factors Influencing Impaired Glucose Tolerance Among Hepatitis B CarriersMedicine 2014; 93(20): e91 doi: 10.1097/MD.0000000000000091
416
Abdelfattah M. Attallah, Mohamed M. Omran, Khaled Farid, Mahmoud El-Bendary, Tarek M. Emran, Mohamed S. Albannan, Ibrahim El-Dosoky. Development of a novel score for liver fibrosis staging and comparison with eight simple laboratory scores in large numbers of HCV-monoinfected patientsClinica Chimica Acta 2012; 413(21-22): 1725 doi: 10.1016/j.cca.2012.06.031
417
Lilia M. Ganova-Raeva, Zoya E. Dimitrova, David S. Campo, Yulin Lin, Sumathi Ramachandran, Guo-liang Xia, Christiane Honisch, Charles R. Cantor, Yury E. Khudyakov. Detection of Hepatitis C Virus Transmission by Use of DNA Mass SpectrometryThe Journal of Infectious Diseases 2013; 207(6): 999 doi: 10.1093/infdis/jis938
418
Kuan-Jen Chen, Chin-Kai Tseng, Fang-Rong Chang, Jin-Iong Yang, Chi-Chen Yeh, Wei-Chun Chen, Shou-Fang Wu, Hsueh-Wei Chang, Jin-Ching Lee, Erica Villa. Aqueous Extract of the Edible Gracilaria tenuistipitata Inhibits Hepatitis C Viral Replication via Cyclooxygenase-2 Suppression and Reduces Virus-Induced InflammationPLoS ONE 2013; 8(2): e57704 doi: 10.1371/journal.pone.0057704
419
Maya Guest, Ashley K. Kable, May M. Boggess, Mark Friedewald. Nurses’ sharps, including needlestick, injuries in public and private healthcare facilities in New South Wales, AustraliaHealthcare infection 2014; 19(2): 65 doi: 10.1071/HI13044
420
Allan Peres-da-Silva, Adilson José de Almeida, Elisabeth Lampe. Genetic diversity of NS3 protease from Brazilian HCV isolates and possible implications for therapy with direct-acting antiviral drugsMemórias do Instituto Oswaldo Cruz 2012; 107(2): 254 doi: 10.1590/S0074-02762012000200016
421
Kathie-Anne Walters, Michael G. Katze. Using high-throughput genomics to study hepatitis C: What determines the outcome of infection?Antiviral Research 2009; 81(3): 198 doi: 10.1016/j.antiviral.2008.12.005
422
Noha Mohamed Hosni Shaheen, Amin Roshdy Soliman, Sahier Omar El-Khashab, Mariam Onsy Farag Hanna. HLA DRB1 Alleles and Hepatitis C Virus Infection in Chronic Kidney Disease PatientsRenal Failure 2013; 35(3): 386 doi: 10.3109/0886022X.2012.761038
423
Livia Rossi, Alejandro Escobar-Gutierrez, Paula Rahal. Advanced Molecular Surveillance of Hepatitis C VirusViruses 2015; 7(3): 1153 doi: 10.3390/v7031153
424
Cuiping Shao, Na Huo, Lanlan Zhao, Ying Gao, Xiaohong Fan, Yingying Zheng, Lifen Wang, Haiying Lu, Xiaoyuan Xu, Xiaohui Guo. The presence of thyroid peroxidase antibody of IgG2 subclass is a risk factor for thyroid dysfunction in chronic hepatitis C patientsEuropean Journal of Endocrinology 2013; 168(5): 717 doi: 10.1530/EJE-12-0775
425
Justin C. Strickland, Michele Staton, Carl G. Leukefeld, Carrie B. Oser, J. Matthew Webster. Hepatitis C antibody reactivity among high-risk rural women: opportunities for services and treatment in the criminal justice systemInternational Journal of Prisoner Health 2018; 14(2): 89 doi: 10.1108/IJPH-03-2017-0012
426
F. Nazari, A.B. Gumel, E.H. Elbasha. Differential characteristics of primary infection and re-infection can cause backward bifurcation in HCV transmission dynamicsMathematical Biosciences 2015; 263: 51 doi: 10.1016/j.mbs.2015.02.002
427
Laura Esteban-Riesco, Frantz Depaulis, Alain Moreau, Yannick Bacq, Frédéric Dubois, Alain Goudeau, Catherine Gaudy-Graffin. Rapid and sustained autologous neutralizing response leading to early spontaneous recovery after HCV infectionVirology 2013; 444(1-2): 90 doi: 10.1016/j.virol.2013.05.037
428
Ednelza da Silva Graça Amoras, Samara Tatielle Monteiro Gomes, Felipe Bonfim Freitas, Bárbara Brasil Santana, Geraldo Ishak, Marialva Tereza Ferreira de Araújo, Sâmia Demachki, Simone Regina Souza da Silva Conde, Marluísa de Oliveira Guimarães Ishak, Ricardo Ishak, Antonio Carlos Rosário Vallinoto, Matias A Avila. NGF and P75NTR Gene Expression Is Associated with the Hepatic Fibrosis Stage Due to Viral and Non-Viral CausesPLOS ONE 2015; 10(3): e0121754 doi: 10.1371/journal.pone.0121754
429
Laetitia Zona, Rajiv Tawar, Mirjam Zeisel, Fei Xiao, Catherine Schuster, Joachim Lupberger, Thomas Baumert. CD81-Receptor Associations — Impact for Hepatitis C Virus Entry and Antiviral TherapiesViruses 2014; 6(2): 875 doi: 10.3390/v6020875
430
Richard T. Johnson, Christopher Power. Emerging Issues in Neurovirology: New Viruses, Diagnostic Tools, and TherapeuticsNeurologic Clinics 2008; 26(3): 855 doi: 10.1016/j.ncl.2008.04.003
431
Jong Yeop Kim, Juhee Cho, Sung Ho Hwang, Ho Kil, Si Hyun Bae, Young Seok Kim, Han Chu Lee, Sook-Hyang Jeong. Behavioral and Healthcare-Associated Risk Factors for Chronic Hepatitis C Virus Infection in KoreaJournal of Korean Medical Science 2012; 27(11): 1371 doi: 10.3346/jkms.2012.27.11.1371
432
Jeroen Witteveldt, Marion Martin-Gans, Peter Simmonds. Enhancement of the Replication of Hepatitis C Virus Replicons of Genotypes 1 to 4 by Manipulation of CpG and UpA Dinucleotide Frequencies and Use of Cell Lines Expressing SECL14L2 for Antiviral Resistance TestingAntimicrobial Agents and Chemotherapy 2016; 60(5): 2981 doi: 10.1128/AAC.02932-15
433
David S. Campo, Yury Khudyakov. Intelligent Network DisRuption Analysis (INDRA): A targeted strategy for efficient interruption of hepatitis C transmissionsInfection, Genetics and Evolution 2018; 63: 204 doi: 10.1016/j.meegid.2018.05.028
434
Inmaculada Castillo, Javier Bartolomé, Juan Antonio Quiroga, Guillermina Barril, Vicente Carreño. Hepatitis C virus infection in the family setting of patients with occult hepatitis CJournal of Medical Virology 2009; 81(7): 1198 doi: 10.1002/jmv.21483
435
Leon D. Averbukh, George Y. Wu. Highlights for Dental Care as a Hepatitis C Risk Factor: A Review of LiteratureJournal of Clinical and Translational Hepatology 2019; (X): 1 doi: 10.14218/JCTH.2019.00023
436
Michael Houghton. The long and winding road leading to the identification of the hepatitis C virusJournal of Hepatology 2009; 51(5): 939 doi: 10.1016/j.jhep.2009.08.004
437
G Lodi, R Pellicano, M Carrozzo. Hepatitis C virus infection and lichen planus: a systematic review with meta-analysisOral Diseases 2010; 16(7): 601 doi: 10.1111/j.1601-0825.2010.01670.x
438
John McLauchlan. Lipid droplets and hepatitis C virus infectionBiochimica et Biophysica Acta (BBA) - Molecular and Cell Biology of Lipids 2009; 1791(6): 552 doi: 10.1016/j.bbalip.2008.12.012
439
Saba Khan, Arpit Bhargava, Neelam Pathak, Kewal. K. Maudar, Subodh Varshney, Pradyumna K. Mishra. Circulating Biomarkers and their Possible Role in Pathogenesis of Chronic Hepatitis B and C Viral InfectionsIndian Journal of Clinical Biochemistry 2011; 26(2): 161 doi: 10.1007/s12291-010-0098-7
440
Camille Raynes-Greenow, Suzanne Polis, Elizabeth Elliott, Winita Hardikar, Alison Kesson, John Kaldor, Cheryl A Jones. Childhood hepatitis C virus infection: An Australian national surveillance study of incident cases over five yearsJournal of Paediatrics and Child Health 2015; 51(11): 1115 doi: 10.1111/jpc.12904
441
Zainab al-mussa, Hawazin Thamair. THE PREVALENCE RATE OF HEPATITIS C VIRUS IN BASRAH CITY AND THE COMMON CAUSATIVE RISK FACTORSIraqi National Journal of Medicine 2019; 1(2): 59 doi: 10.37319/iqnjm.1.2.5
442
Katherine Bornschlegel, Magdalena Berger, Renu K. Garg, Amado Punsalang, Christy M. McKinney, R. Charon Gwynn, Lorna E. Thorpe. Prevalence of Hepatitis C Infection in New York City, 2004Journal of Urban Health 2009; 86(6): 909 doi: 10.1007/s11524-009-9396-x
443
Samia Afzal, Muhammad Idrees, Muhammad Ali, Muhammad Ilyas, Abrar Hussain, Madiha Akram, Sadia Butt, Sana Saleem, Irshadur Rehman, Liaqat Ali, Muhammad Shahid. Envelope 2 protein phosphorylation sites S75 & 277 of hepatitis C virus genotype 1a and interferon resistance: A sequence alignment approachVirology Journal 2011; 8(1) doi: 10.1186/1743-422X-8-71
444
Victoria L. Demetriou, Leondios G. Kostrikis. Near-full genome characterization of unclassified hepatitis c virus strains relating to genotypes 1 and 4Journal of Medical Virology 2011; 83(12): 2119 doi: 10.1002/jmv.22237
445
M Carrozzo. Oral diseases associated with hepatitis C virus infection. Part 1. sialadenitis and salivary glands lymphomaOral Diseases 2008; 14(2): 123 doi: 10.1111/j.1601-0825.2007.01436.x
446
Sam Hopkins, Michael Bobardt, Udayan Chatterji, Jose A. Garcia-Rivera, Precious Lim, Philippe A. Gallay. The Cyclophilin Inhibitor SCY-635 Disrupts Hepatitis C Virus NS5A-Cyclophilin A ComplexesAntimicrobial Agents and Chemotherapy 2012; 56(7): 3888 doi: 10.1128/AAC.00693-12
447
Mahwish Khan, Shah Jahan, Saba Khaliq, Bushra Ijaz, Waqar Ahmad, Baila Samreen, Sajida Hassan. Interaction of the hepatitis C virus (HCV) core with cellular genes in the development of HCV-induced steatosisArchives of Virology 2010; 155(11): 1735 doi: 10.1007/s00705-010-0797-7
448
Ann D Kwong, Robert S Kauffman, Patricia Hurter, Peter Mueller. Discovery and development of telaprevir: an NS3-4A protease inhibitor for treating genotype 1 chronic hepatitis C virusNature Biotechnology 2011; 29(11): 993 doi: 10.1038/nbt.2020
449
Hiromitsu Kumada, Joji Toyota, Takeshi Okanoue, Kazuaki Chayama, Hirohito Tsubouchi, Norio Hayashi. Telaprevir with peginterferon and ribavirin for treatment-naive patients chronically infected with HCV of genotype 1 in JapanJournal of Hepatology 2012; 56(1): 78 doi: 10.1016/j.jhep.2011.07.016
450
Inna Rytsareva, David S. Campo, Yueli Zheng, Seth Sims, Cansu Tetik, Jain Chirag, Sriram P. Chockalingam, Sharma V. Thankachan, Amanda Sue, Srinivas Aluru, Yury Khudyakov. Efficient detection of viral transmission with threshold-based methods2015 IEEE 5th International Conference on Computational Advances in Bio and Medical Sciences (ICCABS) 2015; : 1 doi: 10.1109/ICCABS.2015.7344723
451
Milton W Taylor, Takuma Tsukahara, Jeanette N McClintick, Howard J Edenberg, Paul Kwo. Cyclic changes in gene expression induced by Peg-interferon alfa-2b plus ribavirin in peripheral blood monocytes (PBMC) of hepatitis C patients during the first 10 weeks of treatmentJournal of Translational Medicine 2008; 6(1) doi: 10.1186/1479-5876-6-66
452
Nikolaus Jilg, Wenyu Lin, Jian Hong, Esperance A. Schaefer, David Wolski, James Meixong, Kaku Goto, Cynthia Brisac, Pattranuch Chusri, Dahlene N. Fusco, Stephane Chevaliez, Jay Luther, Kattareeya Kumthip, Thomas J. Urban, Lee F. Peng, Georg M. Lauer, Raymond T. Chung. Kinetic differences in the induction of interferon stimulated genes by interferon-α and interleukin 28B are altered by infection with hepatitis C virusHepatology 2014; 59(4): 1250 doi: 10.1002/hep.26653
453
Samir Rouabhia, Mourad Sadelaoud, Karima Chaabna-Mokrane, Wided Toumi, Ludovico Abenavoli. Hepatitis C virus genotypes in north eastern Algeria: A retrospective studyWorld Journal of Hepatology 2013; 5(7): 393-397 doi: 10.4254/wjh.v5.i7.393
454
Marcel W. Keddeas, Ossama A. Ahmed, Hisham Samy, AbdElaziz Mahmoud, Maha A. El-Tony. Risk assessment of hepatitis C virus seroconversion in haemodialysis patients and units at SohagEgyptian Liver Journal 2014; 4(1): 8 doi: 10.1097/01.ELX.0000440961.86687.60
455
Tae-Won KIM, Jong-Hwan LIM, In-Bae SONG, Sang-Jin PARK, Jae-Won YANG, Jung Cheul SHIN, Joo-Won SUH, Hwa-Young SON, Eun-Sang CHO, Myoung-Seok KIM, Sang-Wook LEE, Jong-Woo KIM, Hyo-In YUN. Hepatoprotective and Anti-Hepatitis C Viral Activity of Platycodon grandiflorum Extract on Carbon Tetrachloride-Induced Acute Hepatic Injury in MiceJournal of Nutritional Science and Vitaminology 2012; 58(3): 187 doi: 10.3177/jnsv.58.187
456
Banishree Saha, Manish C. Choudhary, Shiv K. Sarin. Expression of inhibitory markers is increased on effector memory T cells during hepatitis C virus/HIV coinfection as compared to hepatitis C virus or HIV monoinfectionAIDS 2013; 27(14): 2191 doi: 10.1097/QAD.0b013e32836285e4
457
Julie A. Lemm, John E. Leet, Donald R. O'Boyle, Jeffrey L. Romine, Xiaohua Stella Huang, Daniel R. Schroeder, Jeffrey Alberts, Joseph L. Cantone, Jin-Hua Sun, Peter T. Nower, Scott W. Martin, Michael H. Serrano-Wu, Nicholas A. Meanwell, Lawrence B. Snyder, Min Gao. Discovery of Potent Hepatitis C Virus NS5A Inhibitors with Dimeric StructuresAntimicrobial Agents and Chemotherapy 2011; 55(8): 3795 doi: 10.1128/AAC.00146-11
458
Jun Tao, Jun Liang, Hui Zhang, Lijian Pei, Han-zhu Qian, Matthew C. Chambers, Yan Jiang, Yao Xiao, Jason Blackard. The Molecular Epidemiological Study of HCV Subtypes among Intravenous Drug Users and Non-Injection Drug Users in ChinaPLOS ONE 2015; 10(10): e0140263 doi: 10.1371/journal.pone.0140263
459
Giuseppe Indolfi, Alessandro Nesi, Massimo Resti. Intrafamilial transmission of hepatitis C virusJournal of Medical Virology 2013; 85(4): 608 doi: 10.1002/jmv.23522
460
Eiman Hussein, Jun Teruya. Evaluation of blood supply operation and infectious disease markers in blood donors during the Egyptian revolutionTransfusion 2012; 52(11): 2321 doi: 10.1111/j.1537-2995.2012.03592.x
461
Chao Zhang, Adam Huys, Patricia A. Thibault, Joyce A. Wilson. Requirements for human Dicer and TRBP in microRNA-122 regulation of HCV translation and RNA abundanceVirology 2012; 433(2): 479 doi: 10.1016/j.virol.2012.08.039
462
Alexander Tarr, Tanvi Khera, Kathrin Hueging, Julie Sheldon, Eike Steinmann, Thomas Pietschmann, Richard Brown. Genetic Diversity Underlying the Envelope Glycoproteins of Hepatitis C Virus: Structural and Functional Consequences and the Implications for Vaccine DesignViruses 2015; 7(7): 3995 doi: 10.3390/v7072809
463
NA Alaizari, SA Al-Maweri, HM Al-Shamiri, B Tarakji, B Shugaa-Addin. Hepatitis C virus infections in oral lichen planus: a systematic review and meta-analysisAustralian Dental Journal 2016; 61(3): 282 doi: 10.1111/adj.12382
464
Feng Ni, Smitha Kota, Virginia Takahashi, A. Donny Strosberg, John K. Snyder. Potent inhibitors of hepatitis C core dimerization as new leads for anti-hepatitis C agentsBioorganic & Medicinal Chemistry Letters 2011; 21(8): 2198 doi: 10.1016/j.bmcl.2011.03.014
465
AT R-Viso, MIS Duarte, C Pagliari, ER Fernandes, RA Brasil, G Benard, CC Romano, S Ogusuku, NP Cavalheiro, CE Melo, AA Barone. Tissue and serum immune response in chronic hepatitis C with mild histological lesionsMemórias do Instituto Oswaldo Cruz 2010; 105(1): 25 doi: 10.1590/S0074-02762010000100003
466
Bader Faiyaz Zuberi, Faisal Faiyaz Zuberi, Sajjad Ali Memon, Muhammad Hafeez Qureshi, Sheikh Zafar Ali, Salahuddin Afsar. Sustained virological response based on rapid virological response in genotype-3 chronic hepatitis C treated with standard interferon in the Pakistani populationWorld Journal of Gastroenterology 2008; 14(14): 2218-2221 doi: 10.3748/wjg.14.2218
467
Xiaofei Gao, Qian Cui, Xiang Shi, Jing Su, Zhihang Peng, Xin Chen, Na Lei, Keqin Ding, Lu Wang, Rongbin Yu, Ning Wang. Prevalence and trend of hepatitis C virus infection among blood donors in Chinese mainland: a systematic review and meta-analysisBMC Infectious Diseases 2011; 11(1) doi: 10.1186/1471-2334-11-88
468
Jayant N. Acharya, Vitor H. Pacheco. Neurologic Complications of Hepatitis CThe Neurologist 2008; 14(3): 151 doi: 10.1097/NRL.0b013e31815fa594
469
Chun-Hung Tseng, Chih-Hsin Muo, Chung Y. Hsu, Chia-Hung Kao. Increased Risk of Intracerebral Hemorrhage Among Patients With Hepatitis C Virus InfectionMedicine 2015; 94(46): e2132 doi: 10.1097/MD.0000000000002132
470
Maria Betânia S Silva, Tarcísio M Andrade, Luciano K Silva, Itatiana F Rodart, Gisele B Lopes, Theomira MA Carmo, Maria Alice S Zarife, Inês Dourado, Mitermayer G Reis. Prevalence and genotypes of hepatitis C virus among injecting drug users from Salvador-BA, BrazilMemórias do Instituto Oswaldo Cruz 2010; 105(3): 299 doi: 10.1590/S0074-02762010000300009
471
Atsuko Tsukimoto, Ryuichi Sugiyama, Makoto Abe, Hironori Nishitsuji, Yuko Shimizu, Kunitada Shimotohno, Gota Kawai, Hiroshi Takaku. A new role for PGA1 in inhibiting hepatitis C virus-IRES-mediated translation by targeting viral translation factorsAntiviral Research 2015; 117: 1 doi: 10.1016/j.antiviral.2015.01.013
472
Djadé I. Soumana, Akbar Ali, Celia A. Schiffer. Structural Analysis of Asunaprevir Resistance in HCV NS3/4A ProteaseACS Chemical Biology 2014; 9(11): 2485 doi: 10.1021/cb5006118
473
Michel Ventura, Lucie Martin, Chloé Jaubert, Marie-Line Andréola, Cyril Masante. Hepatitis C virus intragenomic interactions are modulated by the SLVI RNA structure of the core coding sequence Journal of General Virology 2017; 98(4): 633 doi: 10.1099/jgv.0.000719
474
Diego M Flichman, Jorgelina L Blejer, Beatriz I Livellara, Viviana E Re, Sonia Bartoli, Juan A Bustos, Claudia P Ansola, Susana Hidalgo, Martin E Cerda, Alicia E Levin, Adriana Huenul, Victoria Riboldi, Elena MC Treviño, Horacio J Salamone, Felix A Nuñez, Robert J Fernández, Juan F Reybaud, Rodolfo H Campos. Prevalence and trends of markers of hepatitis B virus, hepatitis C virus and human Immunodeficiency virus in Argentine blood donorsBMC Infectious Diseases 2014; 14(1) doi: 10.1186/1471-2334-14-218
475
Helen S. Te, Donald M. Jensen. Epidemiology of Hepatitis B and C Viruses: A Global OverviewClinics in Liver Disease 2010; 14(1): 1 doi: 10.1016/j.cld.2009.11.009
476
Volker Meier, Giuliano Ramadori. Hepatitis C virus virology and new treatment targetsExpert Review of Anti-infective Therapy 2009; 7(3): 329 doi: 10.1586/eri.09.12
477
Mohamed Abd Elaziz, Yasmine S. Moemen, Aboul Ella Hassanien, Shengwu Xiong. Quantitative Structure-Activity Relationship Model for HCVNS5B inhibitors based on an Antlion Optimizer-Adaptive Neuro-Fuzzy Inference SystemScientific Reports 2018; 8(1) doi: 10.1038/s41598-017-19122-y
478
Max Hopwood, Toby Lea, Peter Aggleton. Drug, sex and sociality: Factors associated with the recent sharing of injecting equipment among gay and bisexual men in AustraliaInternational Journal of Drug Policy 2015; 26(2): 210 doi: 10.1016/j.drugpo.2014.10.013
479
Jin Yang, Yunquan Zhang, Lisha Luo, Runtang Meng, Chuanhua Yu. Global Mortality Burden of Cirrhosis and Liver Cancer Attributable to Injection Drug Use, 1990–2016: An Age-Period-Cohort and Spatial Autocorrelation AnalysisInternational Journal of Environmental Research and Public Health 2018; 15(1): 170 doi: 10.3390/ijerph15010170
480
Yun Zhou, Ying Zhang, Zhiqiang Yao, Jonathan Patrick Moorman, Zhansheng Jia. Dendritic cell-based immunity and vaccination against hepatitis C virus infectionImmunology 2012; 136(4): 385 doi: 10.1111/j.1365-2567.2012.03590.x
481
Wei-Chun Chen, Chin-Kai Tseng, Yen-Hsu Chen, Chun-Kuang Lin, Shih-hsien Hsu, Shen-Nien Wang, Jin-Ching Lee, Stephen J Polyak. HCV NS5A Up-Regulates COX-2 Expression via IL-8-Mediated Activation of the ERK/JNK MAPK PathwayPLOS ONE 2015; 10(7): e0133264 doi: 10.1371/journal.pone.0133264
482
Jasmine Riviere Marcelin, Lynda A. Szczech, Stacey Rizza. Core Concepts in Parenchymal Kidney Disease2014; : 209 doi: 10.1007/978-1-4614-8166-9_13
483
Barbara Zanini, Loredana Covolo, Francesco Donato, Alberto Lanzini. Effectiveness and tolerability of combination treatment of chronic hepatitis C in illicit drug users: Meta-analysis of prospective studiesClinical Therapeutics 2010; 32(13): 2139 doi: 10.1016/S0149-2918(11)00021-X
484
Megan G. Hofmeister, Jennifer R. Havens, April M. Young. Silence Surrounding Hepatitis C Status in Risk Relationships Among Rural People Who Use DrugsThe Journal of Primary Prevention 2017; 38(5): 481 doi: 10.1007/s10935-017-0483-6
485
Sania Amr, Emily A Iarocci, Ghada R Nasr, Doa’a Saleh, Jan Blancato, Kirti Shetty, Christopher A Loffredo. Multiple pregnancies, hepatitis C, and risk for hepatocellular carcinoma in Egyptian womenBMC Cancer 2014; 14(1) doi: 10.1186/1471-2407-14-893
486
Stephanie Pfaender, Julia Heyden, Martina Friesland, Sandra Ciesek, Asim Ejaz, Joerg Steinmann, Jochen Steinmann, Angelika Malarski, Heribert Stoiber, Georgios Tsiavaliaris, Werner Bader, Gerhard Jahreis, Thomas Pietschmann, Eike Steinmann. Inactivation of Hepatitis C Virus Infectivity by Human Breast MilkThe Journal of Infectious Diseases 2013; 208(12): 1943 doi: 10.1093/infdis/jit519
487
David S. Campo, June Zhang, Sumathi Ramachandran, Yury Khudyakov. Transmissibility of intra-host hepatitis C virus variantsBMC Genomics 2017; 18(S10) doi: 10.1186/s12864-017-4267-4
488
Nick Scott, Margaret Hellard, Emma Sue McBryde. Modeling hepatitis C virus transmission among people who inject drugs: Assumptions, limitations and future challengesVirulence 2016; 7(2): 201 doi: 10.1080/21505594.2015.1085151
489
Eve-Isabelle Pécheur, Olivier Diaz, Jennifer Molle, Vinca Icard, Pierre Bonnafous, Olivier Lambert, Patrice André. Morphological Characterization and Fusion Properties of Triglyceride-rich Lipoproteins Obtained from Cells Transduced with Hepatitis C Virus GlycoproteinsJournal of Biological Chemistry 2010; 285(33): 25802 doi: 10.1074/jbc.M110.131664
490
Robert Hamatake, Andrew Maynard, Wieslaw M. Kazmierski. Annual Reports in Medicinal Chemistry Volume 47Annual Reports in Medicinal Chemistry 2012; 47: 331 doi: 10.1016/B978-0-12-396492-2.00022-9
491
Nabila El-Bassel, Louisa Gilbert, Assel Terlikbayeva, Chris Beyrer, Elwin Wu, Mingway Chang, Tim Hunt, Leyla Ismayilova, Stacey A. Shaw, Sholpan Primbetova, Yelena Rozental, Baurzhan Zhussupov, Marat Tukeyev. Effects of a Couple-Based Intervention to Reduce Risks for HIV, HCV, and STIs Among Drug-Involved Heterosexual Couples in KazakhstanJAIDS Journal of Acquired Immune Deficiency Syndromes 2014; 67(2): 196 doi: 10.1097/QAI.0000000000000277
492
Margaret Robinson, Yang Tian, Nikos Pagratis, William E. Delaney. Screening of Hepatitis C Virus Inhibitors Using Genotype 1a HCV Replicon Cell LinesCurrent Protocols in Microbiology 2011; 22(1): 17.7.1 doi: 10.1002/9780471729259.mc1707s22
493
Li Yen Goh, Tim Card, Andrew W. Fogarty, Tricia M. McKeever. The association of exposure to hepatitis B and C viruses with lung function and respiratory disease: A population based study from the NHANES III databaseRespiratory Medicine 2014; 108(12): 1733 doi: 10.1016/j.rmed.2014.10.006
494
Gabriel de Deus VIEIRA, Cledson Gonçalves VENTURA, Camila Maciel de SOUSA. OCCURRENCE AND SPATIAL DISTRIBUTION OF HEPATITIS C IN A WESTERN BRAZILIAN AMAZON STATEArquivos de Gastroenterologia 2014; 51(4): 316 doi: 10.1590/S0004-28032014000400009
495
Martina Volarevic, Robert Smolic, Catherine H Wu, George Y Wu. Potential role of RNAi in the treatment of HCV infectionExpert Review of Anti-infective Therapy 2007; 5(5): 823 doi: 10.1586/14787210.5.5.823
496
Brett Hoffman, Qiang Liu. Hepatitis C viral protein translation: mechanisms and implications in developing antiviralsLiver International 2011; 31(10): 1449 doi: 10.1111/j.1478-3231.2011.02543.x
497
Ahmad A. Hamed, Yasser W. Darwish, Manal Hamdy El-Sayed. ADAMTS13 Levels in Young Patients With β-Thalassemia MajorClinical and Applied Thrombosis/Hemostasis 2015; 21(6): 527 doi: 10.1177/1076029614558112
498
Massimo Andreoni, Sergio Babudieri, Savino Bruno, Massimo Colombo, Anna L. Zignego, Vito Di Marco, Giovanni Di Perri, Carlo F. Perno, Massimo Puoti, Gloria Taliani, Erica Villa, Antonio Craxì. Current and future challenges in HCV: insights from an Italian experts panelInfection 2018; 46(2): 147 doi: 10.1007/s15010-017-1093-1
499
Zobair M. Younossi, Ancha Baranova, Arian Afendy, Rochelle Collantes, Maria Stepanova, Ganiraju Manyam, Anita Bakshi, Christopher L. Sigua, Joanne P. Chan, Ayuko A. Iverson, Christopher D. Santini, Sheng-Yung P. Chang. Early gene expression profiles of patients with chronic hepatitis C treated with pegylated interferon-alfa and ribavirinHepatology 2009; 49(3): 763 doi: 10.1002/hep.22729
500
Udayan Chatterji, Michael Bobardt, Lana Schaffer, Malcolm Wood, Philippe A. Gallay, Birke Bartosch. Cyclophilin Inhibitors Remodel the Endoplasmic Reticulum of HCV-Infected Cells in a Unique Pattern Rendering Cells Impervious to a ReinfectionPLOS ONE 2016; 11(7): e0159511 doi: 10.1371/journal.pone.0159511
501
Jin-Ching Lee, Chin-Kai Tseng, Kung-Chia Young, Hung-Yu Sun, Shainn-Wei Wang, Wei-Chun Chen, Chun-Kuang Lin, Yu-Hsuan Wu. Andrographolide exerts anti-hepatitis C virus activity by up-regulating haeme oxygenase-1 via the p38 MAPK/Nrf2 pathway in human hepatoma cellsBritish Journal of Pharmacology 2014; 171(1): 237 doi: 10.1111/bph.12440
502
Mark V. Thomas, Glena Jarboe, Robert Q. Frazer. Infection Control in the Dental OfficeDental Clinics of North America 2008; 52(3): 609 doi: 10.1016/j.cden.2008.02.002
503
Dalia Elsayed Metawlly, Ahmed Noby Amer, Hanan Mostafa Mostafa, Gamal El Din Elsawaf, Ola Abd El Kader. Low cost detection of hepatitis C virus RNA in HCV infected patients by SYBR Green I real-time PCRAlexandria Journal of Medicine 2018; 54(4): 481 doi: 10.1016/j.ajme.2017.11.004
504
Masakuni Tateyama, Hiroshi Yatsuhashi, Naota Taura, Yasuhide Motoyoshi, Shinya Nagaoka, Kenji Yanagi, Seigo Abiru, Koji Yano, Atsumasa Komori, Kiyoshi Migita, Minoru Nakamura, Hiroyasu Nagahama, Yutaka Sasaki, Yuzo Miyakawa, Hiromi Ishibashi. Alpha-fetoprotein above normal levels as a risk factor for the development of hepatocellular carcinoma in patients infected with hepatitis C virusJournal of Gastroenterology 2011; 46(1): 92 doi: 10.1007/s00535-010-0293-6
505
Min Zhong, Eric Peng, Ningwu Huang, Qi Huang, Anja Huq, Meiyen Lau, Richard Colonno, Leping Li. Discovery of functionalized bisimidazoles bearing cyclic aliphatic-phenyl motifs as HCV NS5A inhibitorsBioorganic & Medicinal Chemistry Letters 2014; 24(24): 5731 doi: 10.1016/j.bmcl.2014.10.057
506
S. K. Basnayake, P. J. Easterbrook. Wide variation in estimates of global prevalence and burden of chronic hepatitis B and C infection cited in published literatureJournal of Viral Hepatitis 2016; 23(7): 545 doi: 10.1111/jvh.12519
507
I. V. Astrakhantseva, D. S. Campo, A. Araujo, C.-G Teo, Y. Khudyakov, S. Kamili. Variation in physicochemical properties of the hypervariable region 1 during acute and chronic stages of hepatitis C virus infection2011 IEEE International Conference on Bioinformatics and Biomedicine Workshops (BIBMW) 2011; : 72 doi: 10.1109/BIBMW.2011.6112357
508
Z.A. Randriamanantany, D.H. Rajaonatahina, F.É. Razafimanantsoa, M.T. Rasamindrakotroka, R. Andriamahenina, F.B. Rasoarilalaomanarivo, S.P. Hanitriniala, F.R. Herisoa, O.A. Rakoto-Alson, A. Rasamindrakotroka. Prevalence and trends of hepatitis C virus among blood donors in Antananarivo, from 2003 to 2009Transfusion Clinique et Biologique 2012; 19(2): 52 doi: 10.1016/j.tracli.2011.10.004
509
Shira M. Goldenberg, Julio Montaner, Melissa Braschel, Eugenia Socias, Silvia Guillemi, Kate Shannon. Dual sexual and drug-related predictors of hepatitis C incidence among sex workers in a Canadian setting: gaps and opportunities for scale-up of hepatitis C virus prevention, treatment, and careInternational Journal of Infectious Diseases 2017; 55: 31 doi: 10.1016/j.ijid.2016.12.019
510
Michael W. Fried, Jama M. Darling, Stanley M. Lemon. Schiff's Diseases of the Liver2017; : 628 doi: 10.1002/9781119251316.ch25
511
Ying-Ting Lin, Yu-Hsuan Wu, Chin-Kai Tseng, Chun-Kuang Lin, Wei-Chun Chen, Yao-Chin Hsu, Jin-Ching Lee, Stephen J. Polyak. Green Tea Phenolic Epicatechins Inhibit Hepatitis C Virus Replication via Cycloxygenase-2 and Attenuate Virus-Induced InflammationPLoS ONE 2013; 8(1): e54466 doi: 10.1371/journal.pone.0054466
512
F. Cao, M. J. Donlin, K. Turner, X. Cheng, J. E. Tavis. Genetic and biochemical diversity in the HCV NS5B RNA polymerase in the context of interferon α plus ribavirin therapyJournal of Viral Hepatitis 2011; 18(5): 349 doi: 10.1111/j.1365-2893.2010.01316.x
513
Yousra A. Mohamoud, Suzanne Riome, Laith J. Abu-Raddad. Epidemiology of hepatitis C virus in the Arabian Gulf countries: Systematic review and meta-analysis of prevalenceInternational Journal of Infectious Diseases 2016; 46: 116 doi: 10.1016/j.ijid.2016.03.012
514
Margaret Robinson, Yang Tian, Nikos Pagratis, William E. Delaney. Screening of Hepatitis C Virus Inhibitors Using Genotype 1a HCV Replicon Cell LinesCurrent Protocols in Microbiology 2011; 22(1): 17.7.1 doi: 10.1002/9780471729259.mc1707s22
515
Infectious Causes of Cancer2018; : 106 doi: 10.1002/9780470753651.ch7
516
Paola Pizzillo, Piero Luigi Almasio, Donatella Ferraro, Antonio Craxì, Rosa Di Stefano. HCV genotypes in Sicily: Is there any evidence of a shift?Journal of Medical Virology 2009; 81(6): 1040 doi: 10.1002/jmv.21498
517
Alison B. Jazwinski, Andrew J. Muir. Emerging Therapies in Hepatitis C: Dawn of the Era of the Direct-Acting AntiviralsGastroenterology Clinics of North America 2011; 40(3): 481 doi: 10.1016/j.gtc.2011.06.005
518
Melissa Palmer, Peter B. Bongiorno. Textbook of Natural Medicine2013; : 1409 doi: 10.1016/B978-1-4377-2333-5.00171-1
519
Shu Nishikori, Kenji Takemoto, Shinji Kamisuki, Syo Nakajima, Kouji Kuramochi, Senko Tsukuda, Masashi Iwamoto, Yuri Katayama, Takahiro Suzuki, Susumu Kobayashi, Koichi Watashi, Fumio Sugawara. Anti-hepatitis C Virus Natural Product from a Fungus, Penicillium herqueiJournal of Natural Products 2016; 79(2): 442 doi: 10.1021/acs.jnatprod.5b00555
520
V. M. Fleming, G. Harcourt, E. Barnes, P. Klenerman. Virological footprint of CD4+ T-cell responses during chronic hepatitis C virus infectionJournal of General Virology 2010; 91(6): 1396 doi: 10.1099/vir.0.017699-0
521
Snawar Hussain, Naina Barretto, Susan L Uprichard. New hepatitis C virus drug discovery strategies and model systemsExpert Opinion on Drug Discovery 2012; 7(9): 849 doi: 10.1517/17460441.2012.711312
522
Ryan Buchanan, Kathryn L. Nash. Hepatitis CMedicine 2015; 43(10): 607 doi: 10.1016/j.mpmed.2015.07.008
523
Rohan J. Meshram, Rajesh N. Gacche. Effective epitope identification employing phylogenetic, mutational variability, sequence entropy, and correlated mutation analysis targeting NS5B protein of hepatitis C virus: from bioinformatics to therapeuticsJournal of Molecular Recognition 2015; 28(8): 492 doi: 10.1002/jmr.2466
524
Perrine Roux, Jean‐Marie Le Gall, Marie Debrus, Camélia Protopopescu, Khadim Ndiaye, Baptiste Demoulin, Caroline Lions, Aurelie Haas, Marion Mora, Bruno Spire, Marie Suzan‐Monti, Maria Patrizia Carrieri. Innovative community‐based educational face‐to‐face intervention to reduce HIV, hepatitis C virus and other blood‐borne infectious risks in difficult‐to‐reach people who inject drugs: results from the ANRS–AERLI intervention studyAddiction 2016; 111(1): 94 doi: 10.1111/add.13089
525
Yanli Zeng, Wei Li, Jingtao Li, Junjie Wang, Bin Zhou, Jian Zhang, Shuwen Liu, Yingsong Wu, Jinlin Hou, Yuanping Zhou. Hepatitis C virus amino acid sequence diversity correlates with the outcome of combined interferon/ribavirin therapy in Chinese patients with chronic hepatitis CArchives of Virology 2012; 157(6): 1113 doi: 10.1007/s00705-012-1283-1
526
Jean Marie Ntaganda, Mahamat Saleh Daoussa Haggar, Benjamin Mampassi. Fuzzy Logic Strategy for Solving an Optimal Control Problem of Therapeutic Hepatitis C Virus DynamicsOpen Journal of Applied Sciences 2015; 5(09): 527 doi: 10.4236/ojapps.2015.59051
527
Kairi Mansberg, Karin Kull, Riina Salupere, Tiina Prükk, Benno Margus, Toomas Kariis, Triin Remmel, Külliki Suurmaa, Kristi Ott, Krista Jaago, Jelena Šmidt. A Population-Based Surveillance Study on the Epidemiology of Hepatitis C in EstoniaMedicina 2018; 54(1): 9 doi: 10.3390/medicina54010009
528
Soraya Abad, Almudena Vega, Diego Rincón, Eduardo Hernández, Evangelina Mérida, Nicolás Macías, Raquel Muñoz, Mónica Milla, Jose Luño, Juan Manuel López-Gómez. Eficacia de los antivirales de acción directa en la infección por el virus de la hepatitis C en pacientes en hemodiálisisNefrología 2017; 37(2): 158 doi: 10.1016/j.nefro.2016.10.003
529
Paul Y. Kwo. Boceprevir: a novel nonstructural 3 (NS3) protease inhibitor for the treatment of chronic hepatitis C infectionTherapeutic Advances in Gastroenterology 2012; 5(3): 179 doi: 10.1177/1756283X11436317
530
Philippe Gallay. Handbook of Antimicrobial Resistance2017; : 59 doi: 10.1007/978-1-4939-0694-9_3
531
Danielle Scher, Enes Kanlic, Julia Bader, Melchor Ortiz, Amr Abdelgawad. Hepatitis C Viral Infection as an Associated Risk Factor for Necrotizing FasciitisOrthopedics 2012; 35(4): e510 doi: 10.3928/01477447-20120327-43
532
Adriana Sánchez-García, Clara Patricia Ríos-Ibarra, Ana Rosa Rincón-Sánchez, Rocío Ortiz-López, Aurora Garza-Juárez, Jesús Morlett-Chávez, Herminia Martínez-Rodríguez, Ana María Rivas-Estilla. Use of proteomic analysis tools to identify HCV-proteins down-regulated by acetylsalicylic acidAnnals of Hepatology 2013; 12(5): 725 doi: 10.1016/S1665-2681(19)31313-4
533
V A Malov, E A Ubeeva, I P Ubeeva, S M Nikolaev, K T Umbetova. Treatment of chronic viral hepatitis C with direct acting antiviral agent: reviewTerapevticheskii arkhiv 2019; 91(11): 86 doi: 10.26442/00403660.2019.11.000307
534
Koji Wada, Derek R. Smith, Tomohiro Ishimaru. Reluctance to care for patients with HIV or hepatitis B / C in JapanBMC Pregnancy and Childbirth 2016; 16(1) doi: 10.1186/s12884-016-0822-2
535
Hiam Chemaitelly, Karima Chaabna, Laith J. Abu-Raddad, Massimo Ciccozzi. The Epidemiology of Hepatitis C Virus in the Fertile Crescent: Systematic Review and Meta-AnalysisPLOS ONE 2015; 10(8): e0135281 doi: 10.1371/journal.pone.0135281
536
Eric G Hilgenfeldt, Alex Schlachterman, Roberto J Firpi. Hepatitis C: Treatment of difficult to treat patientsWorld Journal of Hepatology 2015; 7(15): 1953-1963 doi: 10.4254/wjh.v7.i15.1953
537
Akosua Adom Agyeman, Richard Ofori-Asenso, Andy Mprah, George Ashiagbor. Epidemiology of hepatitis C virus in Ghana: a systematic review and meta-analysisBMC Infectious Diseases 2016; 16(1) doi: 10.1186/s12879-016-1708-7
538
F N Germano, C A dos Santos, G Honscha, A Strasburg, B Gabbi, R A Mendoza-Sassi, E A Soares, H N Seuánez, M A Soares, A M B Martínez. Prevalence of hepatitis C virus among users attending a voluntary testing centre in Rio Grande, southern Brazil: predictive factors and hepatitis C virus genotypesInternational Journal of STD & AIDS 2010; 21(7): 466 doi: 10.1258/ijsa.2009.009089
539
Junko Matsuo, Masaaki Mizui, Hajime Okita, Keiko Katayama, Shiomi Aimitsu, Tatsuro Sakata, Makoto Obayashi, Toshio Nakanishi, Kazuaki Chayama, Yuzo Miyakawa, Hiroshi Yoshizawa, Junko Tanaka. Follow up of the 987 blood donors found with hepatitis C virus infection over 9-18 yearsHepatology Research 2012; 42(7): 637 doi: 10.1111/j.1872-034X.2012.00966.x
540
Mo Guan, Wenbo Wang, Xiaoqing Liu, Yimin Tong, Yuan Liu, Hao Ren, Shiying Zhu, Jean Dubuisson, Thomas F. Baumert, Yongzhe Zhu, Haoran Peng, Laure Aurelian, Ping Zhao, Zhongtian Qi. Three Different Functional Microdomains in the Hepatitis C Virus Hypervariable Region 1 (HVR1) Mediate Entry and Immune EvasionJournal of Biological Chemistry 2012; 287(42): 35631 doi: 10.1074/jbc.M112.382341
541
Erica Southgate. Discourse, Power, and Resistance Down UnderTransgressions 2012; 88: 135 doi: 10.1007/978-94-6209-037-8_11
542
Pratima Dibba, Rosann Cholankeril, Andrew Li, Meera Patel, Mariam Fayek, Christy Dibble, Nnenna Okpara, Autumn Hines, Aijaz Ahmed. Hepatitis C in PregnancyDiseases 2018; 6(2): 31 doi: 10.3390/diseases6020031
543
Harold Ariel Muñoz Díaz, Adán José Lúquez Mindiola, Andrés José Gómez Aldana. Fisiopatología de la hepatitis C y diabetes mellitus. Hacia la cura de dos epidemias en el siglo XXIRevista Colombiana de Gastroenterología 2019; 34(3): 277 doi: 10.22516/25007440.322
544
Dita Broz, Lawrence J. Ouellet. Prevalence and Correlates of Former Injection Drug Use Among Young Noninjecting Heroin Users in ChicagoSubstance Use & Misuse 2010; 45(12): 2000 doi: 10.3109/10826081003682875
545
Issifou Yaya, Perrine Roux, Fabienne Marcellin, Linda Wittkop, Laure Esterle, Bruno Spire, Stéphanie Dominguez, Boni Armand Elegbe, Lionel Piroth, Philippe Sogni, Dominique Salmon-Ceron, Maria Patrizia Carrieri, Yury E. Khudyakov. Evolution of patients’ socio-behavioral characteristics in the context of DAA: Results from the French ANRS CO13 HEPAVIH cohort of HIV-HCV co-infected patientsPLOS ONE 2018; 13(7): e0199874 doi: 10.1371/journal.pone.0199874
546
Sabrina de Brito Ramalho Luz Ferrão, José Fernando de Castro Figueiredo, Clara Fumiko Tachibana Yoshida, Afonso Dinis Costa Passos. Prevalência elevada de hepatite C no distrito de Botafogo, cidade de Bebedouro, interior do Estado de São Paulo, Brasil, 2007Cadernos de Saúde Pública 2009; 25(2): 460 doi: 10.1590/S0102-311X2009000200025
547
Karim Si-Tayeb, Jean-Charles Duclos-Vallée, Marie-Anne Petit. Hepatocyte-like cells differentiated from human induced pluripotent stem cells (iHLCs) are permissive to hepatitis C virus (HCV) infection: HCV study gets personalJournal of Hepatology 2012; 57(3): 689 doi: 10.1016/j.jhep.2012.04.012
548
Volker Lohmann. Hepatitis C virus cell culture models: an encomium on basic research paving the road to therapy developmentMedical Microbiology and Immunology 2019; 208(1): 3 doi: 10.1007/s00430-018-0566-x
549
Qaisar Ali, Arshad Jamal, Muhammad Imran, Sajjad Ullah, Irfan Kalam, Shafi Ullah, Ahmed B Waqar. Correlation ofIL28B rs12979860 genotype and gender with spontaneous clearance of HCV infection: a Pakistani cross-section studyPersonalized Medicine 2018; 15(6): 495 doi: 10.2217/pme-2018-0016
550
Xi Chen. Commercial plasma donation and individual health in impoverished rural ChinaHealth Economics Review 2014; 4(1) doi: 10.1186/s13561-014-0030-6
551
Markus S. Kupka. ReproduktionsmedizinSpringer Reference Medizin 2019; : 1 doi: 10.1007/978-3-662-55601-6_42-2
552
T. Masaki, S. Matsunaga, H. Takahashi, K. Nakashima, Y. Kimura, M. Ito, M. Matsuda, A. Murayama, T. Kato, H. Hirano, Y. Endo, S. M. Lemon, T. Wakita, T. Sawasaki, T. Suzuki. Involvement of Hepatitis C Virus NS5A Hyperphosphorylation Mediated by Casein Kinase I-  in Infectious Virus ProductionJournal of Virology 2014; 88(13): 7541 doi: 10.1128/JVI.03170-13
553
Aldemir B. Oliveira-Filho, Leila Sawada, Laine C. Pinto, Daiane Locks, Santana L. Bahia, I. Brasil-Costa, José Alexandre R. Lemos. HCV infection among cocaine users in the state of Pará, Brazilian AmazonArchives of Virology 2013; 158(7): 1555 doi: 10.1007/s00705-013-1627-5
554
Daniel Fuster, Jordi Tor, Celestino Rey-Joly, Robert Muga. Interacciones patogénicas entre alcohol y hepatitis CMedicina Clínica 2012; 138(14): 627 doi: 10.1016/j.medcli.2011.04.019
555
Ivo Ditah, Badr Al Bawardy, Humberto C Gonzalez, Behnam Saberi, Callistus Ditah, Patrick S Kamath, Michael Charlton. Lack of Health Insurance Limits the Benefits of Hepatitis C Virus Screening: Insights from the National Health and Nutrition Examination Hepatitis C Follow-Up StudyAmerican Journal of Gastroenterology 2015; 110(8): 1126 doi: 10.1038/ajg.2015.31
556
Mwumvaneza Mutagoma, Helene Balisanga, Dieudonné Sebuhoro, Aimable Mbituyumuremyi, Eric Remera, Samuel S. Malamba, David J. Riedel, Sabin Nsanzimana. Hepatitis C virus and HIV co-infection among pregnant women in RwandaBMC Infectious Diseases 2017; 17(1) doi: 10.1186/s12879-017-2269-0
557
Dinesh Manvar, Talita de A. Fernandes, Jorge L.O. Domingos, Erdenechimeg Baljinnyam, Amartya Basu, Eurides F.T. Junior, Paulo R.R. Costa, Neerja Kaushik-Basu. Synthesis and biological evaluation of α-aryl-α-tetralone derivatives as hepatitis C virus inhibitorsEuropean Journal of Medicinal Chemistry 2015; 93: 51 doi: 10.1016/j.ejmech.2015.01.057
558
Felicidade Mota Pereira, Maria Alice Sant'ana Zarife, Eliana Almeida Gomes Reis, Mitermayer G. Reis. Indeterminate RIBA results were associated with the absence of hepatitis C virus RNA (HCV-RNA) in blood donorsRevista da Sociedade Brasileira de Medicina Tropical 2014; 47(1): 12 doi: 10.1590/0037-8682-0222-2013
559
Thippawan Chuenchitra, Ram Rangsin, Khunakorn Kana, Sakol Eiumtrakul, Ekachai Sunantarod, Anchalee Jatapai, Kenrad E. Nelson. Prevalence and Risk Factors for Hepatitis C Virus Infection among Young Thai MenThe American Journal of Tropical Medicine and Hygiene 2010; 83(2): 433 doi: 10.4269/ajtmh.2010.09-0749
560
Da-Jun Zhang, Wen-Fang Sun, Zhao-Jin Zhong, Rong-Mei Gao, Hong Yi, Yu-Huan Li, Zong-Gen Peng, Zhuo-Rong Li. Synthesis and Broad-Spectrum Antiviral Activity of Some Novel Benzo-Heterocyclic Amine CompoundsMolecules 2014; 19(1): 925 doi: 10.3390/molecules19010925
561
Ricardo Recarey, Juan Cristina. Bayesian Coalescent Analysis of the Intra-Host Evolution of Hepatitis C Virus: Memory Genomes and Clinical ImplicationsNatural Science 2014; 6(09): 615 doi: 10.4236/ns.2014.69061
562
Zaina Al Kanaani, Sarwat Mahmud, Silva P. Kouyoumjian, Laith J. Abu-Raddad. The epidemiology of hepatitis C virus in Pakistan: systematic review and meta-analysesRoyal Society Open Science 2018; 5(4): 180257 doi: 10.1098/rsos.180257
563
Nargiza Kurbanova, Rehan Qayyum. Association of Hepatitis C Virus Infection with Proteinuria and Glomerular Filtration RateClinical and Translational Science 2015; 8(5): 421 doi: 10.1111/cts.12321
564
Filippo Ansaldi, Andrea Orsi, Laura Sticchi, Bianca Bruzzone, Giancarlo Icardi. Hepatitis C virus in the new era: Perspectives in epidemiology, prevention, diagnostics and predictors of response to therapyWorld Journal of Gastroenterology 2014; 20(29): 9633-9652 doi: 10.3748/wjg.v20.i29.9633
565
Sandro da Costa Ferreira, Marcos de Vasconcelos Carneiro, Fernanda Fernandes Souza, Andreza Corrêa Teixeira, Marcia Guimarães Villanova, José Fernando de Castro Figueiredo, Afonso Dinis Costa Passos, Leandra Naira Zambelli Ramalho, Sergio Zucoloto, Ana de Lourdes Candolo Martinelli. Long-term follow-up of patients with chronic hepatitis C with sustained virologic response to interferonThe Brazilian Journal of Infectious Diseases 2010; 14(4): 330 doi: 10.1016/S1413-8670(10)70070-2
566
Mirjam Kretzschmar, Lucas Wiessing. New challenges for mathematical and statistical modeling of HIV and hepatitis C virus in injecting drug usersAIDS 2008; 22(13): 1527 doi: 10.1097/QAD.0b013e3282ff6265
567
Raf Crabbé, Grégoire Vuagniaux, Jean-Maurice Dumont, Valérie Nicolas-Métral, Judith Marfurt, Laura Novaroli. An evaluation of the cyclophilin inhibitor Debio 025 and its potential as a treatment for chronic hepatitis CExpert Opinion on Investigational Drugs 2009; 18(2): 211 doi: 10.1517/13543780802651583
568
Stephanie Pfaender, Stephanie Walter, Daniel Todt, Patrick Behrendt, Juliane Doerrbecker, Benno Wölk, Michael Engelmann, Ute Gravemann, Axel Seltsam, Joerg Steinmann, Peter D. Burbelo, Frank Klawonn, Karsten Feige, Thomas Pietschmann, Jessika-M. V. Cavalleri, Eike Steinmann. Assessment of cross-species transmission of hepatitis C virus-related non-primate hepacivirus in a population of humans at high risk of exposure Journal of General Virology 2015; 96(9): 2636 doi: 10.1099/vir.0.000208
569
Shafquat M. Rafiq, Harunor Rashid, Elizabeth Haworth, Robert Booy. Hazards of hepatitis at the HajjTravel Medicine and Infectious Disease 2009; 7(4): 239 doi: 10.1016/j.tmaid.2008.09.008
570
Dahee Kim, Ja-Il Goo, Mi Kim, Sung-Jin Lee, Moonju Choi, Thoa Than, Phuong Nguyen, Marc Windisch, Kyeong Lee, Yongseok Choi, Choongho Lee. Suppression of Hepatitis C Virus Genome Replication and Particle Production by a Novel Diacylglycerol Acyltransferases InhibitorMolecules 2018; 23(8): 2083 doi: 10.3390/molecules23082083
571
Liesl M. Hagan, Ana Kasradze, Stephanie J. Salyer, Amiran Gamkrelidze, Maia Alkhazashvili, Gvantsa Chanturia, Nazibrola Chitadze, Roena Sukhiashvili, Marina Shakhnazarova, Steven Russell, Curtis Blanton, Giorgi Kuchukhidze, Davit Baliashvili, Susan Hariri, Stephen Ko, Paata Imnadze, Jan Drobeniuc, Juliette Morgan, Francisco Averhoff. Hepatitis C prevalence and risk factors in Georgia, 2015: setting a baseline for eliminationBMC Public Health 2019; 19(S3) doi: 10.1186/s12889-019-6784-3
572
Nana Wu, Qinjuan Ge, Qingchuan Feng, Jun Zhang, Xiaoxia Liu, Caihong Sun, Yongkang Xu, Guangli He, Chiyu Zhang. High Prevalence of Hepatitis C virus Among Injection Drug Users in Zhenjiang, Jiangsu, ChinaIndian Journal of Virology 2011; 22(2): 77 doi: 10.1007/s13337-011-0041-4
573
Tamer A. Hafez. Hepatitis C in Developing Countries2018; : 25 doi: 10.1016/B978-0-12-803233-6.00003-5
574
Hosam Zaghloul, Mahmoud El-shahat. Recombinase polymerase amplification as a promising tool in hepatitis C virus diagnosisWorld Journal of Hepatology 2014; 6(12): 916-922 doi: 10.4254/wjh.v6.i12.916
575
Miguel Cordero-Coma, Raquel Salazar-Méndez, Taygan Yilmaz. Treatment of severe non-infectious uveitis in high-risk conditions (Part 2): systemic infections; management and safety issuesExpert Opinion on Drug Safety 2015; 14(9): 1353 doi: 10.1517/14740338.2015.1061992
576
Marc G. Ghany, Christopher M. Walker, Patrizia Farci. The Liver2020; : 868 doi: 10.1002/9781119436812.ch65
577
A. C. A. CULASSO, N. ALOISI, M. CANDELA, R. H. CAMPOS, P. BARÉ. Intrafamilial transmission of hepatitis C virus in patients with severe haemophilia AHaemophilia 2012; 18(5): 824 doi: 10.1111/j.1365-2516.2012.02792.x
578
Ming-Ju Hsieh, Mu-Kuan Chen, Chih-Jung Chen, Ming-Chang Hsieh, Yu-Sheng Lo, Yi-Ching Chuang, Hui-Ling Chiou, Shun-Fa Yang. Glabridin induces apoptosis and autophagy through JNK1/2 pathway in human hepatoma cellsPhytomedicine 2016; 23(4): 359 doi: 10.1016/j.phymed.2016.01.005
579
T P Rozina, T M Ignatova, S V Fastovets, E E Starostina, L M Samokhodskaia, T N Krasnova. The first experience of non-interferon therapy of HCV infection in patients with Wilson-Konovalov’s diseaseTerapevticheskii arkhiv 2018; 90(11): 74 doi: 10.26442/terarkh201890114-78
580
Feng Qu, Su-Jun Zheng, Cai-Sheng Wu, Zhi-Xin Jia, Jin-Lan Zhang, Zhong-Ping Duan. Lipidomic profiling of plasma in patients with chronic hepatitis C infectionAnalytical and Bioanalytical Chemistry 2014; 406(2): 555 doi: 10.1007/s00216-013-7479-8
581
Doa’a A. Saleh, Fatma M. Shebl, Samer S. El-Kamary, Laurence S. Magder, Alif Allam, Mohamed Abdel-Hamid, Nabiel Mikhail, Mohamed Hashem, Soraya Sharaf, Sonia K. Stoszek, G. Thomas Strickland. Incidence and risk factors for community-acquired hepatitis C infection from birth to 5 years of age in rural Egyptian childrenTransactions of the Royal Society of Tropical Medicine and Hygiene 2010; 104(5): 357 doi: 10.1016/j.trstmh.2010.01.009
582
Basmattee Boodram, Ronald C. Hershow, Scott J. Cotler, Lawrence J. Ouellet. Chronic hepatitis C virus infection and increases in viral load in a prospective cohort of young, HIV-uninfected injection drug usersDrug and Alcohol Dependence 2011; 119(3): 166 doi: 10.1016/j.drugalcdep.2011.06.005
583
Yan Xu, Qi Zhang. Stem Cells and Cancer in Hepatology2018; : 317 doi: 10.1016/B978-0-12-812301-0.00015-3
584
Helen Caldwell. Preventing, identifying and treating hepatitis CNursing Standard 2019; 34(1): 68 doi: 10.7748/ns.2018.e11321
585
Abdelfattah M. Attallah, Mohamed M. Omran, Wesam A. Nasif, Mohamed F. Ghaly, Abd El-Raheem R. El-Shanshoury, Mohga S. Abdalla, Hayat M. Sharada, Khaled Farid, Wageh El-Shony, El-Sayed M. Moussa, Ehab B. El-Domany, Eman Nour, Ibrahim Eldosoky. Diagnostic Performances of Hepatitis C Virus-NS4 Antigen in Patients with Different Liver PathologiesArchives of Medical Research 2012; 43(7): 555 doi: 10.1016/j.arcmed.2012.09.010
586
Ioannis Mylonas, Stefan Wirth. Infektionserkrankungen der Schwangeren und des Neugeborenen2013; : 129 doi: 10.1007/978-3-540-78325-1_12
587
Pornpun Vivithanaporn, Krista Nelles, Leah DeBlock, Stephen C. Newman, M. John Gill, Christopher Power. Hepatitis C virus co-infection increases neurocognitive impairment severity and risk of death in treated HIV/AIDSJournal of the Neurological Sciences 2012; 312(1-2): 45 doi: 10.1016/j.jns.2011.08.025
588
Ruben Hernaez, Hsin-Chieh Yeh, Mariana Lazo, Hui-Ming Chung, James P. Hamilton, Ayman Koteish, James J. Potter, Frederick L. Brancati, Jeanne M. Clark. Elevated ALT and GGT predict all-cause mortality and hepatocellular carcinoma in Taiwanese male: a case-cohort studyHepatology International 2013; 7(4): 1040 doi: 10.1007/s12072-013-9476-6
589
P. Simmonds. Medical Microbiology2012; : 537 doi: 10.1016/B978-0-7020-4089-4.00067-6
590
B. E. Pickett, R. Striker, E. J. Lefkowitz. Evidence for separation of HCV subtype 1a into two distinct cladesJournal of Viral Hepatitis 2011; 18(9): 608 doi: 10.1111/j.1365-2893.2010.01342.x
591
F. Giudici, B. Bertisch, F. Negro, G. Stirnimann, B. Müllhaupt, D. Moradpour, A. Cerny, O. Keiser. Access to therapy and therapy outcomes in the Swiss Hepatitis C Cohort Study: a person-centred approachJournal of Viral Hepatitis 2016; 23(9): 697 doi: 10.1111/jvh.12535
592
Hongbo Chen, Yinan Yao, Yifan Wang, Hua Zhou, Tianxiang Xu, Jing Liu, Guocheng Wang, Yongfeng Zhang, Xiang Chen, Qingwei Liu, Peng Huang, Rongbin Yu. Polymorphisms of HLA-DM on Treatment Response to Interferon/Ribavirin in Patients with Chronic Hepatitis C Virus Type 1 InfectionInternational Journal of Environmental Research and Public Health 2016; 13(10): 1030 doi: 10.3390/ijerph13101030
593
Alexandre Martins Portelinha Filho, Charles Ulloffo do Nascimento, Talita Nicastro Tannouri, Charlene Troiani, Eloah Lopes Ascêncio, Renata Bonfim, Lourdes Aparecida Zampieri D'Andrea, Luiz Euribel Prestes-Carneiro. Seroprevalence of HBV, HCV and HIV co-infection in selected individuals from state of São Paulo, BrazilMemórias do Instituto Oswaldo Cruz 2009; 104(7): 960 doi: 10.1590/S0074-02762009000700003
594
F. Baghbani-arani, F. Roohvandv, M. R. Aghasadeghi, A. Eidi, S. Amini, F. Motevalli, S. M. Sadat, A. Memarnejadian, G. Khalili. Expression and characterization of Escherichia coli derived hepatitis C virus ARFP/F proteinMolecular Biology 2012; 46(2): 226 doi: 10.1134/S0026893312020033
595
Marie-Claire Kleinegris, Ger H. Koek, Kelly Mast, Eveline H.C. Mestrom, Jef L.N. Wolfs, Edouard M. Bevers. Ribavirin-induced externalization of phosphatidylserine in erythrocytes is predominantly caused by inhibition of aminophospholipid translocase activityEuropean Journal of Pharmacology 2012; 693(1-3): 1 doi: 10.1016/j.ejphar.2012.07.041
596
Mohammad Kargar, Ahzam Askari, Abbas Doosti, Sadegh Ghorbani-Dalini. Loop-Mediated Isothermal Amplification Assay for Rapid Detection of Hepatitis C virusIndian Journal of Virology 2012; 23(1): 18 doi: 10.1007/s13337-012-0067-2
597
Yuan-Ming Lee, Huang-Jie Lin, Yen-Ju Chen, Cheng-Ming Lee, Sheng-Fan Wang, Kai-Yuan Chang, Tzu-Lang Chen, Hsin-Fu Liu, Yi-Ming Arthur Chen. Molecular epidemiology of HCV genotypes among injection drug users in Taiwan: Full-length sequences of two new subtype 6w strains and a recombinant form_2b6wJournal of Medical Virology 2010; 82(1): 57 doi: 10.1002/jmv.21658
598
Soraya Abad, Almudena Vega, Diego Rincón, Eduardo Hernández, Evangelina Mérida, Nicolás Macías, Raquel Muñoz, Mónica Milla, Jose Luño, Juan Manuel López-Gómez. Effectiveness of direct-acting antivirals in Hepatitis C virus infection in haemodialysis patientsNefrología (English Edition) 2017; 37(2): 158 doi: 10.1016/j.nefroe.2017.04.010
599
Victoria L Demetriou, Leondios G Kostrikis. Molecular epidemiology of hepatitis C infection in Cyprus within the general population and high-risk cohortsBMC Research Notes 2011; 4(1) doi: 10.1186/1756-0500-4-468
600
Freke Zuure, Susan Hahné, Thijs van de Laar, Maria Prins, Jim van Steenbergen. Modern Infectious Disease EpidemiologyStatistics for Biology and Health 2009; : 333 doi: 10.1007/978-0-387-93835-6_19
601
Laura Pacini, Rita Graziani, Linda Bartholomew, Raffaele De Francesco, Giacomo Paonessa. Naturally Occurring Hepatitis C Virus Subgenomic Deletion Mutants Replicate Efficiently in Huh-7 Cells and Are trans-Packaged In Vitro To Generate Infectious Defective ParticlesJournal of Virology 2009; 83(18): 9079 doi: 10.1128/JVI.00308-09
602
Celeste Reker, K.M. Islam. Risk factors associated with high prevalence rates of hepatitis C infection in EgyptInternational Journal of Infectious Diseases 2014; 25: 104 doi: 10.1016/j.ijid.2014.02.003
603
Vladimir Alexei Morozov, Sylvie Lagaye. Hepatitis C virus: Morphogenesis, infection and therapyWorld Journal of Hepatology 2018; 10(2): 186-212 doi: 10.4254/wjh.v10.i2.186
604
Z. Dimitrova, D. S. Campo, S. Ramachandran, G. Vaughan, L. Ganova-Raeva, Y. Lin, J. C. Forbi, G. Xia, P. Skums, B. Pearlman, Y. Khudyakov. Assessments of intra- and inter-host diversity of hepatitis C virus using Next Generation Sequencing and Mass spectrometry2011 IEEE International Conference on Bioinformatics and Biomedicine Workshops (BIBMW) 2011; : 79 doi: 10.1109/BIBMW.2011.6112358
605
Kulanthaivel Langeswaran, Subbaraj Gowtham Kumar, Srinivasan Perumal, Rajendran Revathy, Maruthaiveeran Periyasamy Balasubramaniam. Limonin – A citrus limonoid, establish anticancer potential by stabilizing lipid peroxidation and antioxidant status against N-nitrosodiethylamine induced experimental hepatocellular carcinomaBiomedicine & Preventive Nutrition 2013; 3(2): 165 doi: 10.1016/j.bionut.2013.03.006
606
Xhevat Jakupi, Maja M. Lunar, Jana Mlakar, Ivana Matković, Norma P. Tavakoli, Beti Zafirova Ivanovska, Adriana Vince, Mario Poljak. HCV Infection among Injecting Drug Users in Prishtina, KosovoHepatitis Monthly 2018; (In Press) doi: 10.5812/hepatmon.80189
607
Markus S. Kupka. ReproduktionsmedizinSpringer Reference Medizin 2020; : 421 doi: 10.1007/978-3-662-57636-6_42
608
Francisco M. Averhoff, Nancy Glass, Deborah Holtzman. Global Burden of Hepatitis C: Considerations for Healthcare Providers in the United StatesClinical Infectious Diseases 2012; 55(suppl_1): S10 doi: 10.1093/cid/cis361
609
Shakti Singh, Satish Vedi, Subodh Kumar Samrat, Wen Li, Rakesh Kumar, Babita Agrawal, Clive M. Gray. Heterologous Immunity between Adenoviruses and Hepatitis C Virus: A New Paradigm in HCV Immunity and VaccinesPLOS ONE 2016; 11(1): e0146404 doi: 10.1371/journal.pone.0146404
610
Birke Bartosch. Hepatitis C virus and its complex interplay with hepatic glucose and lipid metabolismJournal of Hepatology 2009; 50(5): 845 doi: 10.1016/j.jhep.2009.02.009
611
M. Estée Török. Manson's Tropical Infectious Diseases2014; : 112 doi: 10.1016/B978-0-7020-5101-2.00014-5
612
David Campo, Zoya Dimitrova, Yuri Khudyakov. Bioinformatics Research and ApplicationsLecture Notes in Computer Science 2008; 4983: 146 doi: 10.1007/978-3-540-79450-9_14
613
E. Crouchet, R. Saad, C. Affolter-Zbaraszczuk, J. Ogier, T. F. Baumert, C. Schuster, F. Meyer. Composite vector formulation for multiple siRNA delivery as a host targeting antiviral in a cell culture model of hepatitis C virus (HCV) infectionJournal of Materials Chemistry B 2017; 5(4): 858 doi: 10.1039/C6TB01718E
614
Hana Arshad, Subha Malik. Exploring Perception of Chronic Hepatitis C: An Idiographic Case StudyPakistan Journal of Psychological Research 2020; 34(4): 735 doi: 10.33824/PJPR.2019.34.4.40
615
Philippe A. Gallay. Cyclophilin InhibitorsClinics in Liver Disease 2009; 13(3): 403 doi: 10.1016/j.cld.2009.05.002
616
Jessica Wagoner, Amina Negash, Olivia J. Kane, Laura E. Martinez, Yaakov Nahmias, Nigel Bourne, David M. Owen, Joe Grove, Claire Brimacombe, Jane A. McKeating, Eve-Isabelle Pécheur, Tyler N. Graf, Nicholas H. Oberlies, Volker Lohmann, Feng Cao, John E. Tavis, Stephen J. Polyak. Multiple effects of silymarin on the hepatitis C virus lifecycleHepatology 2010; 51(6): 1912 doi: 10.1002/hep.23587
617
A. L. Baron, A. Schoeniger, P. Becher, C. Baechlein, J.-H. James Ou. Mutational Analysis of the Bovine Hepacivirus Internal Ribosome Entry SiteJournal of Virology 2018; 92(15) doi: 10.1128/JVI.01974-17
618
Seyed Moayed Alavian, Kamran Bagheri Lankarani, Seyed Hossein Aalaei-Andabili, Ali Pouryasin, Nasser Ebrahimi Daryani, Mohsen Nassiri Toosi, Reza Malekzadeh, Mohammad Reza Zali, Mino Mohraz. Treatment of Chronic Hepatitis C Infection: Update of the Recommendations from Scientific Leader’s Meeting-28th July 2011-Tehran, IR IranHepatitis Monthly 2011; 11(9): 703 doi: 10.5812/kowsar.1735143X.501
619
Samar K. Darweesh, Ayman Yosry, Mohammed Salah, Naglaa Zayed, Ahmad Khairy, Abubakr Awad, Mahasen Mabrouk, Ahmed Albuhairi. Acoustic radiation forced impulse-based splenic prediction model using data mining for the noninvasive prediction of esophageal varices in hepatitis C virus advanced fibrosisEuropean Journal of Gastroenterology & Hepatology 2019; 31(12): 1533 doi: 10.1097/MEG.0000000000001458
620
A. Birerdinc, A. Afendy, M. Stepanova, I. Younossi, G. Manyam, A. Baranova, Z. M. Younossi. Functional pathway analysis of genes associated with response to treatment for chronic hepatitis CJournal of Viral Hepatitis 2010; 17(10): 730 doi: 10.1111/j.1365-2893.2009.01235.x
621
Lindsay A. Uribe, Peter Bacchetti, Nicholas Gelman, Esteban Burchard, Mark Fitch, Marc Hellerstein, Mandana Khalili. Impact of Moderate Alcohol Discontinuation on Insulin Action and Secretion in Latinos With and Without Hepatitis CAlcoholism: Clinical and Experimental Research 2018; 42(3): 492 doi: 10.1111/acer.13576
622
Michael Houghton. Prospects for prophylactic and therapeutic vaccines against the hepatitis C virusesImmunological Reviews 2011; 239(1): 99 doi: 10.1111/j.1600-065X.2010.00977.x
623
Marina Matas, Antònia Picornell, Carmen Cifuentes, Antoni Payeras, Antoni Bassa, Francesc Homar, Fernando González-Candelas, F. Xavier López-Labrador, Andrés Moya, Maria M. Ramon, José A. Castro. Generalized Linear Model (GLM) framework for the association of host variables and viral strains with liver fibrosis in HCV/HIV coinfected patientsInfection, Genetics and Evolution 2013; 13: 284 doi: 10.1016/j.meegid.2012.10.020
624
Hiam Chemaitelly, Sarwat Mahmud, Ghina R. Mumtaz, Lenka Benova, Houssein H. Ayoub, Silva P. Kouyoumjian, Zaina Al-Kanaani, Laith J. Abu-Raddad. Handbook of Healthcare in the Arab World2019; : 1 doi: 10.1007/978-3-319-74365-3_138-1
625
Alireza Akbarzadeh Baghban, Asma Pourhoseingholi, Farid Zayeri, Ali Akbar Jafari, Seyed Moayed Alavian. Application of Zero-Inflated Poisson Mixed Models in Prognostic Factors of Hepatitis CBioMed Research International 2013; 2013: 1 doi: 10.1155/2013/403151
626
Keith A. Berggren, Saori Suzuki, Alexander Ploss. Animal Models Used in Hepatitis C Virus ResearchInternational Journal of Molecular Sciences 2020; 21(11): 3869 doi: 10.3390/ijms21113869
627
Xiao-Min Wu, Cheng Jin, Yuan-Long Gu, Wu-Qiang Chen, Mao-Qun Zhu, Shuo Zhang, Zhen Zhang. <p>Gluconokinase IDNK Promotes Cell Proliferation and Inhibits Apoptosis in Hepatocellular Carcinoma</p>OncoTargets and Therapy 2020; : 1767 doi: 10.2147/OTT.S234055
628
Krisztina Hagymási, János Fehér. The effect of body weight reduction on the effectivity of combined peginterferon and ribavirin treatment in chronic HCV hepatitisOrvosi Hetilap 2008; 149(46): 2189 doi: 10.1556/oh.2008.28493
629
Rubenilson Caldas Valois, Luciana Maria Cunha Maradei-Pereira, José Ângelo Barletta Crescente, Aldemir Branco de Oliveira-Filho, José Alexandre Rodrigues Lemos. HCV INFECTION THROUGH PERFORATING AND CUTTING MATERIAL AMONG CANDIDATES FOR BLOOD DONATION IN BELÉM, BRAZILIAN AMAZONRevista do Instituto de Medicina Tropical de São Paulo 2014; 56(6): 511 doi: 10.1590/S0036-46652014000600010
630
Mohamed Emam, Mohamed I. Radwan, Mohamed M. Refaey, Noha E. Shaheen, Safaa Abd-ElMoez, Marian A. Gerges. Prevalence of hepatitis C virus in an elderly population in rural areas of Sharkia governorate, EgyptEgyptian Liver Journal 2015; 5(2): 29 doi: 10.1097/01.ELX.0000463678.53334.c7
631
Mudassar Imran, Hassan Rafique, Adnan Khan, Tufail Malik. A model of bi-mode transmission dynamics of hepatitis C with optimal controlTheory in Biosciences 2014; 133(2): 91 doi: 10.1007/s12064-013-0197-0
632
Nidhi Vaid, Katherine M. Langan, Richard J. Maude. Post-exposure prophylaxis in resource-poor settings: review and recommendations for pre-departure risk assessment and planning for expatriate healthcare workersTropical Medicine & International Health 2013; 18(5): 588 doi: 10.1111/tmi.12080
633
Anil C. Anand. Treatment of chronic hepatitis C: What is new?Apollo Medicine 2014; 11(2): 93 doi: 10.1016/j.apme.2014.05.003
634
Sarwat Mahmud, Vajiheh Akbarzadeh, Laith J. Abu-Raddad. The epidemiology of hepatitis C virus in Iran: Systematic review and meta-analysesScientific Reports 2018; 8(1) doi: 10.1038/s41598-017-18296-9
635
Louise Geddes, Jenny Iversen, Handan Wand, Aryan Esmaeili, Judith Tsui, Margaret Hellard, Gregory Dore, Jason Grebely, Paul Dietze, Julie Bruneau, Maria Prins, Megan D Morris, Naglaa H Shoukry, Andrew R Lloyd, Arthur Y Kim, Georg Lauer, Andrea L Cox, Kimberly Page, Lisa Maher. Sex Discrepancies in the Protective Effect of Opioid Agonist Therapy on Incident Hepatitis C InfectionClinical Infectious Diseases 2020; 70(1): 123 doi: 10.1093/cid/ciz162
636
Arthur Zimmermann. Tumors and Tumor-Like Lesions of the Hepatobiliary Tract2017; : 2931 doi: 10.1007/978-3-319-26956-6_164
637
Sk Md Mosaddek Hossain, Sumanta Ray, Tabassum Sultana Tannee, Anirban Mukhopadhyay. Analyzing Prognosis Characteristics of Hepatitis C using a Biclustering Based ApproachProcedia Computer Science 2017; 115: 282 doi: 10.1016/j.procs.2017.09.136
638
Gerald Friedland. Infectious Disease Comorbidities Adversely Affecting Substance Users With HIV: Hepatitis C and TuberculosisJAIDS Journal of Acquired Immune Deficiency Syndromes 2010; 55: S37 doi: 10.1097/QAI.0b013e3181f9c0b6
639
Wenlian Li, Hongzong Si, Yang Li, Cuizhu Ge, Fucheng Song, Xiuting Ma, Yunbo Duan, Honglin Zhai. 3D-QSAR and molecular docking studies on designing inhibitors of the hepatitis C virus NS5B polymeraseJournal of Molecular Structure 2016; 1117: 227 doi: 10.1016/j.molstruc.2016.03.073
640
Mohamed El-Mesery, Mohammed El-Mowafy, Abdelaziz Elgaml, Laila F. Youssef, Sally Y. Abed. Correlation of Serum Soluble Fibrinogen-Like Protein 2 with Soluble FAS Ligand and Interferon Gamma in Egyptian Hepatitis C Virus-Infected Patients and Hepatocellular Carcinoma PatientsJournal of Interferon & Cytokine Research 2017; 37(8): 342 doi: 10.1089/jir.2016.0128
641
F DeWolfe Miller, Mahmoud S Elzalabany, Sara Hassani, Diego F Cuadros. Epidemiology of hepatitis C virus exposure in Egypt: Opportunities for prevention and evaluationWorld Journal of Hepatology 2015; 7(28): 2849-2858 doi: 10.4254/wjh.v7.i28.2849
642
Tatiana Martins, Janaína Luz Narciso-Schiavon, Leonardo de Lucca Schiavon. Epidemiology of hepatitis C virus infectionRevista da Associação Médica Brasileira (English Edition) 2011; 57(1): 105 doi: 10.1016/S2255-4823(11)70024-8
643
Irshad ur Rehman, Gilberto Vaughan, Michael A. Purdy, Guo-liang Xia, Joseph C. Forbi, Livia Maria Gonçalves Rossi, Sadia Butt, Muhammad Idrees, Yury E. Khudyakov. Genetic history of hepatitis C virus in PakistanInfection, Genetics and Evolution 2014; 27: 318 doi: 10.1016/j.meegid.2014.08.005
644
Edgar Turner Overton, Judith A. Aberg. HIV and Liver Disease2012; : 151 doi: 10.1007/978-1-4419-1712-6_17
645
Leila MMB Pereira, Celina MT Martelli, Regina C Moreira, Edgar Merchan-Hamman, Airton T Stein, Regina Maria A Cardoso, Gerusa M Figueiredo, Ulisses R Montarroyos, Cynthia Braga, Marília D Turchi, Gabriela Coral, Deborah Crespo, Maria Luiza C Lima, Luis Claudio A Alencar, Marcelo Costa, Alex A dos Santos, Ricardo AA Ximenes. Prevalence and risk factors of Hepatitis C virus infection in Brazil, 2005 through 2009: a cross-sectional studyBMC Infectious Diseases 2013; 13(1) doi: 10.1186/1471-2334-13-60
646
Marina Matas, Antònia Picornell, Carmen Cifuentes, Antoni Payeras, Antoni Bassa, Francesc Homar, F. Xavier López-Labrador, Andrés Moya, Maria M. Ramon, José A. Castro. Relating the liver damage with hepatitis C virus polymorphism in core region and human variables in HIV-1-coinfected patientsInfection, Genetics and Evolution 2010; 10(8): 1252 doi: 10.1016/j.meegid.2010.08.009
647
Juan Cristina, Ricardo Recarey. Identification of MicroRNA-Like Molecules Derived from the Antigenome RNA of Hepatitis C Virus: A Bioinformatics ApproachNatural Science 2016; 8(04): 180 doi: 10.4236/ns.2016.84021
648
Azza Masoud Abdelbaky Ahmed, Hanan Abdelftah Temerk, Hamdi Ramdan Galal, Shamardan Ezzeldin S. Bazeed, Serageldeen Sultan. The seropervelance of infectious hepatitis viruses (HBV, HCV and HEV) among blood donors and their correlation to risk factors in Qena governorate, Upper EgyptVirusDisease 2020;  doi: 10.1007/s13337-020-00589-9
649
XIAO-RONG MAO, LI-TING ZHANG, HONG CHEN, PING XIAO, YOU-CHENG ZHANG. Correlation between the genetic variations in interleukin 28B and chronic hepatitis C virus genotypes in the Chinese populationMolecular Medicine Reports 2014; 10(2): 1037 doi: 10.3892/mmr.2014.2242
650
Philippe Roingeard, Marion Depla. The birth and life of lipid droplets: learning from the hepatitis C virusBiology of the Cell 2011; 103(5): 223 doi: 10.1042/BC20100119
651
Jia-Horng Kao, Ming-Lung Yu, Cheng-Yuan Peng, Jeong Heo, Chi-Jen Chu, Ting-Tsung Chang, Youn-Jae Lee, Tsung-Hui Hu, Ki Tae Yoon, Seung Woon Paik, Young Suk Lim, Sang Hoon Ahn, Vasily Isakov, Fiona McPhee, Wenhua Hu, Eugene Scott Swenson, Philip D Yin, Michelle Treitel. Daclatasvir/asunaprevir/beclabuvir, all-oral, fixed-dose combination for patients with chronic hepatitis C virus genotype 1Journal of Gastroenterology and Hepatology 2017; 32(12): 1998 doi: 10.1111/jgh.13796
652
Gamal Badr, Nathalie Bédard, Mohamed S. Abdel-Hakeem, Lydie Trautmann, Bernard Willems, Jean-Pierre Villeneuve, Elias K. Haddad, Rafick P. Sékaly, Julie Bruneau, Naglaa H. Shoukry. Early Interferon Therapy for Hepatitis C Virus Infection Rescues Polyfunctional, Long-Lived CD8+ Memory T CellsJournal of Virology 2008; 82(20): 10017 doi: 10.1128/JVI.01083-08
653
Nicolas Khatmi, Lionel Dany, Khadim Ndiaye, Patrizia Carrieri, Daniela Rojas Castro, Perrine Roux. Impact of an educational intervention on risks associated with drug injection, and on psychosocial factors (PSF) involved in initiating and maintaining new health behaviors over timeAddictive Behaviors 2018; 87: 222 doi: 10.1016/j.addbeh.2018.07.007
654
ReferencesKidney International Supplements 2012; 2(2): 259 doi: 10.1038/kisup.2012.30
655
Juliane Liese, Behnaz Ahangarian Abhari, Simone Fulda. Smac mimetic and oleanolic acid synergize to induce cell death in human hepatocellular carcinoma cellsCancer Letters 2015; 365(1): 47 doi: 10.1016/j.canlet.2015.04.018
656
Jessica Liu, Hwai-I Yang, Mei-Hsuan Lee, Wan-Lun Hsu, Hui-Chi Chen, Chien-Jen Chen. Infection and Cancer: Bi-Directorial Interactions2015; : 23 doi: 10.1007/978-3-319-20669-1_3
657
Javier Briceño, Ruben Ciria, María Pleguezuelo, Manuel de la Mata, Jordi Muntané, Álvaro Naranjo, Juan Sánchez-Hidalgo, Trinidad Marchal, Sebastián Rufián, Pedro López-Cillero. Impact of donor graft steatosis on overall outcome and viral recurrence after liver transplantation for hepatitis C virus cirrhosisLiver Transplantation 2009; 15(1): 37 doi: 10.1002/lt.21566
658
Rabiei Maryam, Mansour-Ghanaei Fariborz, Massoudi R. Hosein, Golshekan Hadi. Oral conditions in hepatitis C virus-infected Iranian patients: a case-control studyJournal of Investigative and Clinical Dentistry 2012; 3(3): 203 doi: 10.1111/j.2041-1626.2012.00121.x
659
Sara Ashtari, Mohsen Vahedi, Mohammad Amin Pourhoseingholi, Maryam Karkhane, Zahra Kimiia, Asma Pourhoseingholi, Azadeh Safaee, Bijan Moghimi-Dehkordi, Mohammad Reza Zali, Seyed Moayed Alavian. Direct Medical Care Costs Associated With Patients Diagnosed With Chronic HCVHepatitis Monthly 2013; 13(4) doi: 10.5812/hepatmon.8415
660
Vadim Brjalin, Riina Salupere, Tatjana Tallo, Tatiana Kuznetsova, Ljudmilla Priimägi, Valentina Tefanova. Efficacy of Peginterferon alfa-2a and Ribavirin Combination Therapy in Treatment-naive Estonian Patients with Chronic Hepatitis CCentral European Journal of Public Health 2012; 20(2): 150 doi: 10.21101/cejph.a3706
661
Malik Muhammad Sohail. Belief in God’s Help During Hepatitis C: A Qualitative Study on Muslim Patients in PakistanJournal of Religion and Health 2020; 59(2): 928 doi: 10.1007/s10943-018-0700-5
662
Fei Zhao, Jin Zhao, Lei Song, Ya-Qing Zhang, Zhong Guo, Ke-Hu Yang. The induction of apoptosis and autophagy in human hepatoma SMMC-7721 cells by combined treatment with vitamin C and polysaccharides extracted from Grifola frondosa Apoptosis 2017; 22(11): 1461 doi: 10.1007/s10495-017-1421-z
663
Marco Pompei, Maria Emilia Di Francesco, Silvia Pesci, Uwe Koch, Sue Ellen Vignetti, Maria Veneziano, Paola Pace, Vincenzo Summa. Novel P2–P4 macrocyclic inhibitors of HCV NS3/4A protease by P3 succinamide fragment depeptidization strategyBioorganic & Medicinal Chemistry Letters 2010; 20(1): 168 doi: 10.1016/j.bmcl.2009.11.005
664
Joseph S. Doyle, Rachel Sacks-Davis, Margaret E. Hellard. Acute Hepatitis C Infection: New Approaches to Surveillance, Treatment and PreventionCurrent Hepatitis Reports 2012; 11(4): 221 doi: 10.1007/s11901-012-0143-5
665
Garima Jindal, Dibyendu Mondal, Arieh Warshel. Exploring the Drug Resistance of HCV ProteaseThe Journal of Physical Chemistry B 2017; 121(28): 6831 doi: 10.1021/acs.jpcb.7b04562
666
Z. M. Younossi, M. Stepanova, F. Nader, Z. Younossi, E. Elsheikh. Associations of chronic hepatitis C with metabolic and cardiac outcomesAlimentary Pharmacology & Therapeutics 2013; 37(6): 647 doi: 10.1111/apt.12234
667
Jorge T. Insua. Is There a Need for Cluster Hepatitis B and C Epidemiological Studies in the Region?: YesCurrent Hepatitis Reports 2013; 12(4): 288 doi: 10.1007/s11901-013-0188-0
668
Kenji Ikeda, Yasuji Arase, Yusuke Kawamura, Hiromi Yatsuji, Hitomi Sezaki, Tetsuya Hosaka, Norio Akuta, Masahiro Kobayashi, Satoshi Saitoh, Fumitaka Suzuki, Yoshiyuki Suzuki, Hiromitsu Kumada. Necessities of Interferon Therapy in Elderly Patients with Chronic Hepatitis CThe American Journal of Medicine 2009; 122(5): 479 doi: 10.1016/j.amjmed.2008.09.045
669
Anuli Nwaohiri, Sarah Schillie, Marc Bulterys, Athena P. Kourtis. Hepatitis C virus infection in children: How do we prevent it and how do we treat it?Expert Review of Anti-infective Therapy 2018; 16(9): 689 doi: 10.1080/14787210.2018.1509707
670
Takeshi SAITO, Michael Gale Jr.. RIG-I mediated hepatic innate immune signaling that controls HCV infection.Uirusu 2008; 58(2): 105 doi: 10.2222/jsv.58.105
671
Rajesh Shah. Hepatitis C Nosode: The preparation and homeopathic pathogenetic trialHomeopathy 2013; 102(3): 207 doi: 10.1016/j.homp.2013.02.002
672
Jean-François Gélinas, Thomas Fabre, Philippe Willems, Reynold C. Leung, Jacob George, Bernard Willems, Julie Bruneau, Naglaa H. Shoukry. IL28B SNP screening and distribution in the French Canadian population using a rapid PCR-based testImmunogenetics 2013; 65(6): 397 doi: 10.1007/s00251-013-0688-7
673
Silvia Martina Ferrari, Poupak Fallahi, Alessandro Antonelli, Salvatore Benvenga. Environmental Issues in Thyroid DiseasesFrontiers in Endocrinology 2017; 8 doi: 10.3389/fendo.2017.00050
674
Jian Cao, Dawei Li. Searching for human oncoviruses: Histories, challenges, and opportunitiesJournal of Cellular Biochemistry 2018; 119(6): 4897 doi: 10.1002/jcb.26717
675
Jyoti Barokar, Allen McCutchan, Reena Deutsch, Bin Tang, Mariana Cherner, Ajay R. Bharti. Neurocognitive impairment is worse in HIV/HCV-coinfected individuals with liver dysfunctionJournal of NeuroVirology 2019; 25(6): 792 doi: 10.1007/s13365-019-00767-6
676
Paul Y. Kwo, Maaz B. Badshah. New hepatitis C virus therapiesCurrent Opinion in Organ Transplantation 2015; 20(3): 235 doi: 10.1097/MOT.0000000000000198
677
Joseph Kluck, Rose M. O’Flynn, David E. Kaplan, Kyong-Mi Chang. Evaluation of the Significance of Pretreatment Liver Biopsy and Baseline Mental Health Disorder Diagnosis on Hepatitis C Treatment Completion Rates at a Veterans Affairs Medical CenterHepatitis Research and Treatment 2013; 2013: 1 doi: 10.1155/2013/653976
678
Livia Maria Gonçalves Rossi, Alejandro Escobar-Gutierrez, Paula Rahal. Multiregion deep sequencing of hepatitis C virus: An improved approach for genetic relatedness studiesInfection, Genetics and Evolution 2016; 38: 138 doi: 10.1016/j.meegid.2015.12.020
679
Tim J Benstead, Colin H Chalk, Natalie E Parks. Treatment for cryoglobulinemic and non-cryoglobulinemic peripheral neuropathy associated with hepatitis C virus infectionCochrane Database of Systematic Reviews 2014;  doi: 10.1002/14651858.CD010404.pub2
680
Ndiémé Ndongo-Thiam, Pascale Berthillon, Elisabeth Errazuriz, Isabelle Bordes, Sylvie De Sequeira, Christian Trépo, Marie-Anne Petit. Long-term propagation of serum hepatitis C virus (HCV) with production of enveloped HCV particles in human HepaRG hepatocytesHepatology 2011; 54(2): 406 doi: 10.1002/hep.24386
681
Silvia Bassani Schuch-Goi, Juliana Nichterwitz Scherer, Felix Henrique Paim Kessler, Anne Orgler Sordi, Flavio Pechansky, Lisia von Diemen. Hepatitis C: clinical and biological features related to different forms of cocaine useTrends in Psychiatry and Psychotherapy 2017; 39(4): 285 doi: 10.1590/2237-6089-2016-0076
682
Katherine J. Hahn, Anita Kohli, Zayani Sims, Shyamasundaran Kottilil. Durable Sustained Virologic Response After Oral Directly Acting Antiviral Therapy Despite Immunosuppressive TreatmentOpen Forum Infectious Diseases 2015; 2(3) doi: 10.1093/ofid/ofv091
683
Fiona McPhee, Yoshiyuki Suzuki, Joji Toyota, Yoshiyasu Karino, Kasuaki Chayama, Yoshiiku Kawakami, Min Lung Yu, Sang Hoon Ahn, Hiroki Ishikawa, Rafia Bhore, Nannan Zhou, Dennis Hernandez, Patricia Mendez, Hiromitsu Kumada. High Sustained Virologic Response to Daclatasvir Plus Asunaprevir in Elderly and Cirrhotic Patients with Hepatitis C Virus Genotype 1b Without Baseline NS5A PolymorphismsAdvances in Therapy 2015; 32(7): 637 doi: 10.1007/s12325-015-0221-5
684
Ozlen Atug, Hakan Akin, Yesim Ozen Alahdab, Berrin Ceyhan, Nurdan Tozun, Osman Ozdogan. Interstitial pneumonitis associated with pegylated interferon-alpha 2a and ribavirin for chronic hepatitis C infection: a case reportCases Journal 2009; 2(1) doi: 10.1186/1757-1626-2-6464
685
G. Mousseau, S. Kota, V. Takahashi, D. N. Frick, A. D. Strosberg. Dimerization-driven interaction of hepatitis C virus core protein with NS3 helicaseJournal of General Virology 2011; 92(1): 101 doi: 10.1099/vir.0.023325-0
686
Zohreh Sharifi, Mahmood Mahmoodian Shooshtari, Fahimeh Rangbar Kermani. Identification of HCV genotypes in HCV infected blood donorsIndian Journal of Microbiology 2010; 50(3): 275 doi: 10.1007/s12088-010-0059-0
687
Limin Chen, Shilin Li, Yujia Li, Xiaoqiong Duan, Bing Liu, Ian McGilvray. Ubiquitin-like protein modifiers and their potential for antiviral and anti-HCV therapyExpert Review of Proteomics 2013; 10(3): 275 doi: 10.1586/epr.13.15
688
Francisca Sosa-Jurado, Verónica L Hernández-Galindo, Daniel Meléndez-Mena, Miguel A Mendoza-Torres, Fernando J Martínez-Arroniz, Verónica Vallejo-Ruiz, Julio Reyes-Leyva, Gerardo Santos-López. Detection of hepatitis C virus RNA in saliva of patients with active infection not associated with periodontal or liver disease severityBMC Infectious Diseases 2014; 14(1) doi: 10.1186/1471-2334-14-72
689
Emilie Crouchet, Mathieu Lefèvre, Eloi R Verrier, Marine A Oudot, Thomas F Baumert, Catherine Schuster. Extracellular lipid-free apolipoprotein E inhibits HCV replication and induces ABCG1-dependent cholesterol effluxGut 2017; 66(5): 896 doi: 10.1136/gutjnl-2015-311289
690
Yasunori Yamaguchi, Akihiro Tamori, Yasuhito Tanaka, Shuji Iwai, Sawako Kobayashi, Hideki Fujii, Hiroyasu Morikawa, Atsushi Hagihara, Masaru Enomoto, Norifumi Kawada. Response-guided therapy for patients with chronic hepatitis who have high viral loads of hepatitis C virus genotype 2Hepatology Research 2012; 42(6): 549 doi: 10.1111/j.1872-034X.2011.00956.x
691
Tatjana Vilibic-Cavlek, Jasmina Kucinar, Bernard Kaic, Maja Vilibic, Nenad Pandak, Ljubo Barbic, Vladimir Stevanovic, Jasmina Vranes. Epidemiology of hepatitis C in Croatia in the European contextWorld Journal of Gastroenterology 2015; 21(32): 9476-9493 doi: 10.3748/wjg.v21.i32.9476
692
Habeeb Salameh, Maen Masadeh, Muhannad Al Hanayneh, Vincent Petros, Matthew Maslonka, Arjun Nanda, Ashwani K Singal. <i>PNPLA3</i> polymorphism increases risk for and severity of chronic hepatitis C liver diseaseWorld Journal of Hepatology 2016; 8(35): 1584-1592 doi: 10.4254/wjh.v8.i35.1584
693
Lillian Gelberg, Marjorie J. Robertson, Lisa Arangua, Barbara D. Leake, Gerald Sumner, Ardis Moe, Ronald M. Andersen, Hal Morgenstern, Adeline Nyamathi. Prevalence, Distribution, and Correlates of Hepatitis C Virus Infection among Homeless Adults in Los AngelesPublic Health Reports 2012; 127(4): 407 doi: 10.1177/003335491212700409
694
Joachim Lupberger, Nicolaas Van Renne, Thomas F. Baumert. Signaling Pathways in Liver Diseases2015; : 459 doi: 10.1002/9781118663387.ch34
695
Maria Teresa Catanese, Helenia Ansuini, Rita Graziani, Thierry Huby, Martine Moreau, Jonathan K. Ball, Giacomo Paonessa, Charles M. Rice, Riccardo Cortese, Alessandra Vitelli, Alfredo Nicosia. Role of Scavenger Receptor Class B Type I in Hepatitis C Virus Entry: Kinetics and Molecular Determinants Journal of Virology 2010; 84(1): 34 doi: 10.1128/JVI.02199-08
696
Annunziata Faustini, Paola Colais, Emanuele Fabrizi, Anna Maria Bargagli, Marina Davoli, Domenico Di Lallo, Anteo Di Napoli, Patrizio Pezzotti, Chiara Sorge, Rita Grillo, Carla Maresca, Olga Recchia, Carlo A Perucci. Hepatic and extra-hepatic sequelae, and prevalence of viral hepatitis C infection estimated from routine data in at-risk groupsBMC Infectious Diseases 2010; 10(1) doi: 10.1186/1471-2334-10-97
697
Satarupa Sengupta, Eleanor Powell, Ling Kong, Jason T. Blackard, Gulam Waris. Effects of HCV on Basal and Tat-Induced HIV LTR ActivationPLoS ONE 2013; 8(6): e64956 doi: 10.1371/journal.pone.0064956
698
Tatiana Martins, Danubia Felippe Grassi de Paula Machado, Fabiana Schuelter-Trevisol, Daisson Jose Trevisol, Roger Augusto Vieira e Silva, Janaina Luz Narciso-Schiavon, Leonardo de Lucca Schiavon. Prevalence and factors associated with HCV infection among elderly individuals in a southern Brazilian cityRevista da Sociedade Brasileira de Medicina Tropical 2013; 46(3): 281 doi: 10.1590/0037-8682-0026-2013
699
Atika Mansoor, Lubna Ali, Noor-ul Sabah, Asraf Hussain Hashmi, Mohammad Haroon Khan, Syed Ali Raza Kazmi, Nafees Ahmad, Saima Siddiqi, Khalid Mehmood Khan. Study of PKRBD in HCV genotype 3a infected patients in response to interferon therapy in Pakistani populationVirology Journal 2013; 10(1) doi: 10.1186/1743-422X-10-352
700
Ivo Ditah, Fausta Ditah, Pardha Devaki, Oforbuike Ewelukwa, Chobufo Ditah, Basile Njei, Henry N. Luma, Michael Charlton. The changing epidemiology of hepatitis C virus infection in the United States: National health and nutrition examination survey 2001 through 2010Journal of Hepatology 2014; 60(4): 691 doi: 10.1016/j.jhep.2013.11.014
701
Markus S. Kupka. ReproduktionsmedizinSpringer Reference Medizin 2019; : 1 doi: 10.1007/978-3-662-55601-6_42-1
702
Giuseppe Indolfi, Elisa Bartolini, Chiara Azzari, Laura Becciolini, Maria Moriondo, Maurizio de Martino, Massimo Resti. Intrafamilial transmission of hepatitis C virus: Infection of the father predicts the risk of perinatal transmissionJournal of Medical Virology 2008; 80(11): 1907 doi: 10.1002/jmv.21316
703
Leila Sawada, Andréia Cristina Costa Pinheiro, Daiane Locks, Adriana do Socorro Coelho Pimenta, Priscila Rocha Rezende, Deborah Maia Crespo, José Ângelo Barletta Crescente, José Alexandre Rodrigues de Lemos, Aldemir Branco de Oliveira Filho. Distribution of hepatitis C virus genotypes among different exposure categories in the State of Pará, Brazilian AmazonRevista da Sociedade Brasileira de Medicina Tropical 2011; 44(1): 8 doi: 10.1590/S0037-86822011000100003
704
XIAO-HUA JIANG, YU-TAO XIE, BO JIANG, MENG-YING TANG, TAO MA, HUA PENG. Inhibition of expression of hepatitis C virus 1b genotype core and NS4B genes in HepG2 cells using artificial microRNAsMolecular Medicine Reports 2015; 12(2): 1905 doi: 10.3892/mmr.2015.3571
705
Antoine Abou Rached, Selim Abou Kheir, Jowana Saba, Walid Ammar. Epidemiology of hepatitis B and hepatitis C in LebanonArab Journal of Gastroenterology 2016; 17(1): 29 doi: 10.1016/j.ajg.2016.01.002
706
Fangfang Chen, Dingyong Sun, Yuming Guo, Wei Guo, Zhengwei Ding, Peilong Li, Jie Li, Lin Ge, Ning Li, Dongmin Li, Zhe Wang, Lu Wang, Ravi Jhaveri. Spatiotemporal Scan and Age-Period-Cohort Analysis of Hepatitis C Virus in Henan, China: 2005–2012PLOS ONE 2015; 10(6): e0129746 doi: 10.1371/journal.pone.0129746
707
Maria A. Sorbera, Michelle L. Friedman, Rebecca Cope. New and Emerging Evidence on the Use of Second-Generation Direct Acting Antivirals for the Treatment of Hepatitis C Virus in Renal ImpairmentJournal of Pharmacy Practice 2017; 30(3): 359 doi: 10.1177/0897190016632128
708
Daniel J. Ruzicka, Jumpei Tetsuka, Go Fujimoto, Tatsuya Kanto. Comorbidities and co-medications in populations with and without chronic hepatitis C virus infection in Japan between 2015 and 2016BMC Infectious Diseases 2018; 18(1) doi: 10.1186/s12879-018-3148-z
709
Sedigheh Amini Kafi-abad, Houri Rezvan, Hassan Abolghasemi, Ali Talebian. Prevalence and trends of human immunodeficiency virus, hepatitis B virus, and hepatitis C virus among blood donors in Iran, 2004 through 2007Transfusion 2009; 49(10): 2214 doi: 10.1111/j.1537-2995.2009.02245.x
710
Salvador Fonseca-Coronado, Gilberto Vaughan, Mayra Yolanda Cruz-Rivera, Juan Carlos Carpio-Pedroza, Karina Ruiz-Tovar, Juan Alberto Ruiz-Pacheco, Alejandro Escobar-Gutiérrez. Interleukin-28B Genotyping by Melt-Mismatch Amplification Mutation Assay PCR Analysis Using Single Nucleotide Polymorphisms rs12979860 and rs8099917, a Useful Tool for Prediction of Therapy Response in Hepatitis C PatientsJournal of Clinical Microbiology 2011; 49(7): 2706 doi: 10.1128/JCM.00877-11
711
Mengping Liu, Maria Tuttle, Min Gao, Julie A. Lemm. Potency and Resistance Analysis of Hepatitis C Virus NS5B Polymerase Inhibitor BMS-791325 on All Major GenotypesAntimicrobial Agents and Chemotherapy 2014; 58(12): 7416 doi: 10.1128/AAC.03851-14
712
Norio Akuta, Joji Toyota, Yoshiyasu Karino, Fusao Ikeda, Akio Ido, Katsuaki Tanaka, Koichi Takaguchi, Atsushi Naganuma, Eiichi Tomita, Kazuaki Chayama, Shigetoshi Fujiyama, Yukiko Inada, Hitoshi Yoshiji, Hideaki Watanabe, Hiroki Ishikawa, Fiona McPhee, Stephanie Noviello, Hiromitsu Kumada. Potent viral suppression and improvements in alpha-fetoprotein and measures of fibrosis in Japanese patients receiving a daclatasvir/asunaprevir/beclabuvir fixed-dose combination for the treatment of HCV genotype-1 infectionJournal of Gastroenterology 2018; 53(9): 1089 doi: 10.1007/s00535-018-1445-3
713
Sunil Gupta, Scott A. Read, Nicholas A. Shackel, Lionel Hebbard, Jacob George, Golo Ahlenstiel. The Role of Micronutrients in the Infection and Subsequent Response to Hepatitis C VirusCells 2019; 8(6): 603 doi: 10.3390/cells8060603
714
L. C. Mendes, P. A. Ferreira, N. Miotto, L. Zanaga, E. S. L. Gonçales, M. N. Pedro, M. S. Lazarini, F. L. G. Júnior, R. S. B. Stucchi, A. G. Vigani. Elastogram quality assessment score in vibration-controlled transient elastography: Diagnostic performance compared to digital morphometric analysis of liver biopsy in chronic hepatitis CJournal of Viral Hepatitis 2018; 25(4): 335 doi: 10.1111/jvh.12822
715
Chin-Kai Tseng, Sung-Po Hsu, Chun-Kuang Lin, Yu-Hsuan Wu, Jin-Ching Lee, Kung-Chia Young. Celastrol inhibits hepatitis C virus replication by upregulating heme oxygenase-1 via the JNK MAPK/Nrf2 pathway in human hepatoma cellsAntiviral Research 2017; 146: 191 doi: 10.1016/j.antiviral.2017.09.010
716
Sudheesh Raveendran, Zhiyan Lu. A short review on early HCC: MRI findings and pathological diagnosisRadiology of Infectious Diseases 2018; 5(2): 91 doi: 10.1016/j.jrid.2017.08.008
717
Michael C. Sneller, Zonghui Hu, Carol A. Langford. A randomized controlled trial of rituximab following failure of antiviral therapy for hepatitis C virus-associated cryoglobulinemic vasculitisArthritis & Rheumatism 2012; 64(3): 835 doi: 10.1002/art.34322
718
Hafsa Aziz, Abida Raza, Javaid Irfan. Optimum predictors of therapeutic outcome in HCV patients in PakistanJournal of Medical Virology 2016; 88(1): 100 doi: 10.1002/jmv.24305
719
Udayan Chatterji, Jose A. Garcia-Rivera, James Baugh, Katarzyna Gawlik, Kelly A. Wong, Weidong Zhong, Clifford A. Brass, Nikolai V. Naoumov, Philippe A. Gallay. The Combination of Alisporivir plus an NS5A Inhibitor Provides Additive to Synergistic Anti-Hepatitis C Virus Activity without Detectable Cross-ResistanceAntimicrobial Agents and Chemotherapy 2014; 58(6): 3327 doi: 10.1128/AAC.00016-14
720
Siamak Salehi, Oliver D. Tavabie, Suman Verma, Mark J. W. McPhail, Farzin Farzaneh, William Bernal, Krish Menon, Kosh Agarwal, Varuna R. Aluvihare. Serum MicroRNA Signatures in Recovery From Acute and Chronic Liver Injury and Selection for Liver TransplantationLiver Transplantation 2020; 26(6): 811 doi: 10.1002/lt.25781
721
Matthew S. Paulson, Huiling Yang, I-hung Shih, Joy Y. Feng, Eric M. Mabery, Margaret F. Robinson, Weidong Zhong, William E. Delaney. Comparison of HCV NS3 protease and NS5B polymerase inhibitor activity in 1a, 1b and 2a replicons and 2a infectious virusAntiviral Research 2009; 83(2): 135 doi: 10.1016/j.antiviral.2009.04.003
722
Ahmed Mohammed Gaballah, Marwa Mohammed Esawy. Comparison of 2 different antibody assay methods, Elecsys Anti-HCVII (Roche) and Vidas Anti-HCV (Biomerieux), for the detection of antibody to hepatitis C virus in EgyptDiagnostic Microbiology and Infectious Disease 2018; 92(2): 107 doi: 10.1016/j.diagmicrobio.2018.05.013
723
Karin Nielsen, Hester J. Scheffer, M. Petrousjka van den Tol, Anders Nilsson. Irreversible Electroporation in Clinical Practice2018; : 139 doi: 10.1007/978-3-319-55113-5_10
724
V. Bekker, S. J. Chanock, M. Yeager, A. A. Hutchinson, T. von Hahn, S. Chen, N. Xiao, M. Dotrang, M. Brown, M. P. Busch, B. R. Edlin, C. M. Rice, T. R. O’Brien. Genetic variation inCLDN1and susceptibility to hepatitis C virus infectionJournal of Viral Hepatitis 2010; 17(3): 192 doi: 10.1111/j.1365-2893.2009.01166.x
725
S. Fonseca-Coronado, A. Escobar-Gutierrez, K. Ruiz-Tovar, M. Y. Cruz-Rivera, P. Rivera-Osorio, M. Vazquez-Pichardo, J. C. Carpio-Pedroza, J. A. Ruiz-Pacheco, F. Cazares, G. Vaughan. Specific Detection of Naturally Occurring Hepatitis C Virus Mutants with Resistance to Telaprevir and Boceprevir (Protease Inhibitors) among Treatment-Naive Infected IndividualsJournal of Clinical Microbiology 2012; 50(2): 281 doi: 10.1128/JCM.05842-11
726
Fabian Elgner, Huimei Ren, Regina Medvedev, Daniela Ploen, Kiyoshi Himmelsbach, Klaus Boller, Eberhard Hildt, J.-H. J. Ou. The Intracellular Cholesterol Transport Inhibitor U18666A Inhibits the Exosome-Dependent Release of Mature Hepatitis C VirusJournal of Virology 2016; 90(24): 11181 doi: 10.1128/JVI.01053-16
727
Aya Mostafa, Sylvia M. Taylor, Mai El-Daly, Mostafa El Hoseiny, Iman Bakr, Naglaa Arafa, Valérie Thiers, François Rimlinger, Mohamed Abdel-Hamid, Arnaud Fontanet, Mostafa K. Mohamed. Is the hepatitis C virus epidemic over in Egypt? Incidence and risk factors of new hepatitis C virus infectionsLiver International 2010; 30(4): 560 doi: 10.1111/j.1478-3231.2009.02204.x
728
George Boon-Bee Goh, Wan-Cheng Chow, Renwei Wang, Jian-Min Yuan, Woon-Puay Koh. Coffee, alcohol and other beverages in relation to cirrhosis mortality: The Singapore Chinese Health StudyHepatology 2014; 60(2): 661 doi: 10.1002/hep.27054
729
Joanna Bladowska, Brygida Knysz, Anna Zimny, Krzysztof Małyszczak, Anna Kołtowska, Paweł Szewczyk, Jacek Gąsiorowski, Michał Furdal, Marek J. Sąsiadek, Linda Chao. Value of Perfusion-Weighted MR Imaging in the Assessment of Early Cerebral Alterations in Neurologically Asymptomatic HIV-1-Positive and HCV-Positive PatientsPLoS ONE 2014; 9(7): e102214 doi: 10.1371/journal.pone.0102214
730
F. Nascimento, E. Borba, A. Philipi, A.C. Guimarães, R. Boff, P. Spada, A. Coitinho, C. Funchal, C. Dani. Leitura A Influência da Composição Corporal e Idade no Perfil Hepático e Prostático de Homens do Município de Flores da Cunha/RSCiência em Movimento - Biociências e Saúde 2013; 15(30): 9 doi: 10.15602/1983-9480/cmbs.v15n30p9-16
731
Claudia Palladino, Ifeanyi Jude Ezeonwumelu, Rute Marcelino, Verónica Briz, Inês Moranguinho, Fátima Serejo, José Fernando Velosa, Rui Tato Marinho, Pedro Borrego, Nuno Taveira. Epidemic history of hepatitis C virus genotypes and subtypes in PortugalScientific Reports 2018; 8(1) doi: 10.1038/s41598-018-30528-0
732
Francisca Monsalve-Castillo, Liliana Gómez-Gamboa, Leonor Chacín-Bonilla, Leticia Porto-Espinoza, Luciana Costa-León. Hepatitis C virus infection in hemodialysis patients in Maracaibo, VenezuelaRevista do Instituto de Medicina Tropical de São Paulo 2012; 54(1): 53 doi: 10.1590/S0036-46652012000100010
733
Myron John Tong, Patrick Weijen Chang, Thatcher Thi Huynh, Alexander Anthony Rosinski, Lori Terese Tong. Adverse events associated with ribavirin in sofosbuvir-based therapies for patients with chronic hepatitis C: A community practice experienceJournal of Digestive Diseases 2016; 17(2): 113 doi: 10.1111/1751-2980.12313
734
Charles S. Chasela, Patrick Wall, Jan Drobeniuc, Caroline C. King, Eyasu Teshale, Mina C. Hosseinipour, Sascha R. Ellington, Mary Codd, Denise J. Jamieson, Rodney J. Knight, Patricia Fitzpatrick, Athena P. Kourtis, Irving F. Hoffman, Dumbani Kayira, Noel Mumba, Deborah D. Kamwendo, Francis Martinson, William Powderly, Charles van der Horst, Saleem Kamili. Prevalence of hepatitis C virus infection among human immunodeficiency virus-1-infected pregnant women in Malawi: The BAN studyJournal of Clinical Virology 2012; 54(4): 318 doi: 10.1016/j.jcv.2012.05.003
735
Andrew T. Maynard, Christopher D. Roberts. Quantifying, Visualizing, and Monitoring Lead OptimizationJournal of Medicinal Chemistry 2016; 59(9): 4189 doi: 10.1021/acs.jmedchem.5b00948
736
Liesl M. Hagan, Raymond F. Schinazi. Best strategies for global HCV eradicationLiver International 2013; 33: 68 doi: 10.1111/liv.12063
737
Silmara Rodrigues Machado, Edison Roberto Parise, Luciana de Carvalho. Coffee has hepatoprotective benefits in Brazilian patients with chronic hepatitis C even in lower daily consumption than in American and European populationsThe Brazilian Journal of Infectious Diseases 2014; 18(2): 170 doi: 10.1016/j.bjid.2013.09.001
738
Daniel Fuster, Judith I. Tsui, Debbie M. Cheng, Emily K. Quinn, Carly Bridden, David Nunes, Howard Libman, Richard Saitz, Jeffrey H. Samet. Impact of Lifetime Alcohol Use on Liver Fibrosis in a Population of HIV-Infected Patients With and Without Hepatitis C CoinfectionAlcoholism: Clinical and Experimental Research 2013; 37(9): 1527 doi: 10.1111/acer.12129
739
Hiam Chemaitelly, Laith J. Abu-Raddad, F. DeWolfe Miller, Ravi Jhaveri. An Apparent Lack of Epidemiologic Association between Hepatitis C Virus Knowledge and the Prevalence of Hepatitis C Infection in a National Survey in EgyptPLoS ONE 2013; 8(7): e69803 doi: 10.1371/journal.pone.0069803
740
Tanaji T. Talele, Payal Arora, Shridhar S. Kulkarni, Maulik R. Patel, Satyakam Singh, Maksim Chudayeu, Neerja Kaushik-Basu. Structure-based virtual screening, synthesis and SAR of novel inhibitors of hepatitis C virus NS5B polymeraseBioorganic & Medicinal Chemistry 2010; 18(13): 4630 doi: 10.1016/j.bmc.2010.05.030
741
Vikas Saxena, Chao-Kuen Lai, Ti-Chun Chao, King-Song Jeng, Michael M. C. Lai. Annexin A2 Is Involved in the Formation of Hepatitis C Virus Replication Complex on the Lipid RaftJournal of Virology 2012; 86(8): 4139 doi: 10.1128/JVI.06327-11
742
Ponni V. Perumalswami, Robert S. Klein. Viral Infections of Humans2014; : 765 doi: 10.1007/978-1-4899-7448-8_33
743
Sanaa M. Kamal. Acute Hepatitis C: A Systematic Review.The American Journal of Gastroenterology 2008; 103(5): 1283 doi: 10.1111/j.1572-0241.2008.01825.x
744
Stephanie Jiménez Irausquin, Austin L. Hughes. Distinctive pattern of sequence polymorphism in the NS3 protein of hepatitis C virus type 1b reflects conflicting evolutionary pressures Journal of General Virology 2008; 89(8): 1921 doi: 10.1099/vir.0.2008/000992-0
745
Kenneth E. Sherman. Thymosin α 1 for treatment of hepatitis C virus: promise and proofAnnals of the New York Academy of Sciences 2010; 1194(1): 136 doi: 10.1111/j.1749-6632.2010.05460.x
746
E. G. GIANNINI, M. BASSO, V. SAVARINO, A. PICCIOTTO. Sustained virological response to pegylated interferon and ribavirin is maintained during long-term follow-up of chronic hepatitis C patientsAlimentary Pharmacology & Therapeutics 2010; 31(4): 502 doi: 10.1111/j.1365-2036.2009.04201.x
747
Paul Y Kwo, Maaz B. Badshah. Treatment of HCV in Patients who Failed First-Generation PI Therapy: a Review of Current LiteratureCurrent Gastroenterology Reports 2015; 17(10) doi: 10.1007/s11894-015-0462-0
748
I. A. Chekmazov, I. O. Ivanikov, G. V. Sapronov, N. Ch. Kirillova, N. N. Vinogradova. Liver cancer: etiology, pathogenesis, results of long-term clinical and epidemiological observationDokazatel'naya gastroenterologiya 2019; 8(1): 5 doi: 10.17116/dokgastro201980115
749
Aécio Flávio Meirelles de Souza, Fábio Heleno de Lima Pace, Júlio Maria Fonseca Chebli, Lincoln Eduardo Villela Vieira de Castro Ferreira. Insulin resistance in non-diabetic patients with chronic hepatitis C: what does it mean?Arquivos Brasileiros de Endocrinologia & Metabologia 2011; 55(6): 412 doi: 10.1590/S0004-27302011000600008
750
Jesmin Mondal, Jayeeta Das, Rajesh Shah, Anisur Rahman Khuda-Bukhsh. A homeopathic nosode, Hepatitis C 30 demonstrates anticancer effect against liver cancer cells in vitro by modulating telomerase and topoisomerase II activities as also by promoting apoptosis via intrinsic mitochondrial pathwayJournal of Integrative Medicine 2016; 14(3): 209 doi: 10.1016/S2095-4964(16)60251-0